{
    "filename": "pdf.pdf",
    "content_type": "application/pdf",
    "file_size": 2087627,
    "metadata": {
        "identifiers": {
            "doi": "10.3390/v12020244",
            "url": "https://www.mdpi.com/1999-4915/12/2/244/pdf"
        },
        "date": 2020,
        "title": "Systematic Comparison of Two Animal-to-Human Transmitted Human Coronaviruses: SARS-CoV-2 and SARS-CoV",
        "author": "Jiabao Xu, Shizhe Zhao, Tieshan Teng, Abualgasim Elgaili Abdalla, Wan Zhu, Longxiang Xie, Yunlong Wang, Xiangqian Guo",
        "affiliations": [
            "Department of Preventive Medicine, Institute of Biomedical Informatics, Bioinformatics Center, Henan Provincial Engineering Center for Tumor Molecular Medicine, School of Basic Medical Sciences, Henan University, Kaifeng 475004, China; xujiabao0907@126.com (J.X.); zhaoshizhe1126@126.com (S.Z.); xiaoshan1220@163.com (T.T.)",
            "Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Jouf University, Sakaka 2014, Saudi Arabia; gasimmicro@gmail.com",
            "Department of Anesthesia, Stanford University, Stanford, CA 94305, USA; ms.wanzhu@gmail.com",
            "Henan Bioengineering Research Center, Zhengzhou 450046, China",
            "Correspondence: xielongxiang123@126.com (L.X.); biowyl@126.com (Y.W.); xqguo@henu.edu.cn (X.G.);"
        ],
        "journal": "Viruses",
        "volume": "12",
        "abstract": "After the outbreak of the severe acute respiratory syndrome (SARS) in the world in 2003, human coronaviruses (HCoVs) have been reported as pathogens that cause severe symptoms in respiratory tract infections. Recently, a new emerged HCoV isolated from the respiratory epithelium of unexplained pneumonia patients in the Wuhan seafood market caused a major disease outbreak and has been named the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This virus causes acute lung symptoms, leading to a condition that has been named as \u201ccoronavirus disease 2019\u201d (COVID-19). The emergence of SARS-CoV-2 and of SARS-CoV caused widespread fear and concern and has threatened global health security. There are some similarities and differences in the epidemiology and clinical features between these two viruses and diseases that are caused by these viruses. The goal of this work is to systematically review and compare between SARS-CoV and SARS-CoV-2 in the context of their virus incubation, originations, diagnosis and treatment methods, genomic and proteomic sequences, and pathogenic mechanisms.",
        "keywords": [
            "coronaviruses",
            "SARS-CoV-2",
            "SARS-CoV",
            "genomic comparison",
            "proteomic comparison",
            "pathogenic mechanism",
            "clinical manifestations"
        ],
        "references": "@article{wang2006a,\n  author = {Wang, L.F. and Shi, Z. and Zhang, S. and Field, H. and Daszak, P. and Eaton, B.T.},\n  title = {Review of bats and SARS},\n  journal = {Emerg. Infect. Dis},\n  date = {2006},\n  volume = {12},\n  medium = {CrossRef},\n  language = {}\n}\n@article{ge2013a,\n  author = {Ge, X.-Y. and Li, J. and Yang, X.-L. and Chmura, A. and Zhu, G. and Epstein, J.H. and Mazet, J.K. and Hu, B. and Zhang, W. and Peng, C.},\n  title = {Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor},\n  journal = {Nature},\n  date = {2013},\n  volume = {503},\n  pages = {535\u2013538},\n  medium = {CrossRef-PubMed},\n  more-authors = {true},\n  language = {}\n}\n@article{chen2016a,\n  author = {Chen, Y. and Guo, D.},\n  title = {Molecular mechanisms of coronavirus RNA capping and methylation},\n  journal = {Virol. Sin},\n  date = {2016},\n  volume = {31},\n  pages = {3\u201311},\n  medium = {CrossRef-PubMed},\n  language = {}\n}\n@article{cui2019a,\n  author = {Cui, J. and Li, F. and Shi, Z.L.},\n  title = {Origin and evolution of pathogenic coronaviruses},\n  journal = {Nat. Rev. Microbiol},\n  date = {2019},\n  volume = {17},\n  pages = {181\u2013192},\n  medium = {CrossRef-PubMed},\n  language = {}\n}\n@article{cauchemez2013a,\n  author = {Cauchemez, S. and Van Kerkhove, M.D. and Riley, S. and Donnelly, C.A. and Fraser, C. and Ferguson, N.M.},\n  title = {Transmission scenarios for Middle East Respiratory Syndrome Coronavirus (MERS-CoV) and how to tell them apart},\n  journal = {Euro Surveill},\n  date = {2013},\n  volume = {18},\n  pages = {18},\n  language = {}\n}\n@CrossRef{gorbalenya-a,\n  author = {Gorbalenya, A.E. and Baker, S.C. and Baric, R.S. and de Groot, R.J. and Drosten, C. and Gulyaeva, A.A. and Haagmans, B.L. and Lauber, C. and Leontovich, A.M. and Neuman, B.W.},\n  title = {Severe acute respiratory syndrome-related coronavirus: The species and its viruses\u2014A statement of the Coronavirus Study Group. bioRxiv 2020},\n  medium = {CrossRef},\n  more-authors = {true},\n  language = {}\n}\n@misc{unknown-a,\n  title = {WHO Named the New Pneumonia \u201cCOVID-19\u201d},\n  url = {http://www.xinhuanet.com/world/202002/12/c_1125561389.htm},\n  unmatched-accessed = {(accessed on 12 February 2020).},\n  language = {},\n  urldate = {Available online:}\n}\n@article{guan2003a,\n  author = {Guan, Y. and Zheng, B.J. and He, Y.Q. and Liu, X.L. and Zhuang, Z.X. and Cheung, C.L. and Luo, S.W. and Li, P.H. and Zhang, L.J. and Butt, K.M.},\n  title = {Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China},\n  journal = {Science},\n  date = {2003},\n  volume = {302},\n  pages = {276\u2013278},\n  medium = {CrossRef},\n  more-authors = {true},\n  language = {}\n}\n@article{ki2015a,\n  author = {Ki, M.},\n  date = {2015},\n  title = {MERS outbreak in Korea: Hospital-to-hospital transmission},\n  journal = {Epidemiol. Health},\n  volume = {37},\n  pages = {37},\n  medium = {CrossRef},\n  language = {}\n}\n@article{azhar2014a,\n  author = {Azhar, E.I. and El-Kafrawy, S.A. and Farraj, S.A. and Hassan, A.M. and Al-Saeed, M.S. and Hashem, A.M. and Madani, T.A.},\n  title = {Evidence for camel-to-human transmission of MERS coronavirus},\n  journal = {N. Engl. J. Med},\n  date = {2014},\n  volume = {370},\n  pages = {2499\u20132505},\n  medium = {CrossRef},\n  language = {}\n}\n@article{chan-a,\n  author = {Chan, J.F.W. and Kok, K.H. and Zhu, Z. and Chu, H. and To, K.K.W. and Yuan, S. and Yuen, K.Y.},\n  title = {Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan},\n  journal = {Emerg. Microbes. Infect},\n  volume = {2020},\n  pages = {221\u2013236},\n  medium = {CrossRef},\n  number = {9},\n  language = {}\n}\n@article{zhao2019a,\n  author = {Zhao, W.M. and Song, S.H. and Chen, M.L. and Zou, D. and Ma, L.N. and Ma, Y.K. and Li, R.J. and Hao, L.L. and Li, C.P. and Tian, D.},\n  journal = {M.; et al. The},\n  date = {2019},\n  title = {Novel Coronavirus Resource},\n  volume = {2020},\n  pages = {1\u20139},\n  unmatched-journal = {Hereditas},\n  number = {36},\n  language = {}\n}\n@techreport{unknown-b,\n  url = {https://www.ncbi.nlm.nih.gov/pubmed/},\n  unmatched-accessed = {(accessed on 14 February 2020).},\n  urldate = {2019-nCoV. Available online:},\n  institution = {NCBI Database}\n}\n@misc{database2020a,\n  author = {Database, G.S.A.I.D.},\n  url = {https://www.gisaid.org/CoV2020/},\n  event = {on 14},\n  date = {2020-02},\n  urldate = {2020 Coronavirus. Available online:}\n}\n@techreport{unknown-c,\n  url = {https://blast.ncbi.nlm.nih.gov/Blast.cgi},\n  unmatched-accessed = {(accessed on 30 January 2020).},\n  urldate = {Available online:},\n  institution = {NCBI Blast}\n}\n@misc{zpicture-a,\n  author = {Zpicture},\n  url = {https://zpicture.dcode.org},\n  unmatched-accessed = {(accessed on 1 February 2020).},\n  urldate = {Available online:}\n}\n@article{kumar2016a,\n  author = {Kumar, S. and Stecher, G. and Tamura, K.},\n  title = {MEGA7: Molecular evolutionary genetics analysis version 7.0 for bigger datasets},\n  journal = {Mol. Biol. Evol},\n  date = {2016},\n  volume = {33},\n  pages = \"1870\u20131874.\" # \"11030\u201311035.\",\n  medium = {CrossRef},\n  unmatched-author = {18. Tamura, K.; Nei, M.; Kumar, S.},\n  source = {Prospects for inferring very large phylogenies by using the neighbor-joining method},\n  unmatched-journal = {Proc. Natl. Acad. Sci. USA},\n  unmatched-volume = {101,},\n  unmatched-pages = {11030\u201311035.},\n  unmatched-medium = {[CrossRef]},\n  unmatched-accessed = {[PubMed] 19.},\n  language = {},\n  urldate = {[PubMed]}\n}\n@article{cheng2007a,\n  author = {Cheng, V.C. and Lau, S.K. and Woo, P.C. and Yuen, K.Y.},\n  title = {Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection},\n  journal = {Clin. Microbiol. Rev},\n  date = {2007},\n  volume = {20},\n  pages = {660\u2013694},\n  medium = {CrossRef},\n  note = {full issue]. Wkly. Epidemiol. Rec},\n  unmatched-journal = {World Health Organization. Weekly Epidemiological Record,},\n  unmatched-volume = {vol. 88, 35},\n  language = {},\n  urldate = {[PubMed] 20.}\n}\n@article{lee2003a,\n  author = {Lee, N. and Hui, D.S. and Wu, A. and Chan, P.K.S. and Cameron, P. and Joynt, G. and Ahuja, A.T. and Yung, M.Y. and Leung, C. and To, K.},\n  title = {A major outbreak of severe acute respiratory syndrome in Hong Kong},\n  journal = {N. Engl. J. Med},\n  date = {2003},\n  volume = {348},\n  pages = {1986\u20131994},\n  medium = {CrossRef},\n  more-authors = {true},\n  language = {}\n}\n@article{poutanen2003a,\n  author = {Poutanen, S. and Low, N.E. and Henry, B. and Finkelstein, S. and Rose, D. and Green, K. and Tellier, R. and Draker, R. and Adachi, D. and Ayers, M.},\n  title = {Identification of severe acute respiratory syndrome in Canada},\n  journal = {N. Engl. J. Med},\n  date = {2003},\n  volume = {348},\n  pages = {1995\u20132005},\n  medium = {CrossRef},\n  more-authors = {true},\n  language = {}\n}\n@article{leo2003a,\n  author = {Leo, Y.S. and Chen, M. and Heng, B.H. and Lee, C.C.},\n  title = {Severe acute respiratory syndrome-Singapore, 2003},\n  journal = {MMWR Morb. Mortal. Wkly. Rep},\n  date = {2003},\n  volume = {52},\n  pages = {405},\n  language = {}\n}\n@misc{organization-a,\n  author = {Organization, World Health},\n  title = {Summary of Probable SARS Cases with Onset of Illness from 1 November 2002 to 31},\n  url = {http://www.who.int/csr/sars/country/table2004_04_21/en/index.html.},\n  unmatched-accessed = {(accessed on 27 January 2020).},\n  language = {},\n  urldate = {July 2003. Available online:}\n}\n@article{nuttall2013a,\n  author = {Nuttall, I. and Dye, C.},\n  title = {The SARS wake-up call},\n  journal = {Science},\n  date = {2013},\n  volume = {339},\n  pages = \"1287\u20131288.\" # \"422\u2013428.\",\n  source = {Chinese Center for Disease Control and Prevention. Epidemic Update and Risk Assessment of},\n  unmatched-volume = {12,},\n  unmatched-pages = {422\u2013428.},\n  language = {},\n  type = {CrossRef] 26. MERS-CoV}\n}\n@techreport{unknown-d,\n  url = {http://www.chinacdc.cn/yyrdgz/202001/P020200128523354919292.pdf},\n  unmatched-accessed = {(accessed on 28 January 2020).},\n  urldate = {Available online:},\n  institution = {Novel Coronavirus}\n}\n@article{gralinski2004a,\n  author = {Gralinski, L.E. and Menachery, V.D.},\n  title = {Return of the Coronavirus: 2019-nCoV},\n  journal = {Viruses},\n  volume = {2020},\n  pages = \"135.\" # \"818.\",\n  medium = {CrossRef},\n  date = {2004},\n  note = {CrossRef] [PubMed] 30},\n  unmatched-author = {29. Wang, J. T.; Sheng, W. H.; Fang, C. T.; Chen, Y. C.; Wang, J. L.; Yu, C. J.; Yang, P. C.},\n  source = {Clinical manifestations, laboratory findings, and treatment outcomes of SARS patients},\n  unmatched-journal = {Emerg. Infect. Dis.},\n  unmatched-volume = {10,},\n  number = {12},\n  unmatched-pages = {818.},\n  language = {},\n  urldate = {[PubMed]}\n}\n@article{fehr2017a,\n  author = {Fehr, A.R. and Channappanavar, R. and Perlman, S.},\n  title = {Middle East respiratory syndrome: Emergence of a pathogenic human coronavirus},\n  journal = {Annu. Rev. Med},\n  date = {2017},\n  volume = {68},\n  pages = {387\u2013399},\n  medium = {CrossRef},\n  publisher = {Trial Version},\n  url = {http://www.nhc.gov.cn/jkj/s3577/202002/573340613ab243b3a7f61df260551dd4/files/c791e5a7ea5149f680fdcb34dac0f54e.pdf},\n  unmatched-author = {31.},\n  source = {National Health Commission of the People\u2019s Republic of China. Diagnosis and Treatment of Pneumonia Caused by 2019-nCoV},\n  unmatched-accessed = {4). Available online: (accessed on 6 February 2020).},\n  language = {},\n  urldate = {[PubMed]}\n}\n@article{yang2019a,\n  author = {Yang, F.},\n  title = {Pulmonary rehabilitation guidelines in the principle of 4S for patients infected with 2019 novel coronavirus},\n  date = {2019},\n  journal = {Zhi},\n  volume = {2020},\n  pages = {004},\n  source = {Zhonghua Jie He He Hu Xi Za},\n  number = {43},\n  language = {}\n}\n@article{lessler2009a,\n  author = {Lessler, J. and Reich, N.G. and Brookmeyer, R. and Perl, T.M. and Nelson, K.E. and Cummings, D.A.},\n  title = {Incubation periods of acute respiratory viral infections: A systematic review},\n  journal = {Lancet. Infect. Dis},\n  date = {2009},\n  volume = {9},\n  pages = \"291\u2013300.\" # \"207.\",\n  medium = {CrossRef},\n  note = {CrossRef] 35},\n  unmatched-author = {34. Meltzer, M. I.},\n  source = {Multiple contact dates and SARS incubation periods},\n  unmatched-journal = {Emerg. Infect. Dis.},\n  unmatched-volume = {10,},\n  unmatched-pages = {207.},\n  language = {}\n}\n@article{zhu-a,\n  author = {Zhu, N. and Zhang, D. and Wang, W. and Li, X. and Yang, B. and Song, J. and Zhao, X. and Huang, B. and Shi, W. and Lu, R.},\n  title = {A novel coronavirus from patients with pneumonia in China, 2019},\n  journal = {N. Engl. J. Med},\n  volume = {2020},\n  pages = {727\u2013733},\n  note = {CrossRef] 36},\n  more-authors = {true},\n  number = {382},\n  language = {}\n}\n@misc{yang-a,\n  author = {Yang, Y. and Lu, Q. and Liu, M. and Wang, Y. and Zhang, A. and Jalali, N. and Dean, N. and Longini, I. and Halloran, M.E. and Xu, B.},\n  title = {Epidemiological and clinical features of the 2019 novel coronavirus outbreak in China. medRxiv 2020},\n  date = {[CrossRef] 37.},\n  more-authors = {true},\n  language = {}\n}\n@article{chan-yeung2003a,\n  author = {Chan-Yeung, M. and Xu, R.H.},\n  title = {SARS: Epidemiology},\n  journal = {Respirology},\n  date = {2003},\n  volume = {8},\n  pages = {9\u201314},\n  language = {}\n}\n@article{wang-a,\n  author = {Wang, C. and Horby, P.W. and Hayden, F.G. and Gao, G.F.},\n  title = {A novel coronavirus outbreak of global health concern},\n  journal = {Lancet},\n  volume = {2020},\n  pages = {470\u2013473},\n  note = {CrossRef] 39},\n  number = {395},\n  language = {}\n}\n@CrossRef{peiris2003a,\n  author = {Peiris, J.S. and Yuen, K.Y. and Osterhaus, A.D. and St\u00f6hr, K.},\n  title = {The severe acute respiratory syndrome},\n  editor = {Med, N.Engl J.},\n  date = {2003},\n  volume = {349},\n  pages = {2431\u20132441},\n  medium = {CrossRef},\n  language = {},\n  urldate = {[PubMed] 40.}\n}\n@article{leung2004a,\n  author = {Leung, G.M. and Hedley, A.J. and Ho, L.-M. and Chau, P. and Wong, I.O. and Thach, T.Q. and Ghani, A.C. and Donnelly, C. and Fraser, C. and Riley, S.},\n  title = {The epidemiology of severe acute respiratory syndrome in the 2003 Hong Kong epidemic: An analysis of all 1755 patients},\n  journal = {Ann. Intern. Med},\n  date = {2004},\n  volume = {141},\n  pages = {662\u2013673},\n  url = {http://m.news.cctv.com/2020/01/23/ARTIEw78LIxqpgx6Ilm7NkBo200123.shtml},\n  more-authors = {true},\n  unmatched-journal = {Infectious Disease Expert Li Lanjuan Responded to Six Questions},\n  unmatched-accessed = {(accessed on 23 January 2020).},\n  language = {},\n  type = {CrossRef] [PubMed] 41},\n  urldate = {of 2019-nCoV. Available online:}\n}\n@article{li2020a,\n  author = {Li, Q. and Guan, X. and Wu, P. and Wang, X. and Zhou, L. and Tong, Y. and Ren, R. and Leung, K.S. and Lau, E.H. and Wong, J.Y.},\n  date = {2020},\n  medium = {CrossRef},\n  title = {Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China},\n  journal = {Lancet},\n  volume = {2020},\n  pages = {497\u2013506},\n  unmatched-author = {43. Huang, C.; Wang, Y.; Li, X.; Ren, L.; Zhao, J.; Hu, Y.; Zhang, L.; Fan, G.; Xu, J.; Gu, X.; et al.},\n  more-authors = {true},\n  unmatched-medium = {[CrossRef]},\n  number = {395},\n  language = {},\n  urldate = {[PubMed]}\n}\n@article{chen-a,\n  author = {Chen, N. and Zhou, M. and Dong, X. and Qu, J. and Gong, F. and Han, Y. and Qiu, Y. and Wang, J. and Liu, Y. and Wei, Y.},\n  title = {Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study},\n  journal = {Lancet},\n  volume = {2020},\n  pages = {507\u2013513},\n  medium = {CrossRef},\n  more-authors = {true},\n  number = {395},\n  language = {}\n}\n@misc{unknown-e,\n  title = {Press Conference of the National Health Commission of the People\u2019s Republic of China on 3},\n  url = {http://www.nhc.gov.cn/wjw/xwfbh/xwzb.shtml},\n  unmatched-accessed = {(accessed on 4 February 2020).},\n  language = {},\n  urldate = {February 2020. Available online:}\n}\n@article{yuan2010a,\n  author = {Yuan, J. and Hon, C.-C. and Li, Y. and Wang, D. and Xu, G. and Zhang, H. and Zhou, P. and Poon, L. and Lam, T.Y. and Leung, F.C.-C.},\n  title = {Intraspecies diversity of SARS-like coronaviruses in Rhinolophus sinicus and its implications for the origin of SARS coronaviruses in humans},\n  journal = {J. Gen. Virol},\n  date = {2010},\n  volume = {91},\n  pages = {1058\u20131062},\n  medium = {CrossRef-PubMed},\n  more-authors = {true},\n  language = {}\n}\n@article{phan-a,\n  author = {Phan, T.},\n  title = {Novel coronavirus: From discovery to clinical diagnostics},\n  journal = {Infect. Genet. Evol},\n  volume = {2020},\n  pages = {104211},\n  medium = {CrossRef},\n  number = {79},\n  language = {}\n}\n@article{wang2005a,\n  author = {Wang, M. and Yan, M. and Xu, H. and Liang, W. and Kan, B. and Zheng, B. and Chen, H. and Zheng, H. and Xu, Y. and Zhang, E.},\n  title = {SARS-CoV infection in a restaurant from palm civet},\n  journal = {Emerg. Infect. Dis},\n  date = {2005},\n  volume = {11},\n  pages = {1860},\n  medium = {CrossRef},\n  more-authors = {true},\n  language = {}\n}\n@CrossRef{zhou-a,\n  author = {Zhou, P. and Yang, X.-L. and Wang, X.-G. and Hu, B. and Zhang, L. and Zhang, W. and Si, H.-R. and Zhu, Y. and Li, B. and Huang, C.-L.},\n  title = {Discovery of a novel coronavirus associated with the recent pneumonia outbreak in humans and its potential bat origin. bioRxiv 2020},\n  medium = {CrossRef},\n  more-authors = {true},\n  language = {}\n}\n@CrossRef{guo-a,\n  author = {Guo, Q. and Li, M. and Wang, C. and Wang, P. and Fang, Z. and Tan, J. and Wu, S. and Xiao, Y. and Zhu, H.},\n  title = {Host and infectivity prediction of Wuhan 2019 novel coronavirus using deep learning algorithm. bioRxiv 2020},\n  medium = {CrossRef},\n  language = {}\n}\n@article{ji-a,\n  author = {Ji, W. and Wang, W. and Zhao, X. and Zai, J. and Li, X.},\n  title = {Homologous recombination within the spike glycoprotein of the newly identified coronavirus may boost cross-species transmission from snake to human},\n  journal = {J. Med. Virol},\n  volume = {2020},\n  pages = {433\u2013440},\n  medium = {CrossRef},\n  number = {92},\n  language = {}\n}\n@misc{unknown-f,\n  title = {South China Agricultural University: Pangolin May Be a Potential Intermediate Host of New Coronavirus},\n  url = {http://www.chinanews.com/sh/2020/02-07/9082279.shtml},\n  unmatched-accessed = {(accessed on 7 February 2020).},\n  language = {},\n  urldate = {Available online:}\n}\n@article{chowell2004a,\n  author = {Chowell, G. and Castillo-Chavez, C. and Fenimore, P.W. and Kribs-Zaleta, C.M. and Arriola, L. and Hyman, J.M.},\n  title = {Model parameters and outbreak control for SARS},\n  journal = {Emerg. Infect. Dis},\n  date = {2004},\n  volume = {10},\n  medium = {CrossRef-PubMed},\n  language = {}\n}\n@article{lau2010a,\n  author = {Lau, E.H.Y. and Hsiung, C.A. and Cowling, B.J. and Chen, C.-H. and Ho, L.-M. and Tsang, T. and Chang, C.-W. and Donnelly, C. and Leung, G.M.},\n  title = {A comparative epidemiologic analysis of SARS in Hong Kong, Beijing and Taiwan},\n  journal = {BMC Infect. Dis},\n  date = {2010},\n  volume = {10},\n  pages = {50},\n  medium = {CrossRef-PubMed},\n  language = {}\n}\n@techreport{unknown-g,\n  title = {Distribution of Pneumonia Infected by 2019-nCoV},\n  url = {Available},\n  language = {},\n  urldate = {online: http://2019ncov.chinacdc.cn/2019-nCoV/(on 15 February 2020).},\n  institution = {Chinese Center for Disease Control and Prevention}\n}\n@misc{unknown-h,\n  title = {Real-time Updates of COVID-19 Epidemic in China},\n  url = {https://ncov.dxy.cn/ncovh5/view/pneumonia},\n  unmatched-accessed = {(accessed on 15 February 2020).},\n  language = {},\n  urldate = {Available online:}\n}\n@article{nishiura-a,\n  author = {Nishiura, H. and Jung, S.-M. and Linton, N. and Kinoshita, R. and Yang, Y. and Hayashi, K. and Kobayashi, T. and Yuan, B. and Akhmetzhanov, A.R.},\n  title = {The extent of transmission of novel coronavirus in Wuhan, China, 2020},\n  journal = {J. Clin. Med},\n  volume = {2020},\n  pages = {330},\n  medium = {CrossRef},\n  number = {9},\n  language = {}\n}\n@article{li-a,\n  author = {Li, X. and Zai, J. and Wang, X. and Li, Y.},\n  title = {Potential of large \u2018first generation\u2019 human-to-human transmission of 2019-nCoV},\n  journal = {J. Med. Virol},\n  volume = {2020},\n  pages = {448\u2013454},\n  medium = {CrossRef},\n  number = {92},\n  language = {}\n}\n@article{carlos2019a,\n  author = {Carlos, W.G. and Dela Cruz, C.S. and Cao, B. and Pasnick, S. and Jamil, S.},\n  journal = {Novel Wuhan},\n  date = {2019},\n  title = {Coronavirus},\n  pages = {7\u20138},\n  medium = {CrossRef},\n  unmatched-journal = {Am. J. Respir. Crit. Care Med.},\n  language = {}\n}\n@book{unknown-i,\n  title = {the People\u2019s Republic of China. The Role of Fecal-Oral Transmission in All transmission Still Need Further},\n  publisher = {Observation and Research. Available},\n  url = {http://news.cctv.com/2020/02/13/ARTISJWExxLSLWoL8mtJos97200213.shtml},\n  unmatched-accessed = {(accessed on 13 February 2020).},\n  language = {},\n  urldate = {online:},\n  organization = {National Health Commission of}\n}\n@techreport{unknown-j,\n  title = {There Is No Evidence That the New Coronavirus Can Be Transmitted through Aerosol},\n  url = {http://news.cctv.com/2020/02/09/ARTIiVFnLC1ww5sTSMqbcXlz200209.shtml},\n  unmatched-accessed = {(accessed on 9 February 2020).},\n  language = {},\n  urldate = {Available online:},\n  institution = {Chinese Center for Disease Control and Prevention}\n}\n@article{lau2004a,\n  author = {Lau, J.T. and Tsui, H. and Lau, M. and Yang, X.},\n  title = {SARS transmission, risk factors, and prevention in Hong Kong},\n  journal = {Emerg. Infect. Dis},\n  date = {2004},\n  volume = {10},\n  pages = {587},\n  medium = {CrossRef},\n  language = {}\n}\n@article{lu-a,\n  author = {Lu, H. and Stratton, C.W. and Tang, Y.W.},\n  title = {Outbreak of Pneumonia of Unknown Etiology in Wuhan China: The Mystery and the Miracle},\n  journal = {J. Med. Virol},\n  volume = {2020},\n  pages = {401\u2013402},\n  medium = {CrossRef},\n  number = {92},\n  language = {}\n}\n@article{rouquet2005a,\n  author = {Rouquet, P. and Froment, J.-M. and Bermejo, M. and Kilbourn, A. and Karesh, W. and Reed, P. and Kumulungui, B. and Yaba, P. and Delicat, A. and Rollin, P.E.},\n  title = {Wild animal mortality monitoring and human Ebola outbreaks, Gabon and Republic of Congo, 2001\u20132003},\n  journal = {Emerg. Infect. Dis},\n  date = {2005},\n  volume = {11},\n  pages = {283},\n  medium = {CrossRef},\n  more-authors = {true},\n  language = {}\n}\n@article{yoo-a,\n  author = {Yoo, J.H.},\n  title = {The Fight against the 2019-nCoV Outbreak: An Arduous March Has Just Begun},\n  journal = {J. Korean Med. Sci},\n  volume = {2020},\n  pages = {56},\n  medium = {CrossRef},\n  number = {35},\n  language = {}\n}\n@article{de2016a,\n  author = {De Wit, E. and van Doremalen, N. and Falzarano, D. and Munster, V.J.},\n  title = {SARS and MERS: Recent insights into emerging coronaviruses},\n  journal = {Nat. Rev. Microbiol},\n  date = {2016},\n  volume = {14},\n  pages = {523},\n  medium = {CrossRef-PubMed},\n  language = {}\n}\n@techreport{unknown-k,\n  title = {The First New Coronavirus Species Information Was Published by the National Pathogen Microorganism Resource Bank},\n  url = {http://www.chinacdc.cn/yw_9324/202001/t20200124_211413.html},\n  unmatched-accessed = {(accessed on 1 February 2020).},\n  language = {},\n  urldate = {Available online:},\n  institution = {Chinese Center for Disease Control and Prevention}\n}\n@article{zeng2007a,\n  author = {Zeng, Q. and Khan, K. and Wu, J. and Zhu, H.},\n  title = {The utility of preemptive mass influenza vaccination in controlling a SARS outbreak during flu season},\n  journal = {Math. Biosci. Eng},\n  date = {2007},\n  volume = {4},\n  pages = {739},\n  medium = {PubMed},\n  language = {}\n}\n@article{wang2019a,\n  author = {Wang, N. and Luo, C. and Liu, H. and Yang, X.-L. and Hu, B. and Zhang, W. and Li, B. and Zhu, Y. and Zhu, G. and Shen, X.},\n  title = {Characterization of a New Member of Alphacoronavirus with Unique Genomic Features in Rhinolophus Bats},\n  journal = {Viruses},\n  date = {2019},\n  volume = {11},\n  pages = {379},\n  medium = {CrossRef-PubMed},\n  more-authors = {true},\n  language = {}\n}\n@article{bhadra2015a,\n  author = {Bhadra, S. and Jiang, Y.S. and Kumar, M.R. and Johnson, R.F. and Hensley, L.E. and Ellington, A.D.},\n  title = {Real-time sequence-validated loop-mediated isothermal amplification assays for detection of Middle East respiratory syndrome coronavirus (MERS-CoV)},\n  journal = {PLoS ONE},\n  date = {2015},\n  volume = {10},\n  pages = {0123126},\n  medium = {CrossRef-PubMed},\n  language = {}\n}\n@article{chan2015a,\n  author = {Chan, J.F.-W. and Choi, G.K.-Y. and Tsang, A.K.-L. and Tee, K.-M. and Lam, H.-Y. and Yip, C.C.-Y. and To, K.K.-W. and Cheng, V.C.-C. and Yeung, M.L. and Lau, S.K.},\n  title = {Development and evaluation of novel real-time reverse transcription-PCR assays with locked nucleic acid probes targeting leader sequences of human-pathogenic coronaviruses},\n  journal = {J. Clin. Microbiol},\n  date = {2015},\n  volume = {53},\n  pages = {2722\u20132726},\n  medium = {CrossRef},\n  more-authors = {true},\n  language = {}\n}\n@article{wu2000a,\n  author = {Wu, P. and Hao, X. and Lau, E.H.Y. and Wong, J.Y. and Leung, K.S.M. and Wu, J.T. and Cowling, B.J. and Leung, G.M.},\n  title = {Real-time tentative assessment of the epidemiological characteristics of novel coronavirus infections in Wuhan, China, as at 22 January 2020},\n  journal = {Euro. Surveill},\n  volume = {2020},\n  date = {2000},\n  medium = {CrossRef},\n  number = {25},\n  language = {}\n}\n@misc{administration-a,\n  author = {Administration, National Medical Products},\n  title = {National Medical Products Administration Examined and Approved the New Nucleic Acid Test Reagent of Coronavirus Again},\n  url = {http://www.nmpa.gov.cn/WS04/CL2056/374398.html},\n  unmatched-accessed = {(accessed on 28 January 2020).},\n  language = {},\n  urldate = {Available online:}\n}\n@article{chen-b,\n  author = {Chen, Y. and Liu, Q. and Guo, D.},\n  title = {Emerging coronaviruses: Genome structure, replication, and pathogenesis},\n  journal = {J. Med. Virol},\n  volume = {2020},\n  pages = {418\u2013423},\n  medium = {CrossRef},\n  number = {92},\n  language = {}\n}\n@article{cinatl2003a,\n  author = {Cinatl, J. and Morgenstern, B. and Bauer, G. and Chandra, P. and Rabenau, H. and Doerr, H.W.},\n  title = {Treatment of SARS with human interferons},\n  journal = {Lancet},\n  date = {2003},\n  volume = {362},\n  pages = {293\u2013294},\n  medium = {CrossRef},\n  language = {}\n}\n@article{chu2004a,\n  author = {Chu, C.M. and Cheng, V.C.C. and Hung, I.F.N. and Wong, M.M.L. and Chan, K. and Kao, R.Y. and Poon, L. and Wong, C.L.P. and Guan, Y. and Peiris, J.S.M.},\n  title = {Role of lopinavir/ritonavir in the treatment of SARS: Initial virological and clinical findings},\n  journal = {Thorax},\n  date = {2004},\n  volume = {59},\n  pages = {252\u2013256},\n  medium = {CrossRef},\n  more-authors = {true},\n  language = {}\n}\n@incollection{lu2019a,\n  author = {Lu, H.},\n  title = {Drug treatment options for the 2019-new coronavirus},\n  date = {2019},\n  url = {http://wjw.beijing.gov.cn/wjwh/ztzl/xxgzbd/202001/t20200126_1621354.html},\n  source = {Biosci. Trends 2020. [CrossRef] 78. Beijing Municipal Health Commission. Explanation on the Situation that Drugs for AIDS Can Be Tried to Treat Pneumonia Caused by 2019-nCoV Infection},\n  unmatched-accessed = {(accessed on 26 January 2020).},\n  language = {},\n  urldate = {Available online:}\n}\n@book{unknown-l,\n  title = {The Joint Research Team of Shanghai Institute of Materia Medica, Chinese Academy of Sciences, and ShanghaiTech University Discovered a Batch of Old Drugs and Traditional Chinese Medicines with Therapeutic},\n  publisher = {Potential for COVID-19},\n  url = {http://www.shanghaitech.edu.cn/2020/0125/c1001a50141/page.htm},\n  unmatched-accessed = {(accessed on 25 January 2020).},\n  language = {},\n  urldate = {Available online:}\n}\n@techreport{unknown-m,\n  title = {High-Resolution Crystal Structure of 2019-nCoV Coronavirus 3CL Hydrolase (Mpro) was Announced by the Joint Research Team of Shanghai Institute of Materia Medica, Chinese Academy},\n  url = {http://www.shanghaitech.edu.cn/2020/0126/c1001a50145/page.htm},\n  unmatched-accessed = {(accessed on 26 January 2020).},\n  language = {},\n  urldate = {Available online:},\n  institution = {of Sciences, and ShanghaiTech University}\n}\n@article{xu-a,\n  author = {Xu, Z. and Peng, C. and Shi, Y. and Zhu, Z. and Mu, K. and Wang, X. and Zhu, W.},\n  title = {Nelfinavir was predicted to be a potential inhibitor of 2019 nCov main protease by an integrative approach combining homology modelling, molecular docking and binding free energy calculation. bioRxiv 2020},\n  journal = {[CrossRef]},\n  volume = {82},\n  pages = {222},\n  note = {CrossRef] [PubMed] 83},\n  unmatched-author = {Sheahan, T. P.; Sims, A. C.; Leist, S. R.; Sch\u00e4fer, A.; Won, J.; Brown, A. J.; Montgomery, S. A.; Hogg, A.; Babusis, D.; Clarke, M. O.; et al.},\n  source = {Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV},\n  unmatched-journal = {Nat. Commun.},\n  unmatched-volume = {2020, 11,},\n  language = {}\n}\n@article{mulangu2019a,\n  author = {Mulangu, S. and Dodd, L.E. and Davey, R.T. and Mbaya, O.T. and Proschan, M. and Mukadi, D. and Manzo, M.L. and Nzolo, D. and Oloma, A.T. and Ibanda, A.},\n  title = {A randomized, controlled trial of Ebola virus disease therapeutics},\n  journal = {N. Engl. J. Med},\n  date = {2019},\n  volume = {381},\n  pages = {2293\u20132303},\n  medium = {CrossRef-PubMed},\n  more-authors = {true},\n  language = {}\n}\n@article{holshue2019a,\n  author = {Holshue, M.L. and DeBolt, C. and Lindquist, S. and Lofy, K.H. and Wiesman, J. and Bruce, H. and Spitters, C. and Ericson, K. and Wilkerson, S. and Tural, A.},\n  journal = {First Case of},\n  date = {2019},\n  title = {Novel Coronavirus in the United States},\n  medium = {CrossRef},\n  more-authors = {true},\n  unmatched-journal = {N. Engl. J. Med.},\n  language = {}\n}\n@CrossRef{song2019a,\n  author = {Song, G. and Cheng, M.Q. and Wei, X.W.},\n  title = {Research progress on novel coronavirus},\n  date = {2019},\n  medium = {CrossRef},\n  source = {related drugs in vitro/vivo. Bing Du Xue Bao 2020},\n  language = {}\n}\n@misc{unknown-n,\n  title = {China-Japan Friendship Hospital: Clinical Experimental Research Work Is Being Carried Out on Remdesivir},\n  url = {http://www.chinanews.com/sh/shipin/cns-d/2020/02-12/news847712.shtml},\n  unmatched-accessed = {(accessed on 12 February 2020).},\n  language = {},\n  urldate = {Available online:}\n}\n@article{lai1996a,\n  author = {Lai, M.M.},\n  title = {Recombination in large RNA viruses: Coronaviruses. Semin},\n  journal = {Virol},\n  date = {1996},\n  volume = {7},\n  pages = \"381\u2013388.\" # \"3995\u20134008.\",\n  medium = {CrossRef},\n  unmatched-author = {88. Woo, P. C. Y.; Lau, S. K.; Lam, C. S. F.; Lau, C. C. Y.; Tsang, A. K. L.; Lau, J. H. N.; Bai, R.; Teng, J. L. L.; Tsang, C. C. C.; Wang, M.; et al.},\n  source = {Discovery of seven novel Mammalian and avian coronaviruses in the genus deltacoronavirus supports bat coronaviruses as the gene source of alphacoronavirus and betacoronavirus and avian coronaviruses as the gene source of gammacoronavirus and deltacoronavirus},\n  unmatched-journal = {J. Virol.},\n  unmatched-volume = {86,},\n  unmatched-pages = {3995\u20134008.},\n  language = {}\n}\n@article{lu2019b,\n  author = {Lu, R. and Zhao, X. and Li, J. and Niu, P. and Yang, B. and Wu, H. and Wang, W. and Song, H. and Huang, B. and Zhu, N.},\n  title = {Genomic characterisation and epidemiology of 2019 novel coronavirus: Implications for virus origins and receptor binding},\n  journal = {Lancet},\n  volume = {2020},\n  pages = \"565\u2013574.\" # \"101.\",\n  medium = {CrossRef},\n  date = {2019},\n  unmatched-author = {90. Shi, C. S.; Nabar, N. R.; Huang, N. N.; Kehrl, J. H.},\n  more-authors = {true},\n  source = {SARS-Coronavirus Open Reading Frame-8b triggers intracellular stress pathways and activates NLRP3 inflammasomes},\n  unmatched-journal = {Cell Death Discov.},\n  unmatched-volume = {5,},\n  number = {395},\n  unmatched-pages = {101.},\n  language = {}\n}\n@article{menachery2017a,\n  author = {Menachery, V.D. and Graham, R.L. and Baric, R.S.},\n  title = {Jumping species\u2014A mechanism for coronavirus persistence and survival},\n  journal = {Curr. Opin. Virol},\n  date = {2017},\n  volume = {23},\n  pages = {1\u20137},\n  publisher = {CrossRef] 92},\n  language = {}\n}\n@article{wang2018a,\n  author = {Wang, N. and Li, S.-Y. and Yang, X.-L. and Huang, H.-M. and Zhang, Y.-J. and Guo, H. and Luo, C.-M. and Miller, M. and Zhu, G. and Chmura, A.},\n  title = {Serological evidence of bat SARS-related coronavirus infection in humans, China},\n  journal = {Virol. Sin},\n  date = {2018},\n  volume = {33},\n  pages = {104\u2013107},\n  medium = {CrossRef},\n  more-authors = {true},\n  language = {},\n  urldate = {[PubMed] 93.}\n}\n@article{xia2019a,\n  author = {Xia, S. and Yan, L. and Xu, W. and Agrawal, A.S. and Algaissi, A. and Tseng, C.-T.K. and Wang, Q. and Du, L. and Tan, W. and Wilson, I.A.},\n  title = {A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike},\n  journal = {Sci. Adv},\n  date = {2019},\n  volume = {5},\n  pages = {4580},\n  note = {CrossRef] [PubMed] 94},\n  more-authors = {true},\n  language = {}\n}\n@article{nicholls2003a,\n  author = {Nicholls, J. and DONG, X.P. and Jiang, G. and Peiris, M.},\n  title = {SARS: Clinical virology and pathogenesis},\n  journal = {Respirology},\n  date = {2003},\n  volume = {8},\n  pages = {6\u20138},\n  medium = {CrossRef},\n  language = {},\n  urldate = {[PubMed] 95.}\n}\n@article{he2006a,\n  author = {He, L. and Ding, Y. and Zhang, Q. and Che, X. and He, Y. and Shen, H. and Wang, H. and Li, Z. and Zhao, L. and Geng, J.},\n  title = {Expression of elevated levels of pro-inflammatory cytokines in SARS-CoV-infected ACE2+ cells in SARS patients: Relation to the acute lung injury and pathogenesis of SARS},\n  journal = {J. Pathol},\n  date = {2006},\n  volume = {210},\n  pages = {288\u2013297},\n  note = {CrossRef] [PubMed] 96},\n  more-authors = {true},\n  language = {}\n}\n@article{hamming2004a,\n  author = {Hamming, I. and Timens, W. and Bulthuis, M.L.C. and Lely, A.T. and Navis, G.J. and van Goor, H.},\n  title = {Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis},\n  journal = {J. Pathol},\n  date = {2004},\n  volume = {203},\n  pages = {631\u2013637},\n  medium = {CrossRef},\n  language = {},\n  urldate = {[PubMed] 97.}\n}\n@article{perlman2009a,\n  author = {Perlman, S. and Netland, J.},\n  title = {Coronaviruses post-SARS: Update on replication and pathogenesis},\n  journal = {Nat. Rev. Microbiol},\n  date = {2009},\n  volume = {7},\n  pages = {439\u2013450},\n  note = {CrossRef] 98},\n  language = {}\n}\n@article{ding2003a,\n  author = {Ding, Y. and Wang, H. and Shen, H. and Li, Z. and Geng, J. and Han, H. and Cai, J. and Li, X. and Kang, W. and Weng, D.},\n  title = {The clinical pathology of severe acute respiratory syndrome (SARS): A report from China},\n  journal = {J. Pathol},\n  date = {2003},\n  more-authors = {true},\n  language = {}\n}\n@article{ding2004a,\n  author = {Ding, Y. and He, L. and Zhang, Q. and Huang, Z. and Che, X.-Y. and Hou, J.-L. and Wang, H. and Shen, H. and Qiu, L. and Li, Z.},\n  title = {Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: Implications for pathogenesis and virus transmission pathways},\n  journal = {J. Pathol},\n  date = {2004},\n  volume = {203},\n  pages = \"622\u2013630.\" # \"S20\u2013S24.\",\n  unknown = {CrossRef] 100. HUI},\n  unmatched-author = {D. S. C.; WONG, P. C.; Wang, C.},\n  more-authors = {true},\n  source = {SARS: Clinical features and diagnosis},\n  unmatched-journal = {Respirology},\n  unmatched-volume = {8,},\n  unmatched-pages = {S20\u2013S24.},\n  language = {}\n}\n@article{millet2015a,\n  author = {Millet, J.K. and Whittaker, G.R.},\n  title = {Host cell proteases: Critical determinants of coronavirus tropism and pathogenesis},\n  journal = {Virus. Res},\n  date = {2015},\n  volume = {202},\n  pages = {120\u2013134},\n  note = {CrossRef] 102},\n  language = {}\n}\n@article{zhou2020a,\n  author = {Zhou, P. and Yang, X.-L. and Wang, X.-G. and Hu, B. and Zhang, L. and Zhang, W. and Si, H.-R. and Zhu, Y. and Li, B. and Huang, C.-L.},\n  title = {A pneumonia outbreak associated with a new coronavirus of probable bat origin},\n  journal = {Nature},\n  date = {2020},\n  medium = {CrossRef},\n  more-authors = {true},\n  language = {},\n  urldate = {[PubMed] 103.}\n}\n@article{kuba2005a,\n  author = {Kuba, K. and Imai, Y. and Rao, S. and Gao, H. and Guo, F. and Guan, B. and Huan, Y. and Yang, P. and Zhang, Y. and Deng, W.},\n  title = {A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus\u2013induced lung injury},\n  journal = {Nat. Med},\n  date = {2005},\n  volume = {11},\n  pages = {875\u2013879},\n  medium = {CrossRef-PubMed},\n  more-authors = {true},\n  language = {}\n}\n@article{imai2005a,\n  author = {Imai, Y. and Kuba, K. and Rao, S. and Huan, Y. and Guo, F. and Guan, B. and Yang, P. and Sarao, R. and Wada, T. and Leong-Poi, H.},\n  title = {Angiotensin-converting enzyme 2 protects from severe acute lung failure},\n  journal = {Nature},\n  date = {2005},\n  volume = {436},\n  pages = {112\u2013116},\n  medium = {CrossRef-PubMed},\n  more-authors = {true},\n  language = {}\n}\n@article{li2003a,\n  author = {Li, W. and Moore, M.J. and Vasilieva, N. and Sui, J. and Wong, S.K. and Berne, M.A. and Somasundaran, M. and Sullivan, J.L. and Luzuriaga, K. and Greenough, T.C.},\n  title = {Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus},\n  journal = {Nature},\n  date = {2003},\n  volume = {426},\n  pages = {450\u2013454},\n  medium = {CrossRef},\n  more-authors = {true},\n  language = {}\n}\n@article{wan2020a,\n  author = {Wan, Y. and Shang, J. and Graham, R. and Baric, R.S. and Li, F.},\n  title = {Receptor recognition by novel coronavirus from Wuhan: An analysis based on decade-long structural studies of SARS},\n  journal = {J. Virol},\n  date = {2020},\n  medium = {CrossRef},\n  language = {}\n}\n@article{bassetti2019a,\n  author = {Bassetti, M. and Vena, A. and Roberto Giacobbe, D.},\n  title = {The Novel Chinese Coronavirus},\n  date = {2019},\n  journal = {Eur. J. Clin. Investig},\n  medium = {CrossRef},\n  source = {Infections: Challenges for fighting the storm},\n  language = {}\n}\n@article{su2016a,\n  author = {Su, S. and Wong, G. and Shi, W. and Liu, J. and Lai, A.C. and Zhou, J. and Liu, W. and Bi, Y. and Gao, G.F.},\n  title = {Epidemiology, genetic recombination, and pathogenesis of coronaviruses},\n  journal = {Trends. Microbiol},\n  date = {2016},\n  volume = {24},\n  pages = {490\u2013502},\n  medium = {CrossRef},\n  language = {}\n}\n@CrossRef{chu2014a,\n  author = {Chu, D.K.W. and Poon, L. and Gomaa, M. and Shehata, M. and Perera, R.A. and Abu Zeid, D. and El Rifay, A.S. and Siu, L.Y. and Guan, Y. and Webby, R.J.},\n  title = {MERS coronaviruses in dromedary camels, Egypt},\n  source = {Emerg. Infect. Dis.},\n  date = {2014},\n  volume = {20},\n  medium = {CrossRef},\n  more-authors = {true},\n  language = {}\n}\n",
        "links": [
            "http://www.mdpi.com/1999-4915/12/2/244/s1",
            "http://www.mdpi.com/journal/viruses",
            "http://www.mdpi.com/1999-4915/12/2/244/s1"
        ],
        "emails": [
            "gasimmicro@gmail.com",
            "xqguo@henu.edu.cn",
            "xielongxiang123@126.com",
            "zhaoshizhe1126@126.com",
            "xiaoshan1220@163.com",
            "biowyl@126.com",
            "xujiabao0907@126.com",
            "ms.wanzhu@gmail.com"
        ],
        "pages": "244",
        "references_ris": "TY  - JOUR\nAU  - Wang, L.F.\nAU  - Shi, Z.\nAU  - Zhang, S.\nAU  - Field, H.\nAU  - Daszak, P.\nAU  - Eaton, B.T.\nTI  - Review of bats and SARS\nT2  - Emerg. Infect. Dis\nPY  - 2006\nDA  - 2006\nVL  - 12\nC1  - CrossRef\nLA  - \nER  - \n\nTY  - JOUR\nAU  - Ge, X.-Y.\nAU  - Li, J.\nAU  - Yang, X.-L.\nAU  - Chmura, A.\nAU  - Zhu, G.\nAU  - Epstein, J.H.\nAU  - Mazet, J.K.\nAU  - Hu, B.\nAU  - Zhang, W.\nAU  - Peng, C.\nTI  - Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor\nT2  - Nature\nPY  - 2013\nDA  - 2013\nVL  - 503\nSP  - 535\nEP  - 538\nC1  - CrossRef-PubMed\nC1  - true\nLA  - \nER  - \n\nTY  - JOUR\nAU  - Chen, Y.\nAU  - Guo, D.\nTI  - Molecular mechanisms of coronavirus RNA capping and methylation\nT2  - Virol. Sin\nPY  - 2016\nDA  - 2016\nVL  - 31\nSP  - 3\nEP  - 11\nC1  - CrossRef-PubMed\nLA  - \nER  - \n\nTY  - JOUR\nAU  - Cui, J.\nAU  - Li, F.\nAU  - Shi, Z.L.\nTI  - Origin and evolution of pathogenic coronaviruses\nT2  - Nat. Rev. Microbiol\nPY  - 2019\nDA  - 2019\nVL  - 17\nSP  - 181\nEP  - 192\nC1  - CrossRef-PubMed\nLA  - \nER  - \n\nTY  - JOUR\nAU  - Cauchemez, S.\nAU  - Van Kerkhove, M.D.\nAU  - Riley, S.\nAU  - Donnelly, C.A.\nAU  - Fraser, C.\nAU  - Ferguson, N.M.\nTI  - Transmission scenarios for Middle East Respiratory Syndrome Coronavirus (MERS-CoV) and how to tell them apart\nT2  - Euro Surveill\nPY  - 2013\nDA  - 2013\nVL  - 18\nSP  - 18\nLA  - \nER  - \n\nTY  - GEN\nAU  - Gorbalenya, A.E.\nAU  - Baker, S.C.\nAU  - Baric, R.S.\nAU  - de Groot, R.J.\nAU  - Drosten, C.\nAU  - Gulyaeva, A.A.\nAU  - Haagmans, B.L.\nAU  - Lauber, C.\nAU  - Leontovich, A.M.\nAU  - Neuman, B.W.\nTI  - Severe acute respiratory syndrome-related coronavirus: The species and its viruses\u2014A statement of the Coronavirus Study Group. bioRxiv 2020\nC1  - CrossRef\nC1  - true\nLA  - \nER  - \n\nTY  - GEN\nTI  - WHO Named the New Pneumonia \u201cCOVID-19\u201d\nUR  - http://www.xinhuanet.com/world/202002/12/c_1125561389.htm\nC1  - (accessed on 12 February 2020).\nLA  - \nC1  - Available online:\nER  - \n\nTY  - JOUR\nAU  - Guan, Y.\nAU  - Zheng, B.J.\nAU  - He, Y.Q.\nAU  - Liu, X.L.\nAU  - Zhuang, Z.X.\nAU  - Cheung, C.L.\nAU  - Luo, S.W.\nAU  - Li, P.H.\nAU  - Zhang, L.J.\nAU  - Butt, K.M.\nTI  - Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China\nT2  - Science\nPY  - 2003\nDA  - 2003\nVL  - 302\nSP  - 276\nEP  - 278\nC1  - CrossRef\nC1  - true\nLA  - \nER  - \n\nTY  - JOUR\nAU  - Ki, M.\nPY  - 2015\nDA  - 2015\nTI  - MERS outbreak in Korea: Hospital-to-hospital transmission\nT2  - Epidemiol. Health\nVL  - 37\nSP  - 37\nC1  - CrossRef\nLA  - \nER  - \n\nTY  - JOUR\nAU  - Azhar, E.I.\nAU  - El-Kafrawy, S.A.\nAU  - Farraj, S.A.\nAU  - Hassan, A.M.\nAU  - Al-Saeed, M.S.\nAU  - Hashem, A.M.\nAU  - Madani, T.A.\nTI  - Evidence for camel-to-human transmission of MERS coronavirus\nT2  - N. Engl. J. Med\nPY  - 2014\nDA  - 2014\nVL  - 370\nSP  - 2499\nEP  - 2505\nC1  - CrossRef\nLA  - \nER  - \n\nTY  - JOUR\nAU  - Chan, J.F.W.\nAU  - Kok, K.H.\nAU  - Zhu, Z.\nAU  - Chu, H.\nAU  - To, K.K.W.\nAU  - Yuan, S.\nAU  - Yuen, K.Y.\nTI  - Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan\nT2  - Emerg. Microbes. Infect\nVL  - 2020\nSP  - 221\nEP  - 236\nC1  - CrossRef\nIS  - 9\nLA  - \nER  - \n\nTY  - JOUR\nAU  - Zhao, W.M.\nAU  - Song, S.H.\nAU  - Chen, M.L.\nAU  - Zou, D.\nAU  - Ma, L.N.\nAU  - Ma, Y.K.\nAU  - Li, R.J.\nAU  - Hao, L.L.\nAU  - Li, C.P.\nAU  - Tian, D.\nT2  - M.; et al. The\nPY  - 2019\nDA  - 2019\nTI  - Novel Coronavirus Resource\nVL  - 2020\nSP  - 1\nEP  - 9\nC1  - Hereditas\nIS  - 36\nLA  - \nER  - \n\nTY  - RPRT\nUR  - https://www.ncbi.nlm.nih.gov/pubmed/\nC1  - (accessed on 14 February 2020).\nC1  - 2019-nCoV. Available online:\nC1  - NCBI Database\nER  - \n\nTY  - GEN\nAU  - Database, G.S.A.I.D.\nUR  - https://www.gisaid.org/CoV2020/\nC1  - on 14\nPY  - 2020\nDA  - 2020/02\nC1  - 2020 Coronavirus. Available online:\nER  - \n\nTY  - RPRT\nUR  - https://blast.ncbi.nlm.nih.gov/Blast.cgi\nC1  - (accessed on 30 January 2020).\nC1  - Available online:\nC1  - NCBI Blast\nER  - \n\nTY  - GEN\nAU  - Zpicture\nUR  - https://zpicture.dcode.org\nC1  - (accessed on 1 February 2020).\nC1  - Available online:\nER  - \n\nTY  - JOUR\nAU  - Kumar, S.\nAU  - Stecher, G.\nAU  - Tamura, K.\nTI  - MEGA7: Molecular evolutionary genetics analysis version 7.0 for bigger datasets\nT2  - Mol. Biol. Evol\nPY  - 2016\nDA  - 2016\nVL  - 33\nSP  - \"1870\nEP  - 1874.\" # \"11030\nC1  - CrossRef\nC1  - 18. Tamura, K.; Nei, M.; Kumar, S.\nT2  - Prospects for inferring very large phylogenies by using the neighbor-joining method\nC1  - Proc. Natl. Acad. Sci. USA\nC1  - 101,\nC1  - 11030\u201311035.\nC1  - [CrossRef]\nC1  - [PubMed] 19.\nLA  - \nC1  - [PubMed]\nER  - \n\nTY  - JOUR\nAU  - Cheng, V.C.\nAU  - Lau, S.K.\nAU  - Woo, P.C.\nAU  - Yuen, K.Y.\nTI  - Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection\nT2  - Clin. Microbiol. Rev\nPY  - 2007\nDA  - 2007\nVL  - 20\nSP  - 660\nEP  - 694\nC1  - CrossRef\nN1  - full issue]. Wkly. Epidemiol. Rec\nC1  - World Health Organization. Weekly Epidemiological Record,\nC1  - vol. 88, 35\nLA  - \nC1  - [PubMed] 20.\nER  - \n\nTY  - JOUR\nAU  - Lee, N.\nAU  - Hui, D.S.\nAU  - Wu, A.\nAU  - Chan, P.K.S.\nAU  - Cameron, P.\nAU  - Joynt, G.\nAU  - Ahuja, A.T.\nAU  - Yung, M.Y.\nAU  - Leung, C.\nAU  - To, K.\nTI  - A major outbreak of severe acute respiratory syndrome in Hong Kong\nT2  - N. Engl. J. Med\nPY  - 2003\nDA  - 2003\nVL  - 348\nSP  - 1986\nEP  - 1994\nC1  - CrossRef\nC1  - true\nLA  - \nER  - \n\nTY  - JOUR\nAU  - Poutanen, S.\nAU  - Low, N.E.\nAU  - Henry, B.\nAU  - Finkelstein, S.\nAU  - Rose, D.\nAU  - Green, K.\nAU  - Tellier, R.\nAU  - Draker, R.\nAU  - Adachi, D.\nAU  - Ayers, M.\nTI  - Identification of severe acute respiratory syndrome in Canada\nT2  - N. Engl. J. Med\nPY  - 2003\nDA  - 2003\nVL  - 348\nSP  - 1995\nEP  - 2005\nC1  - CrossRef\nC1  - true\nLA  - \nER  - \n\nTY  - JOUR\nAU  - Leo, Y.S.\nAU  - Chen, M.\nAU  - Heng, B.H.\nAU  - Lee, C.C.\nTI  - Severe acute respiratory syndrome-Singapore, 2003\nT2  - MMWR Morb. Mortal. Wkly. Rep\nPY  - 2003\nDA  - 2003\nVL  - 52\nSP  - 405\nLA  - \nER  - \n\nTY  - GEN\nAU  - Organization, World Health\nTI  - Summary of Probable SARS Cases with Onset of Illness from 1 November 2002 to 31\nUR  - http://www.who.int/csr/sars/country/table2004_04_21/en/index.html.\nC1  - (accessed on 27 January 2020).\nLA  - \nC1  - July 2003. Available online:\nER  - \n\nTY  - GEN\nAU  - Nuttall, I.\nAU  - Dye, C.\nTI  - The SARS wake-up call\nT2  - Science\nPY  - 2013\nDA  - 2013\nVL  - 339\nSP  - \"1287\nEP  - 1288.\" # \"422\nT2  - Chinese Center for Disease Control and Prevention. Epidemic Update and Risk Assessment of\nC1  - 12,\nC1  - 422\u2013428.\nLA  - \nER  - \n\nTY  - RPRT\nUR  - http://www.chinacdc.cn/yyrdgz/202001/P020200128523354919292.pdf\nC1  - (accessed on 28 January 2020).\nC1  - Available online:\nC1  - Novel Coronavirus\nER  - \n\nTY  - JOUR\nAU  - Gralinski, L.E.\nAU  - Menachery, V.D.\nTI  - Return of the Coronavirus: 2019-nCoV\nT2  - Viruses\nVL  - 2020\nSP  - \"135.\" # \"818.\"\nC1  - CrossRef\nPY  - 2004\nDA  - 2004\nN1  - CrossRef] [PubMed] 30\nC1  - 29. Wang, J. T.; Sheng, W. H.; Fang, C. T.; Chen, Y. C.; Wang, J. L.; Yu, C. J.; Yang, P. C.\nT2  - Clinical manifestations, laboratory findings, and treatment outcomes of SARS patients\nC1  - Emerg. Infect. Dis.\nC1  - 10,\nIS  - 12\nC1  - 818.\nLA  - \nC1  - [PubMed]\nER  - \n\nTY  - JOUR\nAU  - Fehr, A.R.\nAU  - Channappanavar, R.\nAU  - Perlman, S.\nTI  - Middle East respiratory syndrome: Emergence of a pathogenic human coronavirus\nT2  - Annu. Rev. Med\nPY  - 2017\nDA  - 2017\nVL  - 68\nSP  - 387\nEP  - 399\nC1  - CrossRef\nPB  - Trial Version\nUR  - http://www.nhc.gov.cn/jkj/s3577/202002/573340613ab243b3a7f61df260551dd4/files/c791e5a7ea5149f680fdcb34dac0f54e.pdf\nC1  - 31.\nT2  - National Health Commission of the People\u2019s Republic of China. Diagnosis and Treatment of Pneumonia Caused by 2019-nCoV\nC1  - 4). Available online: (accessed on 6 February 2020).\nLA  - \nC1  - [PubMed]\nER  - \n\nTY  - JOUR\nAU  - Yang, F.\nTI  - Pulmonary rehabilitation guidelines in the principle of 4S for patients infected with 2019 novel coronavirus\nPY  - 2019\nDA  - 2019\nT2  - Zhi\nVL  - 2020\nSP  - 004\nT2  - Zhonghua Jie He He Hu Xi Za\nIS  - 43\nLA  - \nER  - \n\nTY  - JOUR\nAU  - Lessler, J.\nAU  - Reich, N.G.\nAU  - Brookmeyer, R.\nAU  - Perl, T.M.\nAU  - Nelson, K.E.\nAU  - Cummings, D.A.\nTI  - Incubation periods of acute respiratory viral infections: A systematic review\nT2  - Lancet. Infect. Dis\nPY  - 2009\nDA  - 2009\nVL  - 9\nSP  - \"291\nEP  - 300.\" # \"207.\"\nC1  - CrossRef\nN1  - CrossRef] 35\nC1  - 34. Meltzer, M. I.\nT2  - Multiple contact dates and SARS incubation periods\nC1  - Emerg. Infect. Dis.\nC1  - 10,\nC1  - 207.\nLA  - \nER  - \n\nTY  - JOUR\nAU  - Zhu, N.\nAU  - Zhang, D.\nAU  - Wang, W.\nAU  - Li, X.\nAU  - Yang, B.\nAU  - Song, J.\nAU  - Zhao, X.\nAU  - Huang, B.\nAU  - Shi, W.\nAU  - Lu, R.\nTI  - A novel coronavirus from patients with pneumonia in China, 2019\nT2  - N. Engl. J. Med\nVL  - 2020\nSP  - 727\nEP  - 733\nN1  - CrossRef] 36\nC1  - true\nIS  - 382\nLA  - \nER  - \n\nTY  - GEN\nAU  - Yang, Y.\nAU  - Lu, Q.\nAU  - Liu, M.\nAU  - Wang, Y.\nAU  - Zhang, A.\nAU  - Jalali, N.\nAU  - Dean, N.\nAU  - Longini, I.\nAU  - Halloran, M.E.\nAU  - Xu, B.\nTI  - Epidemiological and clinical features of the 2019 novel coronavirus outbreak in China. medRxiv 2020\nPY  - [CrossRef] 37.\nDA  - [CrossRef] 37.\nC1  - true\nLA  - \nER  - \n\nTY  - JOUR\nAU  - Chan-Yeung, M.\nAU  - Xu, R.H.\nTI  - SARS: Epidemiology\nT2  - Respirology\nPY  - 2003\nDA  - 2003\nVL  - 8\nSP  - 9\nEP  - 14\nLA  - \nER  - \n\nTY  - JOUR\nAU  - Wang, C.\nAU  - Horby, P.W.\nAU  - Hayden, F.G.\nAU  - Gao, G.F.\nTI  - A novel coronavirus outbreak of global health concern\nT2  - Lancet\nVL  - 2020\nSP  - 470\nEP  - 473\nN1  - CrossRef] 39\nIS  - 395\nLA  - \nER  - \n\nTY  - GEN\nAU  - Peiris, J.S.\nAU  - Yuen, K.Y.\nAU  - Osterhaus, A.D.\nAU  - St\u00f6hr, K.\nTI  - The severe acute respiratory syndrome\nA2  - Med, N.Engl J.\nPY  - 2003\nDA  - 2003\nVL  - 349\nSP  - 2431\nEP  - 2441\nC1  - CrossRef\nLA  - \nC1  - [PubMed] 40.\nER  - \n\nTY  - GEN\nAU  - Leung, G.M.\nAU  - Hedley, A.J.\nAU  - Ho, L.-M.\nAU  - Chau, P.\nAU  - Wong, I.O.\nAU  - Thach, T.Q.\nAU  - Ghani, A.C.\nAU  - Donnelly, C.\nAU  - Fraser, C.\nAU  - Riley, S.\nTI  - The epidemiology of severe acute respiratory syndrome in the 2003 Hong Kong epidemic: An analysis of all 1755 patients\nT2  - Ann. Intern. Med\nPY  - 2004\nDA  - 2004\nVL  - 141\nSP  - 662\nEP  - 673\nUR  - http://m.news.cctv.com/2020/01/23/ARTIEw78LIxqpgx6Ilm7NkBo200123.shtml\nC1  - true\nC1  - Infectious Disease Expert Li Lanjuan Responded to Six Questions\nC1  - (accessed on 23 January 2020).\nLA  - \nC1  - of 2019-nCoV. Available online:\nER  - \n\nTY  - JOUR\nAU  - Li, Q.\nAU  - Guan, X.\nAU  - Wu, P.\nAU  - Wang, X.\nAU  - Zhou, L.\nAU  - Tong, Y.\nAU  - Ren, R.\nAU  - Leung, K.S.\nAU  - Lau, E.H.\nAU  - Wong, J.Y.\nPY  - 2020\nDA  - 2020\nC1  - CrossRef\nTI  - Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China\nT2  - Lancet\nVL  - 2020\nSP  - 497\nEP  - 506\nC1  - 43. Huang, C.; Wang, Y.; Li, X.; Ren, L.; Zhao, J.; Hu, Y.; Zhang, L.; Fan, G.; Xu, J.; Gu, X.; et al.\nC1  - true\nC1  - [CrossRef]\nIS  - 395\nLA  - \nC1  - [PubMed]\nER  - \n\nTY  - JOUR\nAU  - Chen, N.\nAU  - Zhou, M.\nAU  - Dong, X.\nAU  - Qu, J.\nAU  - Gong, F.\nAU  - Han, Y.\nAU  - Qiu, Y.\nAU  - Wang, J.\nAU  - Liu, Y.\nAU  - Wei, Y.\nTI  - Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study\nT2  - Lancet\nVL  - 2020\nSP  - 507\nEP  - 513\nC1  - CrossRef\nC1  - true\nIS  - 395\nLA  - \nER  - \n\nTY  - GEN\nTI  - Press Conference of the National Health Commission of the People\u2019s Republic of China on 3\nUR  - http://www.nhc.gov.cn/wjw/xwfbh/xwzb.shtml\nC1  - (accessed on 4 February 2020).\nLA  - \nC1  - February 2020. Available online:\nER  - \n\nTY  - JOUR\nAU  - Yuan, J.\nAU  - Hon, C.-C.\nAU  - Li, Y.\nAU  - Wang, D.\nAU  - Xu, G.\nAU  - Zhang, H.\nAU  - Zhou, P.\nAU  - Poon, L.\nAU  - Lam, T.Y.\nAU  - Leung, F.C.-C.\nTI  - Intraspecies diversity of SARS-like coronaviruses in Rhinolophus sinicus and its implications for the origin of SARS coronaviruses in humans\nT2  - J. Gen. Virol\nPY  - 2010\nDA  - 2010\nVL  - 91\nSP  - 1058\nEP  - 1062\nC1  - CrossRef-PubMed\nC1  - true\nLA  - \nER  - \n\nTY  - JOUR\nAU  - Phan, T.\nTI  - Novel coronavirus: From discovery to clinical diagnostics\nT2  - Infect. Genet. Evol\nVL  - 2020\nSP  - 104211\nC1  - CrossRef\nIS  - 79\nLA  - \nER  - \n\nTY  - JOUR\nAU  - Wang, M.\nAU  - Yan, M.\nAU  - Xu, H.\nAU  - Liang, W.\nAU  - Kan, B.\nAU  - Zheng, B.\nAU  - Chen, H.\nAU  - Zheng, H.\nAU  - Xu, Y.\nAU  - Zhang, E.\nTI  - SARS-CoV infection in a restaurant from palm civet\nT2  - Emerg. Infect. Dis\nPY  - 2005\nDA  - 2005\nVL  - 11\nSP  - 1860\nC1  - CrossRef\nC1  - true\nLA  - \nER  - \n\nTY  - GEN\nAU  - Zhou, P.\nAU  - Yang, X.-L.\nAU  - Wang, X.-G.\nAU  - Hu, B.\nAU  - Zhang, L.\nAU  - Zhang, W.\nAU  - Si, H.-R.\nAU  - Zhu, Y.\nAU  - Li, B.\nAU  - Huang, C.-L.\nTI  - Discovery of a novel coronavirus associated with the recent pneumonia outbreak in humans and its potential bat origin. bioRxiv 2020\nC1  - CrossRef\nC1  - true\nLA  - \nER  - \n\nTY  - GEN\nAU  - Guo, Q.\nAU  - Li, M.\nAU  - Wang, C.\nAU  - Wang, P.\nAU  - Fang, Z.\nAU  - Tan, J.\nAU  - Wu, S.\nAU  - Xiao, Y.\nAU  - Zhu, H.\nTI  - Host and infectivity prediction of Wuhan 2019 novel coronavirus using deep learning algorithm. bioRxiv 2020\nC1  - CrossRef\nLA  - \nER  - \n\nTY  - JOUR\nAU  - Ji, W.\nAU  - Wang, W.\nAU  - Zhao, X.\nAU  - Zai, J.\nAU  - Li, X.\nTI  - Homologous recombination within the spike glycoprotein of the newly identified coronavirus may boost cross-species transmission from snake to human\nT2  - J. Med. Virol\nVL  - 2020\nSP  - 433\nEP  - 440\nC1  - CrossRef\nIS  - 92\nLA  - \nER  - \n\nTY  - GEN\nTI  - South China Agricultural University: Pangolin May Be a Potential Intermediate Host of New Coronavirus\nUR  - http://www.chinanews.com/sh/2020/02-07/9082279.shtml\nC1  - (accessed on 7 February 2020).\nLA  - \nC1  - Available online:\nER  - \n\nTY  - JOUR\nAU  - Chowell, G.\nAU  - Castillo-Chavez, C.\nAU  - Fenimore, P.W.\nAU  - Kribs-Zaleta, C.M.\nAU  - Arriola, L.\nAU  - Hyman, J.M.\nTI  - Model parameters and outbreak control for SARS\nT2  - Emerg. Infect. Dis\nPY  - 2004\nDA  - 2004\nVL  - 10\nC1  - CrossRef-PubMed\nLA  - \nER  - \n\nTY  - JOUR\nAU  - Lau, E.H.Y.\nAU  - Hsiung, C.A.\nAU  - Cowling, B.J.\nAU  - Chen, C.-H.\nAU  - Ho, L.-M.\nAU  - Tsang, T.\nAU  - Chang, C.-W.\nAU  - Donnelly, C.\nAU  - Leung, G.M.\nTI  - A comparative epidemiologic analysis of SARS in Hong Kong, Beijing and Taiwan\nT2  - BMC Infect. Dis\nPY  - 2010\nDA  - 2010\nVL  - 10\nSP  - 50\nC1  - CrossRef-PubMed\nLA  - \nER  - \n\nTY  - RPRT\nTI  - Distribution of Pneumonia Infected by 2019-nCoV\nUR  - Available\nLA  - \nC1  - online: http://2019ncov.chinacdc.cn/2019-nCoV/(on 15 February 2020).\nC1  - Chinese Center for Disease Control and Prevention\nER  - \n\nTY  - GEN\nTI  - Real-time Updates of COVID-19 Epidemic in China\nUR  - https://ncov.dxy.cn/ncovh5/view/pneumonia\nC1  - (accessed on 15 February 2020).\nLA  - \nC1  - Available online:\nER  - \n\nTY  - JOUR\nAU  - Nishiura, H.\nAU  - Jung, S.-M.\nAU  - Linton, N.\nAU  - Kinoshita, R.\nAU  - Yang, Y.\nAU  - Hayashi, K.\nAU  - Kobayashi, T.\nAU  - Yuan, B.\nAU  - Akhmetzhanov, A.R.\nTI  - The extent of transmission of novel coronavirus in Wuhan, China, 2020\nT2  - J. Clin. Med\nVL  - 2020\nSP  - 330\nC1  - CrossRef\nIS  - 9\nLA  - \nER  - \n\nTY  - JOUR\nAU  - Li, X.\nAU  - Zai, J.\nAU  - Wang, X.\nAU  - Li, Y.\nTI  - Potential of large \u2018first generation\u2019 human-to-human transmission of 2019-nCoV\nT2  - J. Med. Virol\nVL  - 2020\nSP  - 448\nEP  - 454\nC1  - CrossRef\nIS  - 92\nLA  - \nER  - \n\nTY  - JOUR\nAU  - Carlos, W.G.\nAU  - Dela Cruz, C.S.\nAU  - Cao, B.\nAU  - Pasnick, S.\nAU  - Jamil, S.\nT2  - Novel Wuhan\nPY  - 2019\nDA  - 2019\nTI  - Coronavirus\nSP  - 7\nEP  - 8\nC1  - CrossRef\nC1  - Am. J. Respir. Crit. Care Med.\nLA  - \nER  - \n\nTY  - BOOK\nTI  - the People\u2019s Republic of China. The Role of Fecal-Oral Transmission in All transmission Still Need Further\nPB  - Observation and Research. Available\nUR  - http://news.cctv.com/2020/02/13/ARTISJWExxLSLWoL8mtJos97200213.shtml\nC1  - (accessed on 13 February 2020).\nLA  - \nC1  - online:\nC1  - National Health Commission of\nER  - \n\nTY  - RPRT\nTI  - There Is No Evidence That the New Coronavirus Can Be Transmitted through Aerosol\nUR  - http://news.cctv.com/2020/02/09/ARTIiVFnLC1ww5sTSMqbcXlz200209.shtml\nC1  - (accessed on 9 February 2020).\nLA  - \nC1  - Available online:\nC1  - Chinese Center for Disease Control and Prevention\nER  - \n\nTY  - JOUR\nAU  - Lau, J.T.\nAU  - Tsui, H.\nAU  - Lau, M.\nAU  - Yang, X.\nTI  - SARS transmission, risk factors, and prevention in Hong Kong\nT2  - Emerg. Infect. Dis\nPY  - 2004\nDA  - 2004\nVL  - 10\nSP  - 587\nC1  - CrossRef\nLA  - \nER  - \n\nTY  - JOUR\nAU  - Lu, H.\nAU  - Stratton, C.W.\nAU  - Tang, Y.W.\nTI  - Outbreak of Pneumonia of Unknown Etiology in Wuhan China: The Mystery and the Miracle\nT2  - J. Med. Virol\nVL  - 2020\nSP  - 401\nEP  - 402\nC1  - CrossRef\nIS  - 92\nLA  - \nER  - \n\nTY  - JOUR\nAU  - Rouquet, P.\nAU  - Froment, J.-M.\nAU  - Bermejo, M.\nAU  - Kilbourn, A.\nAU  - Karesh, W.\nAU  - Reed, P.\nAU  - Kumulungui, B.\nAU  - Yaba, P.\nAU  - Delicat, A.\nAU  - Rollin, P.E.\nTI  - Wild animal mortality monitoring and human Ebola outbreaks, Gabon and Republic of Congo, 2001\u20132003\nT2  - Emerg. Infect. Dis\nPY  - 2005\nDA  - 2005\nVL  - 11\nSP  - 283\nC1  - CrossRef\nC1  - true\nLA  - \nER  - \n\nTY  - JOUR\nAU  - Yoo, J.H.\nTI  - The Fight against the 2019-nCoV Outbreak: An Arduous March Has Just Begun\nT2  - J. Korean Med. Sci\nVL  - 2020\nSP  - 56\nC1  - CrossRef\nIS  - 35\nLA  - \nER  - \n\nTY  - JOUR\nAU  - De Wit, E.\nAU  - van Doremalen, N.\nAU  - Falzarano, D.\nAU  - Munster, V.J.\nTI  - SARS and MERS: Recent insights into emerging coronaviruses\nT2  - Nat. Rev. Microbiol\nPY  - 2016\nDA  - 2016\nVL  - 14\nSP  - 523\nC1  - CrossRef-PubMed\nLA  - \nER  - \n\nTY  - RPRT\nTI  - The First New Coronavirus Species Information Was Published by the National Pathogen Microorganism Resource Bank\nUR  - http://www.chinacdc.cn/yw_9324/202001/t20200124_211413.html\nC1  - (accessed on 1 February 2020).\nLA  - \nC1  - Available online:\nC1  - Chinese Center for Disease Control and Prevention\nER  - \n\nTY  - JOUR\nAU  - Zeng, Q.\nAU  - Khan, K.\nAU  - Wu, J.\nAU  - Zhu, H.\nTI  - The utility of preemptive mass influenza vaccination in controlling a SARS outbreak during flu season\nT2  - Math. Biosci. Eng\nPY  - 2007\nDA  - 2007\nVL  - 4\nSP  - 739\nC1  - PubMed\nLA  - \nER  - \n\nTY  - JOUR\nAU  - Wang, N.\nAU  - Luo, C.\nAU  - Liu, H.\nAU  - Yang, X.-L.\nAU  - Hu, B.\nAU  - Zhang, W.\nAU  - Li, B.\nAU  - Zhu, Y.\nAU  - Zhu, G.\nAU  - Shen, X.\nTI  - Characterization of a New Member of Alphacoronavirus with Unique Genomic Features in Rhinolophus Bats\nT2  - Viruses\nPY  - 2019\nDA  - 2019\nVL  - 11\nSP  - 379\nC1  - CrossRef-PubMed\nC1  - true\nLA  - \nER  - \n\nTY  - JOUR\nAU  - Bhadra, S.\nAU  - Jiang, Y.S.\nAU  - Kumar, M.R.\nAU  - Johnson, R.F.\nAU  - Hensley, L.E.\nAU  - Ellington, A.D.\nTI  - Real-time sequence-validated loop-mediated isothermal amplification assays for detection of Middle East respiratory syndrome coronavirus (MERS-CoV)\nT2  - PLoS ONE\nPY  - 2015\nDA  - 2015\nVL  - 10\nSP  - 0123126\nC1  - CrossRef-PubMed\nLA  - \nER  - \n\nTY  - JOUR\nAU  - Chan, J.F.-W.\nAU  - Choi, G.K.-Y.\nAU  - Tsang, A.K.-L.\nAU  - Tee, K.-M.\nAU  - Lam, H.-Y.\nAU  - Yip, C.C.-Y.\nAU  - To, K.K.-W.\nAU  - Cheng, V.C.-C.\nAU  - Yeung, M.L.\nAU  - Lau, S.K.\nTI  - Development and evaluation of novel real-time reverse transcription-PCR assays with locked nucleic acid probes targeting leader sequences of human-pathogenic coronaviruses\nT2  - J. Clin. Microbiol\nPY  - 2015\nDA  - 2015\nVL  - 53\nSP  - 2722\nEP  - 2726\nC1  - CrossRef\nC1  - true\nLA  - \nER  - \n\nTY  - JOUR\nAU  - Wu, P.\nAU  - Hao, X.\nAU  - Lau, E.H.Y.\nAU  - Wong, J.Y.\nAU  - Leung, K.S.M.\nAU  - Wu, J.T.\nAU  - Cowling, B.J.\nAU  - Leung, G.M.\nTI  - Real-time tentative assessment of the epidemiological characteristics of novel coronavirus infections in Wuhan, China, as at 22 January 2020\nT2  - Euro. Surveill\nVL  - 2020\nPY  - 2000\nDA  - 2000\nC1  - CrossRef\nIS  - 25\nLA  - \nER  - \n\nTY  - GEN\nAU  - Administration, National Medical Products\nTI  - National Medical Products Administration Examined and Approved the New Nucleic Acid Test Reagent of Coronavirus Again\nUR  - http://www.nmpa.gov.cn/WS04/CL2056/374398.html\nC1  - (accessed on 28 January 2020).\nLA  - \nC1  - Available online:\nER  - \n\nTY  - JOUR\nAU  - Chen, Y.\nAU  - Liu, Q.\nAU  - Guo, D.\nTI  - Emerging coronaviruses: Genome structure, replication, and pathogenesis\nT2  - J. Med. Virol\nVL  - 2020\nSP  - 418\nEP  - 423\nC1  - CrossRef\nIS  - 92\nLA  - \nER  - \n\nTY  - JOUR\nAU  - Cinatl, J.\nAU  - Morgenstern, B.\nAU  - Bauer, G.\nAU  - Chandra, P.\nAU  - Rabenau, H.\nAU  - Doerr, H.W.\nTI  - Treatment of SARS with human interferons\nT2  - Lancet\nPY  - 2003\nDA  - 2003\nVL  - 362\nSP  - 293\nEP  - 294\nC1  - CrossRef\nLA  - \nER  - \n\nTY  - JOUR\nAU  - Chu, C.M.\nAU  - Cheng, V.C.C.\nAU  - Hung, I.F.N.\nAU  - Wong, M.M.L.\nAU  - Chan, K.\nAU  - Kao, R.Y.\nAU  - Poon, L.\nAU  - Wong, C.L.P.\nAU  - Guan, Y.\nAU  - Peiris, J.S.M.\nTI  - Role of lopinavir/ritonavir in the treatment of SARS: Initial virological and clinical findings\nT2  - Thorax\nPY  - 2004\nDA  - 2004\nVL  - 59\nSP  - 252\nEP  - 256\nC1  - CrossRef\nC1  - true\nLA  - \nER  - \n\nTY  - CHAP\nAU  - Lu, H.\nTI  - Drug treatment options for the 2019-new coronavirus\nPY  - 2019\nDA  - 2019\nUR  - http://wjw.beijing.gov.cn/wjwh/ztzl/xxgzbd/202001/t20200126_1621354.html\nT2  - Biosci. Trends 2020. [CrossRef] 78. Beijing Municipal Health Commission. Explanation on the Situation that Drugs for AIDS Can Be Tried to Treat Pneumonia Caused by 2019-nCoV Infection\nC1  - (accessed on 26 January 2020).\nLA  - \nC1  - Available online:\nER  - \n\nTY  - BOOK\nTI  - The Joint Research Team of Shanghai Institute of Materia Medica, Chinese Academy of Sciences, and ShanghaiTech University Discovered a Batch of Old Drugs and Traditional Chinese Medicines with Therapeutic\nPB  - Potential for COVID-19\nUR  - http://www.shanghaitech.edu.cn/2020/0125/c1001a50141/page.htm\nC1  - (accessed on 25 January 2020).\nLA  - \nC1  - Available online:\nER  - \n\nTY  - RPRT\nTI  - High-Resolution Crystal Structure of 2019-nCoV Coronavirus 3CL Hydrolase (Mpro) was Announced by the Joint Research Team of Shanghai Institute of Materia Medica, Chinese Academy\nUR  - http://www.shanghaitech.edu.cn/2020/0126/c1001a50145/page.htm\nC1  - (accessed on 26 January 2020).\nLA  - \nC1  - Available online:\nC1  - of Sciences, and ShanghaiTech University\nER  - \n\nTY  - JOUR\nAU  - Xu, Z.\nAU  - Peng, C.\nAU  - Shi, Y.\nAU  - Zhu, Z.\nAU  - Mu, K.\nAU  - Wang, X.\nAU  - Zhu, W.\nTI  - Nelfinavir was predicted to be a potential inhibitor of 2019 nCov main protease by an integrative approach combining homology modelling, molecular docking and binding free energy calculation. bioRxiv 2020\nT2  - [CrossRef]\nVL  - 82\nSP  - 222\nN1  - CrossRef] [PubMed] 83\nC1  - Sheahan, T. P.; Sims, A. C.; Leist, S. R.; Sch\u00e4fer, A.; Won, J.; Brown, A. J.; Montgomery, S. A.; Hogg, A.; Babusis, D.; Clarke, M. O.; et al.\nT2  - Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV\nC1  - Nat. Commun.\nC1  - 2020, 11,\nLA  - \nER  - \n\nTY  - JOUR\nAU  - Mulangu, S.\nAU  - Dodd, L.E.\nAU  - Davey, R.T.\nAU  - Mbaya, O.T.\nAU  - Proschan, M.\nAU  - Mukadi, D.\nAU  - Manzo, M.L.\nAU  - Nzolo, D.\nAU  - Oloma, A.T.\nAU  - Ibanda, A.\nTI  - A randomized, controlled trial of Ebola virus disease therapeutics\nT2  - N. Engl. J. Med\nPY  - 2019\nDA  - 2019\nVL  - 381\nSP  - 2293\nEP  - 2303\nC1  - CrossRef-PubMed\nC1  - true\nLA  - \nER  - \n\nTY  - JOUR\nAU  - Holshue, M.L.\nAU  - DeBolt, C.\nAU  - Lindquist, S.\nAU  - Lofy, K.H.\nAU  - Wiesman, J.\nAU  - Bruce, H.\nAU  - Spitters, C.\nAU  - Ericson, K.\nAU  - Wilkerson, S.\nAU  - Tural, A.\nT2  - First Case of\nPY  - 2019\nDA  - 2019\nTI  - Novel Coronavirus in the United States\nC1  - CrossRef\nC1  - true\nC1  - N. Engl. J. Med.\nLA  - \nER  - \n\nTY  - GEN\nAU  - Song, G.\nAU  - Cheng, M.Q.\nAU  - Wei, X.W.\nTI  - Research progress on novel coronavirus\nPY  - 2019\nDA  - 2019\nC1  - CrossRef\nT2  - related drugs in vitro/vivo. Bing Du Xue Bao 2020\nLA  - \nER  - \n\nTY  - GEN\nTI  - China-Japan Friendship Hospital: Clinical Experimental Research Work Is Being Carried Out on Remdesivir\nUR  - http://www.chinanews.com/sh/shipin/cns-d/2020/02-12/news847712.shtml\nC1  - (accessed on 12 February 2020).\nLA  - \nC1  - Available online:\nER  - \n\nTY  - JOUR\nAU  - Lai, M.M.\nTI  - Recombination in large RNA viruses: Coronaviruses. Semin\nT2  - Virol\nPY  - 1996\nDA  - 1996\nVL  - 7\nSP  - \"381\nEP  - 388.\" # \"3995\nC1  - CrossRef\nC1  - 88. Woo, P. C. Y.; Lau, S. K.; Lam, C. S. F.; Lau, C. C. Y.; Tsang, A. K. L.; Lau, J. H. N.; Bai, R.; Teng, J. L. L.; Tsang, C. C. C.; Wang, M.; et al.\nT2  - Discovery of seven novel Mammalian and avian coronaviruses in the genus deltacoronavirus supports bat coronaviruses as the gene source of alphacoronavirus and betacoronavirus and avian coronaviruses as the gene source of gammacoronavirus and deltacoronavirus\nC1  - J. Virol.\nC1  - 86,\nC1  - 3995\u20134008.\nLA  - \nER  - \n\nTY  - JOUR\nAU  - Lu, R.\nAU  - Zhao, X.\nAU  - Li, J.\nAU  - Niu, P.\nAU  - Yang, B.\nAU  - Wu, H.\nAU  - Wang, W.\nAU  - Song, H.\nAU  - Huang, B.\nAU  - Zhu, N.\nTI  - Genomic characterisation and epidemiology of 2019 novel coronavirus: Implications for virus origins and receptor binding\nT2  - Lancet\nVL  - 2020\nSP  - \"565\nEP  - 574.\" # \"101.\"\nC1  - CrossRef\nPY  - 2019\nDA  - 2019\nC1  - 90. Shi, C. S.; Nabar, N. R.; Huang, N. N.; Kehrl, J. H.\nC1  - true\nT2  - SARS-Coronavirus Open Reading Frame-8b triggers intracellular stress pathways and activates NLRP3 inflammasomes\nC1  - Cell Death Discov.\nC1  - 5,\nIS  - 395\nC1  - 101.\nLA  - \nER  - \n\nTY  - JOUR\nAU  - Menachery, V.D.\nAU  - Graham, R.L.\nAU  - Baric, R.S.\nTI  - Jumping species\u2014A mechanism for coronavirus persistence and survival\nT2  - Curr. Opin. Virol\nPY  - 2017\nDA  - 2017\nVL  - 23\nSP  - 1\nEP  - 7\nPB  - CrossRef] 92\nLA  - \nER  - \n\nTY  - JOUR\nAU  - Wang, N.\nAU  - Li, S.-Y.\nAU  - Yang, X.-L.\nAU  - Huang, H.-M.\nAU  - Zhang, Y.-J.\nAU  - Guo, H.\nAU  - Luo, C.-M.\nAU  - Miller, M.\nAU  - Zhu, G.\nAU  - Chmura, A.\nTI  - Serological evidence of bat SARS-related coronavirus infection in humans, China\nT2  - Virol. Sin\nPY  - 2018\nDA  - 2018\nVL  - 33\nSP  - 104\nEP  - 107\nC1  - CrossRef\nC1  - true\nLA  - \nC1  - [PubMed] 93.\nER  - \n\nTY  - JOUR\nAU  - Xia, S.\nAU  - Yan, L.\nAU  - Xu, W.\nAU  - Agrawal, A.S.\nAU  - Algaissi, A.\nAU  - Tseng, C.-T.K.\nAU  - Wang, Q.\nAU  - Du, L.\nAU  - Tan, W.\nAU  - Wilson, I.A.\nTI  - A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike\nT2  - Sci. Adv\nPY  - 2019\nDA  - 2019\nVL  - 5\nSP  - 4580\nN1  - CrossRef] [PubMed] 94\nC1  - true\nLA  - \nER  - \n\nTY  - JOUR\nAU  - Nicholls, J.\nAU  - DONG, X.P.\nAU  - Jiang, G.\nAU  - Peiris, M.\nTI  - SARS: Clinical virology and pathogenesis\nT2  - Respirology\nPY  - 2003\nDA  - 2003\nVL  - 8\nSP  - 6\nEP  - 8\nC1  - CrossRef\nLA  - \nC1  - [PubMed] 95.\nER  - \n\nTY  - JOUR\nAU  - He, L.\nAU  - Ding, Y.\nAU  - Zhang, Q.\nAU  - Che, X.\nAU  - He, Y.\nAU  - Shen, H.\nAU  - Wang, H.\nAU  - Li, Z.\nAU  - Zhao, L.\nAU  - Geng, J.\nTI  - Expression of elevated levels of pro-inflammatory cytokines in SARS-CoV-infected ACE2+ cells in SARS patients: Relation to the acute lung injury and pathogenesis of SARS\nT2  - J. Pathol\nPY  - 2006\nDA  - 2006\nVL  - 210\nSP  - 288\nEP  - 297\nN1  - CrossRef] [PubMed] 96\nC1  - true\nLA  - \nER  - \n\nTY  - JOUR\nAU  - Hamming, I.\nAU  - Timens, W.\nAU  - Bulthuis, M.L.C.\nAU  - Lely, A.T.\nAU  - Navis, G.J.\nAU  - van Goor, H.\nTI  - Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis\nT2  - J. Pathol\nPY  - 2004\nDA  - 2004\nVL  - 203\nSP  - 631\nEP  - 637\nC1  - CrossRef\nLA  - \nC1  - [PubMed] 97.\nER  - \n\nTY  - JOUR\nAU  - Perlman, S.\nAU  - Netland, J.\nTI  - Coronaviruses post-SARS: Update on replication and pathogenesis\nT2  - Nat. Rev. Microbiol\nPY  - 2009\nDA  - 2009\nVL  - 7\nSP  - 439\nEP  - 450\nN1  - CrossRef] 98\nLA  - \nER  - \n\nTY  - JOUR\nAU  - Ding, Y.\nAU  - Wang, H.\nAU  - Shen, H.\nAU  - Li, Z.\nAU  - Geng, J.\nAU  - Han, H.\nAU  - Cai, J.\nAU  - Li, X.\nAU  - Kang, W.\nAU  - Weng, D.\nTI  - The clinical pathology of severe acute respiratory syndrome (SARS): A report from China\nT2  - J. Pathol\nPY  - 2003\nDA  - 2003\nC1  - true\nLA  - \nER  - \n\nTY  - JOUR\nAU  - Ding, Y.\nAU  - He, L.\nAU  - Zhang, Q.\nAU  - Huang, Z.\nAU  - Che, X.-Y.\nAU  - Hou, J.-L.\nAU  - Wang, H.\nAU  - Shen, H.\nAU  - Qiu, L.\nAU  - Li, Z.\nTI  - Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: Implications for pathogenesis and virus transmission pathways\nT2  - J. Pathol\nPY  - 2004\nDA  - 2004\nVL  - 203\nSP  - \"622\nEP  - 630.\" # \"S20\nC1  - CrossRef] 100. HUI\nC1  - D. S. C.; WONG, P. C.; Wang, C.\nC1  - true\nT2  - SARS: Clinical features and diagnosis\nC1  - Respirology\nC1  - 8,\nC1  - S20\u2013S24.\nLA  - \nER  - \n\nTY  - JOUR\nAU  - Millet, J.K.\nAU  - Whittaker, G.R.\nTI  - Host cell proteases: Critical determinants of coronavirus tropism and pathogenesis\nT2  - Virus. Res\nPY  - 2015\nDA  - 2015\nVL  - 202\nSP  - 120\nEP  - 134\nN1  - CrossRef] 102\nLA  - \nER  - \n\nTY  - JOUR\nAU  - Zhou, P.\nAU  - Yang, X.-L.\nAU  - Wang, X.-G.\nAU  - Hu, B.\nAU  - Zhang, L.\nAU  - Zhang, W.\nAU  - Si, H.-R.\nAU  - Zhu, Y.\nAU  - Li, B.\nAU  - Huang, C.-L.\nTI  - A pneumonia outbreak associated with a new coronavirus of probable bat origin\nT2  - Nature\nPY  - 2020\nDA  - 2020\nC1  - CrossRef\nC1  - true\nLA  - \nC1  - [PubMed] 103.\nER  - \n\nTY  - JOUR\nAU  - Kuba, K.\nAU  - Imai, Y.\nAU  - Rao, S.\nAU  - Gao, H.\nAU  - Guo, F.\nAU  - Guan, B.\nAU  - Huan, Y.\nAU  - Yang, P.\nAU  - Zhang, Y.\nAU  - Deng, W.\nTI  - A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus\u2013induced lung injury\nT2  - Nat. Med\nPY  - 2005\nDA  - 2005\nVL  - 11\nSP  - 875\nEP  - 879\nC1  - CrossRef-PubMed\nC1  - true\nLA  - \nER  - \n\nTY  - JOUR\nAU  - Imai, Y.\nAU  - Kuba, K.\nAU  - Rao, S.\nAU  - Huan, Y.\nAU  - Guo, F.\nAU  - Guan, B.\nAU  - Yang, P.\nAU  - Sarao, R.\nAU  - Wada, T.\nAU  - Leong-Poi, H.\nTI  - Angiotensin-converting enzyme 2 protects from severe acute lung failure\nT2  - Nature\nPY  - 2005\nDA  - 2005\nVL  - 436\nSP  - 112\nEP  - 116\nC1  - CrossRef-PubMed\nC1  - true\nLA  - \nER  - \n\nTY  - JOUR\nAU  - Li, W.\nAU  - Moore, M.J.\nAU  - Vasilieva, N.\nAU  - Sui, J.\nAU  - Wong, S.K.\nAU  - Berne, M.A.\nAU  - Somasundaran, M.\nAU  - Sullivan, J.L.\nAU  - Luzuriaga, K.\nAU  - Greenough, T.C.\nTI  - Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus\nT2  - Nature\nPY  - 2003\nDA  - 2003\nVL  - 426\nSP  - 450\nEP  - 454\nC1  - CrossRef\nC1  - true\nLA  - \nER  - \n\nTY  - JOUR\nAU  - Wan, Y.\nAU  - Shang, J.\nAU  - Graham, R.\nAU  - Baric, R.S.\nAU  - Li, F.\nTI  - Receptor recognition by novel coronavirus from Wuhan: An analysis based on decade-long structural studies of SARS\nT2  - J. Virol\nPY  - 2020\nDA  - 2020\nC1  - CrossRef\nLA  - \nER  - \n\nTY  - JOUR\nAU  - Bassetti, M.\nAU  - Vena, A.\nAU  - Roberto Giacobbe, D.\nTI  - The Novel Chinese Coronavirus\nPY  - 2019\nDA  - 2019\nT2  - Eur. J. Clin. Investig\nC1  - CrossRef\nT2  - Infections: Challenges for fighting the storm\nLA  - \nER  - \n\nTY  - JOUR\nAU  - Su, S.\nAU  - Wong, G.\nAU  - Shi, W.\nAU  - Liu, J.\nAU  - Lai, A.C.\nAU  - Zhou, J.\nAU  - Liu, W.\nAU  - Bi, Y.\nAU  - Gao, G.F.\nTI  - Epidemiology, genetic recombination, and pathogenesis of coronaviruses\nT2  - Trends. Microbiol\nPY  - 2016\nDA  - 2016\nVL  - 24\nSP  - 490\nEP  - 502\nC1  - CrossRef\nLA  - \nER  - \n\nTY  - GEN\nAU  - Chu, D.K.W.\nAU  - Poon, L.\nAU  - Gomaa, M.\nAU  - Shehata, M.\nAU  - Perera, R.A.\nAU  - Abu Zeid, D.\nAU  - El Rifay, A.S.\nAU  - Siu, L.Y.\nAU  - Guan, Y.\nAU  - Webby, R.J.\nTI  - MERS coronaviruses in dromedary camels, Egypt\nT2  - Emerg. Infect. Dis.\nPY  - 2014\nDA  - 2014\nVL  - 20\nC1  - CrossRef\nC1  - true\nLA  - \nER  - \n\n",
        "author_conclusions": [],
        "table_captions": [
            {
                "id": "1",
                "caption": "Comparison of SARS and COVID-19"
            },
            {
                "id": "2",
                "caption": "Comparison of protein sequences SARS-CoV-2 and SARS-CoV by Blastp"
            },
            {
                "id": "3",
                "caption": "Proposed questions to study SARS-CoV-2 for future studies"
            },
            {
                "id": "S1",
                "caption": "The genomic information of latest SARS-CoV-2 strains"
            }
        ],
        "figure_captions": [],
        "tables_url": "https://scholarcy.nyc3.digitaloceanspaces.com/tables/docker-test/cc4d0387dcd6f483d1115bb68d0fa294.xlsx"
    },
    "sections": {
        "introduction": [
            "Coronaviruses (CoVs) are a group of viruses that co-infect humans and other vertebrate animals. CoV infections affect the respiratory, gastrointestinal, liver, and central nervous systems of humans, livestock, birds, bats, mice, and many other wild animals [<a class=\"ref-link\" id=\"c1\" href=\"#r1\">1</a>\u2013<a class=\"ref-link\" id=\"c3\" href=\"#r3\">3</a>]. For example, severe acute respiratory syndrome (SARS) in 2002 and the Middle East respiratory syndrome (MERS) in 2012 were both coronaviruses that transmitted from animals to humans [<a class=\"ref-link\" id=\"c4\" href=\"#r4\">4</a>,<a class=\"ref-link\" id=\"c5\" href=\"#r5\">5</a>]. The source of unexplained pneumonia was first discovered in Wuhan in Dec, 2019, and SARS-CoV-2, a new coronavirus, was isolated from the respiratory epithelium of patients. It belongs to a new evolutionary branch within the CoV. On Feb. 11th, 2020, the new coronavirus was officially renamed \u201cSARS-CoV-2\u201d from \u201c2019-nCoV\u201d [<a class=\"ref-link\" id=\"c6\" href=\"#r6\">6</a>]. The disease caused by SARS-CoV-2 was called \u201ccoronavirus disease 2019\u201d (COVID-19) [<a class=\"ref-link\" id=\"c7\" href=\"#r7\">7</a>]. According to"
        ],
        "methods": [
            "2.1. Data Collection<br/><br/>The complete genomic sequences of SARS-CoV-2 were obtained from 2019 Novel Coronavirus Resource (2019nCoVR) [<a class=\"ref-link\" id=\"c12\" href=\"#r12\">12</a>] and two databases, including the National Center for Biotechnology Information (NCBI) [<a class=\"ref-link\" id=\"c13\" href=\"#r13\">13</a>] and Global Initiative on Sharing All Influenza Data (GISAID) [<a class=\"ref-link\" id=\"c14\" href=\"#r14\">14</a>]. The DNA sequences of two other representative CoVs (SARS-CoV and MERS-CoV) were included for comparative analysis. The genomic information of latest SARS-CoV-2 strains is shown in Table S1.<br/><br/>2.2. Homology Analysis<br/><br/>The amino acid sequences of 28 proteins in SARS-CoV-2 were compared with those of SARS-CoV to analyze protein homology by using NCBI Blastp [<a class=\"ref-link\" id=\"c15\" href=\"#r15\">15</a>]. Proteins from SARS and SARS-CoV-2 were treated as homologous: identity value \u2265 65%, query coverage \u2265 95%.",
            "Treatment<br/><br/>SARS Nov. 16th, 2002 in Foshan, Guangdong<br/><br/>SARS-CoV Paguma larvata Rhinolophus sinicus<br/><br/>RNA virus \u03b2-coronavirus<br/><br/>29,751 1\u20134 days on average    Young adults<br/><br/>1:1.25 9.60% Fever, cough, myalgia, dyspnea, and diarrhea Droplets or close contacts Beijing, Guangdong, Shanxi in China RT-PCR, rRT-PCR, RT-LAMP, rRT-LAMP, Coronavirus detection kit Glucocorticoid and interferon<br/><br/>COVID-19 Dec. 07th, 2019 in Wuhan, Hubei<br/><br/>SARS-CoV-2 Pangolin, Mink (Possible) Rhinolophus affinis (Possible)<br/><br/>29,903 3\u20137 days on average People who have not been exposed to<br/><br/>SARS-CoV-2 2.70:1 2.10%"
        ],
        "results": [
            "The differences and similarities of clinical characteristics between COVID-19 and SARS were summarized in Table 1.<br/><br/>Items First occurrence<br/><br/>Pathogen Intermediate host<br/><br/>Definitive host Virus type<br/><br/>Species pathogen Total DNA sequence length of pathogen    Latency<br/><br/>Susceptible people<br/><br/>Male\u2013female patient ratio Mortality<br/><br/>Clinical symptoms<br/><br/>Propagation mode Major regional distribution"
        ],
        "discussion": [
            "As a large number of people have left Wuhan, the control of the epidemic situation is extremely urgent, and the treatments of COVID-19 are imminent. On Feb. 14th, 2020, there were more than 54,000 confirmed patients in Hubei province, China [<a class=\"ref-link\" id=\"c55\" href=\"#r55\">55</a>]. Due to the lack of effective antiviral drugs, the prognosis of patients solely depends on their age and physical condition [<a class=\"ref-link\" id=\"c74\" href=\"#r74\">74</a>]. Although it was reported that the clinically recovered patients exceed the number of dead, the majority of the patients are still not cured in hospital. In addition, the potential adaptive mutation of SARS-CoV-2 makes it difficult for vaccine development. Therefore, it is urgent for us to develop more sensitive inspection methods and effective drugs."
        ],
        "supplementary": [
            "Materials: The following are available online at http://www.mdpi.com/1999-4915/12/2/244/s1, Figure S1: Phylogeny of SARS-CoV-2, SARS-CoV and MERS-CoV. Unrooted phylogenetic relationships are represented by constructing Neighbor-Joining tree. Table S1: The genomic information of latest SARS-CoV-2 strains<br/><br/>Author Contributions: Conceptualization, L.X., Y.W. and X.G.; methodology, J.X. and W.Z.; software, S.Z. and W.Z.; validation, J.X., S.Z. and T.T.; formal analysis, J.X. and S.Z.; writing\u2014original draft preparation, J.X. and S.Z.; writing\u2014review and editing, L.X., Y.W., W.Z. and X.G.; visualization, J.X., S.Z., and A.E.A.; funding acquisition, L.X., Y.W. and X.G. All authors have read and agreed to the published version of the manuscript."
        ],
        "funding": [
            "This work was supported by the 2020 New Coronavirus Prevention and Control Emergency Project (grant no. 201100310300), the Program for Innovative Talents of Science and Technology in Henan Province (grant no. 18HASTIT048)."
        ],
        "acknowledgments": [
            "All the genomic data of SARS-CoV-2 is from GISAID, NCBI/GenBank, NMDC, CNGB/CNGBdb and 2019nCoVR (Table S1). Here, we would like to express our gratitude to all units and individuals who are responsible for the sample collection and data submission."
        ],
        "disclosures": [
            "The authors declare no conflict of interest."
        ],
        "supplementary_references": {
            "supplementary_data_references": [
                "Supplementary Materials"
            ],
            "supplementary_figure_references": [
                "Table S1",
                "Figure S1"
            ]
        },
        "objectives": [
            "The goal of this work is to systematically review and compare between SARS-CoV and SARS-CoV-2 in the context of their virus incubation, originations, diagnosis and treatment methods, genomic and proteomic sequences, and pathogenic mechanisms"
        ]
    },
    "structured_content": {
        "1. Introduction": [
            "Coronaviruses (CoVs) are a group of viruses that co-infect humans and other vertebrate animals. CoV infections affect the respiratory, gastrointestinal, liver, and central nervous systems of humans, livestock, birds, bats, mice, and many other wild animals [<a class=\"ref-link\" id=\"c1\" href=\"#r1\">1</a>\u2013<a class=\"ref-link\" id=\"c3\" href=\"#r3\">3</a>]. For example, severe acute respiratory syndrome (SARS) in 2002 and the Middle East respiratory syndrome (MERS) in 2012 were both coronaviruses that transmitted from animals to humans [<a class=\"ref-link\" id=\"c4\" href=\"#r4\">4</a>,<a class=\"ref-link\" id=\"c5\" href=\"#r5\">5</a>]. The source of unexplained pneumonia was first discovered in Wuhan in Dec, 2019, and SARS-CoV-2, a new coronavirus, was isolated from the respiratory epithelium of patients. It belongs to a new evolutionary branch within the CoV. On Feb. 11th, 2020, the new coronavirus was officially renamed \u201cSARS-CoV-2\u201d from \u201c2019-nCoV\u201d [<a class=\"ref-link\" id=\"c6\" href=\"#r6\">6</a>]. The disease caused by SARS-CoV-2 was called \u201ccoronavirus disease 2019\u201d (COVID-19) [<a class=\"ref-link\" id=\"c7\" href=\"#r7\">7</a>]. According to",
            "Viruses 2020, 12, 244 the data released by the National Health Commission of the People\u2019s Republic of China, SARS-CoV-2 was most likely transmitted from wild bats to humans, and all the above three CoVs can transmit from person to person [<a class=\"ref-link\" id=\"c8\" href=\"#r8\">8</a>\u2013<a class=\"ref-link\" id=\"c10\" href=\"#r10\">10</a>]. SARS-CoV-2 shares a highly similar gene sequence and behavior pattern with SARS-CoV [<a class=\"ref-link\" id=\"c11\" href=\"#r11\">11</a>]. This paper summarized the similarities and differences between SARS-CoV-2 and SARS-CoV, both of which cause major disease outbreaks in China and worldwide, which will provide comprehensive reference for epidemic prevention."
        ],
        "2. Materials and Methods": [],
        "2.1. Data Collection": [
            "The complete genomic sequences of SARS-CoV-2 were obtained from 2019 Novel Coronavirus Resource (2019nCoVR) [<a class=\"ref-link\" id=\"c12\" href=\"#r12\">12</a>] and two databases, including the National Center for Biotechnology Information (NCBI) [<a class=\"ref-link\" id=\"c13\" href=\"#r13\">13</a>] and Global Initiative on Sharing All Influenza Data (GISAID) [<a class=\"ref-link\" id=\"c14\" href=\"#r14\">14</a>]. The DNA sequences of two other representative CoVs (SARS-CoV and MERS-CoV) were included for comparative analysis. The genomic information of latest SARS-CoV-2 strains is shown in Table S1."
        ],
        "2.2. Homology Analysis": [
            "The amino acid sequences of 28 proteins in SARS-CoV-2 were compared with those of SARS-CoV to analyze protein homology by using NCBI Blastp [<a class=\"ref-link\" id=\"c15\" href=\"#r15\">15</a>]. Proteins from SARS and SARS-CoV-2 were treated as homologous: identity value \u2265 65%, query coverage \u2265 95%."
        ],
        "2.3. Phylogenetic Analysis": [
            "Comparative genomic analyses of SARS-CoV-2 and SARS-CoV were performed by zpicture for the global comparison [<a class=\"ref-link\" id=\"c16\" href=\"#r16\">16</a>]. Multiple sequence alignment and the construction of phylogenetic trees of 38 CoVs were conducted using MEGA7 [<a class=\"ref-link\" id=\"c17\" href=\"#r17\">17</a>]. The evolutionary distances were calculated using the Maximum Composite Likelihood method [<a class=\"ref-link\" id=\"c18\" href=\"#r18\">18</a>]."
        ],
        "3. Results": [
            "The differences and similarities of clinical characteristics between COVID-19 and SARS were summarized in Table 1."
        ],
        "Diagnostic methods": [
            "1:1.25 9.60% Fever, cough, myalgia, dyspnea, and diarrhea Droplets or close contacts Beijing, Guangdong, Shanxi in China RT-PCR, rRT-PCR, RT-LAMP, rRT-LAMP, Coronavirus detection kit Glucocorticoid and interferon",
            "Droplets or close contacts Hubei, especially Wuhan in China RT-PCR, rRT-PCR, RT-LAMP, rRT-LAMP, Coronavirus detection kit Lopinavir/ritonavir (in testing)",
            "3.1. COVID-19 and SARS\u2014the Initial Events the COhMnindaNeijssooterrviM.rbe2ugi7ntiitoiohsnnt,ar2yl00o2f,HaeraelstBpheiraijanitnnogro,yuGniullcaneCnedgshstdihneoaarntugtp,htSieshdaanicnuxiGteinuraenspgdiroantHoguryPbresoiy,vneisndpcreoec,miCaelhlhyinaWad[ut1hh9ua].nsIfinnarFCrehebsi,nu2al0t0e3d, in 305 cases and five deaths R[2T0-]P. CTRh,erRfoTl-lPoCwRin, gRTm-LoAnMthP, ,there werReTc-lPuCsRte,rrsRoTf-PaCtyRp,iRcaTl-LpAnMeuPm, onia repoDritaegdnionstoicthmeretphaordtss of mrRaTin-lLaAnMd PC,hCinoaro, nHaovnirgusKdoentgec[t2io1n], CanraRdTa-L[A22M],Pa,nCdoSroinngavapiroursed[e2t3e]c.tiIonnJul, 2003, SATRrSe-aCtmoVenstpread acrossG2lu6ccoocuonrttircioeisdkiinat nsdixincotenrtfienreonnts, and caLuospeidnaavciur/mrituolknaiattivvier (8i,n09te6sctiansge)s and 774 deaths (9.6%) [<a class=\"ref-link\" id=\"c24\" href=\"#r24\">24</a>]. In particular, a higher mortality (21%) was found in hospital personnel [<a class=\"ref-link\" id=\"c25\" href=\"#r25\">25</a>,<a class=\"ref-link\" id=\"c26\" href=\"#r26\">26</a>].",
            "3.1O. nCODVeIcD. -1299atnhd, S2A01R9S,\u2014ththee hIneiatilathl Edveenptasrtments of Hubei Province received a report that four employees of the South China Seafood Wholesale Market were diagnosed with unknown-caused pneumoOnniaNinova. 2lo7ctha,l 2h0o0s2p, iatarle, swpihriacthorwy ailslntehses fierrustptreedpoinrtGouf aSnAgRdoSn-CgoPVr-o2vi[n2c7e],. COhninDa e[c1.9]3. 1Inst,F2e0b1, 9, the2N00a3t,iotnhealCHheinaeltshe CMoimnimstrisysioofnHoefaPltehoapnlenoRuenpcuebdlitchoaft CthhisinaacuantedrCeshpiinraetsoerCy esnytnedrrfoomr De ihsaedastehuCsonfatrrol andrePsureltveedntiinon30(5ChcainseasCaDndC)fipvaertdiceiapthatsed[20in]. tThheeinfvoellsotwigiantgiomn oanntdh,cathseer-esewarecrheincgluwsteorrsko[2f 7a]t.yOpincatlhe sNaomp[8w2e,n03ae9d]du.6aaImycny,aostsJ,nhuetieslha, age2rnoe0ndpv0u3oe7m,rr7tnSe4bmAdedRreiennSoa-ttfoChoptsohfaVe(Wt9rie.sp6unp%ahtrrsea)tasni[nd2or4ffeae]lm.ccerItaaneosidsnepsdlwaa2rn6iitntidhccfuooCSlurhaAmnrinR,taraaStie,i-hosHCingioonhaVnebsg-rio2xKmuccotooontnrnhgtttaeii[nln2idute1yin]es,est(Cs2at,1saoa%enncao)lddiuwmactabab[su2rew2fsoa]eo,kudarsnlnaddtdocwiuSnsimiodnhceugoi.ealsatBppytioyitv[ra2teelh8e]. datpeeorsfotnhniselp[2a5p,e2r6\u2019]s. submission, a cumulative 67,081 cases and 1,526 deaths (2.1%) were reported worldwide. In Wuhan, China, the number is 37,914. The main timeline of SARS and COVID-19 epidemic development were shown in Figure 1a,b, respectively.",
            "FigFuigruer1e. 1T.iTmimeleinlieneofofSASARRSS(a(a))aannddCCOOVVIIDD--1199 ((bb)) eeppiiddeemmiiccddeevveeloloppmmeennt.t.",
            "3.2. ClinOicnalDSeycm. p2t9otmhs, 2019, the health departments of Hubei Province received a report that four emTphleoiyneietisalosfytmhepStoomutshoCf ShAinRaSSpeaatfioeondtsWwheroelefseavleerM(1a0r0k%et),wcoeureghdi(a6g1n.8o%se),dmwyiathlgiuan(k4n8.o7w%n),-cdayusspendea (40.p8n%e)u,manodnidaiainrrahleoac(a3l1h.6o%sp)it[a2l9,]w, ahnicdhthweapsrtohgenfiorssitsroefppoarttioefnStsAwRaSs-CaossVo-c2ia[2te7d]. wOnithDheco.s3t1cshta, r2a0c1t9e,rtihsteics (incNluadtiionngalaHgee,algtehnCdoemr, metics.s)io[3n0o].f PDeuorpinlegRheopsupbiltiacliozfaCtihoinn,araenspdirCahtoinreysediCsternetsesr ofocrcuDrirseedasienC9o0n.8tr%olof S9.A8Ras[\u00b12anS8md3]p..eP0aNrdtdeioaevawyney,tansstdth[i[ao2e2yn99sg]],(.o.CtvDThheheuirnenrnaimdunCmuegDnrbtatChetorie)ofpodnWfaifrspruteoaihactmisiapeennadcttriesoesduelienarianfssseeeect,hdtoesenodisnimnewfvoteirettmopshtaisaSgtetAiaiveotRneinorStensa-CbrdaeoonesuVvdpt-ei2crtlaohacseptoeoen-drsdtyieisnaledeuraicuesshkestironteoopgsusectwbnlwiroimeaara,ksbkla[yws2nm7tooa]rp.vlsdhOeoworncapiitegdehteenye.ioaf, andBtyhrtohme bdoacteytoofpethniisa pwaipthera\u2019sn usupbrmegiusslaiotino,naocfuamspualrattaitveetr6a7n,0s8a1mcinasaesse (aAnSdT1),,5a2l6andineaetahms i(n2o.1t%ra)nwsfeerraese (ALT), lactic dehydrogenase (LDH), and C-reactive protein (CRP) [<a class=\"ref-link\" id=\"c29\" href=\"#r29\">29</a>].",
            "dyspnea (40.8%), and diarrhea (31.6%) [<a class=\"ref-link\" id=\"c29\" href=\"#r29\">29</a>], and the prognosis of patients was associated with host characteristics (including age, gender, etc.) [<a class=\"ref-link\" id=\"c30\" href=\"#r30\">30</a>]. During hospitalization, respiratory distress occurred in 90.8% of SARS patients [<a class=\"ref-link\" id=\"c29\" href=\"#r29\">29</a>]. The duration from disease onset to severe respiratory distress was an average of 9.8 \u00b1 3.0 days [<a class=\"ref-link\" id=\"c29\" href=\"#r29\">29</a>]. During the disease course, some patients developed leukopenia, lymphopeVniirau,seasn2d020th, 1r2o,m24b4 ocytopenia with an upregulation of aspartate transaminase (AST), alanine aminotransferase (ALT), lactic dehydrogenase (LDH), and C-reactive protein (CRP) [<a class=\"ref-link\" id=\"c29\" href=\"#r29\">29</a>].",
            "In comparIisnonco, mCOpaVrIiDso-n19, sChOoVwIeDd-1si9msihlaorwtreedndssimwiliathr StrAeRndSspawtiiethntsSA[2R8S]. Fpeavtieern, tfsat[i2g8u]e. , Faenvder, fatigue, dry coughaanredtdhreymcaoiungmhaanriefetshtaetimonasinofmthaenpifaetsiteanttios,nws hoiflethneaspaal tcioenngtse,stwiohni,lerunnansyalncoosne,gaenstdioonth, errunny nose, symptomsanodf oththeerupsypmerptroemspsiroaftothrye utrpapcterarreespriarraet.orByetijriancgt aCreenrtaerres. fBoerijiDngiseCaesnesterCsofnotrroDlisaenadses Control PreventionaninddPicraetveednttihoantinthdeictaytepdicathl actatshee otyf pCicOaVl cIDas-e19ofhCaOs VaIDpr-o1g9rheasssivaepraogggrreasvsaivtieonagpgrroacveastsio. n process. COVID-19CcOanVbIDe -c1la9ssciafniedbeinctolalsisgihfite,dnoinrmtoall,igshevt,erneo, ramndalc, rsiteivcaelret,ypaensdbcarsietdicaolnttyhpeessevbearsietdy oofnthtehe severity disease [31o]f: (t1h)eMdilidsecaassees[3\u20141t]h: e(c1l)inMicialdl sycamspest\u2014omthsewcelrienimcaillds,yamndptnoompsnweuemreonmiaildw,aasnfdounnod ponnetuhme onia was chest compfouutnedd toonmtohgeracphhesyt (cCoTm)p; u(2te) dnotormmaolgrcaapsehsy\u2014(fCeTv)e;r,(2r)esnpoirrmataolrycassyems\u2014ptfoemvesr,, arensdpipraattoiernytssymptoms, found to haanvde pimataigenintgs fmouannidfestotathioavnes oimf pagnienugmmonainai;fe(3s)tasteiovnesreocfapsense\u2014umonoenoiaf; t(h3e) fsoelvloewreincgastehsr\u2014eeone of the conditionsf:oRlleoswpiinragtothryreedicsotrnedsist,iornessp: iRreastopriryatroartye d\u2265i3st0retsims, eress/pmiraintor(iynrraetest\u2265in3g0sttiamtee,sr/mefienrs(itnoroesxtyinggenstate, refers saturationt\u2264o9o3x%yg),epnasrattiualraatritoenria\u2264l 9o3x%yg),epnaprtrieaslsaurrteer(iPalaoOx2y)g/oexnypgreenssaubrseo(rPpatOio2n)/cooxnycgeenntraabtsioonrp(tFioiOn2c)o\u2264ncentration 300 mmH(gFiO(12)m\u2264m3H00gm=m0H.1g33(1 kmPma)H; g(4=) 0c.r1it3i3caklPcaa);se(4s)\u2014crointiecaol fcatshees\u2014foolnloewoifntghethforleleowcionngdtihtiroenesc: onditions: RespiratorRyefsapiliuraretoarnydfatihlue rneeaenddfothr emneecehdanfoicraml veecnhtainlaitciaolnv, esnhtoiclakt,ioonr,thsheoacsks,oocriattheedafsasiloucrieatoefdoftahileurre of other organs reqourigrianngs trheequinirteinngsitvheecianrteenusnivite[3c2ar].eTuhneitc[u3r2r]e.nTthcelincuicrarledntatcalisnhicoawl sdathtaatshthoewms athjoartittyheofmthajeority of the deaths occduerraetdhsinoctchuerorelddeirnptahteieonltdse. rHpoawtieevnetsr., sHeovwereevcears, essevhearveecbaeseens hdaovceumbeeennteddocinumyoeunntegdaidnuyltosung adults who havewunhioquheavfeacutonrisq,upeafraticctuolrasr,lpyatrhtoicsuelawrliyththchorsoenwicitdhisceharsoensi,csudcisheaasseds,iasbuecthesasordhiaebpeatteistisorBh. epatitis B. Those withThaolosengw-ittehrma luosnego-tfehrmormusoenoefshoorrimmomnuens oosruipmpmreusnsaonsutsp, panredssdaenctrse,aasnedd dimecmreuanseedfuimncmtiounn,e function, are likely taoregelitkseelvyetroelgyeitnsfeevceteredl.y infected.",
            "The incubaTthioeninpceuriboadtioonf SpAeRriSodis o1f\u20134SAdRaySs i[s331]\u2013.4Hdoawyesv[e3r3,]i.n Ha osmweavllenr,uimnbaersmofapllantiuenmtsb,etrheof patients, incubationthpeeriniocdubmataiyonbpeelroinogdemr athyabne1lo0ndgaeyrsth[3a4n].10Itdhaayss b[3e4e]n. Idtehmasonbseternatdedemthoantsttrhaeteldattehnactythoef latency of COVID-19CvOarVieIDs -fr1o9mva3r\u2013ie7sdfaroyms o3n\u20137avdearyasgeo,nfoarveurpagtoe,1f4orduapysto[3154]. dDauyrsin[3g5t]h. iDs uinrcinugbatthioisninpceuriboadt,ion period, patients arpeactoienntatsgaiorue sc,oanntdagiitohuass, baneednitrehpaosrbteedenthreapt oeartcehdctahsaetienafcehctecadsoeninafveectreadgeo3n.7a7veortahgeer p3.e7o7polether people (uncertain(tuynrcaenrgtaei2n.t2y3-r4a.n8g2e) [23.62]3.-B4.y82c)o[m36p]a. rBisyonco, mwpeafroiusonnd, twhaetftohuenadvtehraatgtehleataevnecryagoef ClaOteVncIDy -o1f9CisOVID-19 is slightly lonslgiegrhtthlyanlotnhgaetrotfhSaAn RthSa.t of SARS.",
            "AccordingAtcocotrhdeindgetmoothgeradpehmicoginrafoprhmicaitniofonrmofatSioAnRoSf SpAatRieSnptsa,tiiennftesc,tiinofnecoticocnurorcecdurirnedailnl algleage groups groups (th(ethaevaevreargaegeagaegewwaass\u22664455))[[3377].].TThheererewwasasa paropproprtoiortnioalndaliffdeirfefnercenbceetwbeetwn emenalemaanlde faenmdale (female female (fempraeldeopmreindaonmcein)a[n37c]e,)w[3it7h],awmitahlea-tmo-afelem-taol-efermatiaoleofra1t:i1o.2o5f[13:81]..2I5n[a3d8]d. iItnionad, hdoitsiponit,alhsotsapffithaal d a higher staff had arishkigdhueertoritshkedpuroextimo athl eintperroaxcitmioanls iwnittehralcatrigoenns uwmitbherlsafrrgoemntuhme binefresctferdompopthuelaitniofenc.teFdor example, populationh.oFsopritaexl satmaffplaec,choousnpteitdalfosrta2f2f%acocfoaulnl cteadsefsoirn2H2o%ngofKaolnl gcaasneds 2in2.8H%oningGKuoannggdaonndg2[23.78]%. Tihne mortality Guangdoncgau[3s7e]d. TbyheSAmRoSrtianlictryeacsaeudsewditbhyaSgAe (R>S6i4ncyreeaarsse)d[3w7]i,tahnadgteh(e>o6v4eryaelalrms)o[r3ta7l]i,taynrdattehdeuorvinegratlhle outbreak mortality roafteSAduRrSinwgatshesotiumtbartedakaot f9.S6A%R[S39w,4a0s].estimated at 9.6% [<a class=\"ref-link\" id=\"c39\" href=\"#r39\">39</a>,<a class=\"ref-link\" id=\"c40\" href=\"#r40\">40</a>].",
            "Li et al repLoi retteadl.threapt opretoepdlethwathpoehoapvle wnohtobheaenveenxpoot sbeedentoexSpAoRsSe-dCtooVS-A2 RarSe-CalolVs-u2scaerpetaiblllesutosceptible to COVID-19C[O41V].IDA-m19on[4g1]t.hAe m8,8o6n6g pthaeti8e,n8t6s6wphatoiehnatsvewbheoehnacvoenbfieremnecdonwfiirtmh eCdOwViItDh -C1O9,VnIeDa-r1ly9, hnaelafrolyf half of the the patientpsahtaievnetsbeheanvaegbeeden50aygeeadrs50oryoeladresro(r47o.l7d%e)r [(3467]..7T%h)e[m36a]l.eT-thoe-femmaalele-troa-tfieomisalaebroauttio2.i7s:1ab[3o8u]t 2.7:1 [<a class=\"ref-link\" id=\"c38\" href=\"#r38\">38</a>] and the avaenrdagteheinacvuebraatgioeninpceurbioadtioisn 5p.e2rdioadysis[452.2].dHayows [e4v2e]r., HseovwereeveCrO, sVeIvDe-r1e9CcOasVeIsDa-n1d9 cdaesaetshasnd deaths have mosthlyavbeeemnoisntltyhebemenididnleth-aegmedidaddluel-tasgaenddadthueltesldanerdlythweiethldleornlyg wsmitohklionngghsimstorkiiensgohr iostohreires or other basic diseases, such as heart disease and hypertension [<a class=\"ref-link\" id=\"c43\" href=\"#r43\">43</a>,<a class=\"ref-link\" id=\"c44\" href=\"#r44\">44</a>]. At the time that this paper was been submitted, COVID-19 patients mortality rate was 2.1% [<a class=\"ref-link\" id=\"c45\" href=\"#r45\">45</a>]."
        ],
        "3.5. Animal Reservoirs": [
            "In 2010, Shi et al isolated a SARS-like coronavirus which was highly homologous to the SARS-CoV, confirming that Rhinolophus sinicus (Chinese rufous horseshoe bat) was a natural host of the SARS-CoV [<a class=\"ref-link\" id=\"c46\" href=\"#r46\">46</a>]. Bats are known to be hosts for 30 coronaviruses based on complete genomic sequences analysis [<a class=\"ref-link\" id=\"c47\" href=\"#r47\">47</a>]. Epidemiological investigations have shown that civet cats in the wildlife market were the direct source of SARS-CoV [<a class=\"ref-link\" id=\"c48\" href=\"#r48\">48</a>]. Among the four patients with SARS discovered during the winter of 2003-2004, two were waitresses at a restaurant in Guangzhou, China, and one was a customer who",
            "Virusebs a2s0i2c0,d1i2s,e2a4s4es, such as heart disease and hypertension [<a class=\"ref-link\" id=\"c43\" href=\"#r43\">43</a>,<a class=\"ref-link\" id=\"c44\" href=\"#r44\">44</a>]. At the time that this paper was 5beoef n17 submitted, COVID-19 patients mortality rate was 2.1% [<a class=\"ref-link\" id=\"c45\" href=\"#r45\">45</a>].",
            "ate in3.5th. eAnreimstaaluRreasnetrvaoisrhsort distance from a civet cage. All six civets in this cage were tested positive for SARSI-nCo2V01[04,8]S.hi et al isolated a SARS-like coronavirus which was highly homologous to the STAhReSn-eCwoVe,mcoerngfiirnmgiSnAgRthSa-Ct RohVi-n2olsohpahruesssainbiocuust 8(C0%hinoefstehreugfoeunse hseoqrsueesnhcoee obfaSt)AwRaSs-Ca onVa,tureralelahsoesdt obfy the MthielitSaAryRSM-CeodVica[4l6R].esBeaatsrcahreInksntiotwutne toof bNeahnojisntsg fMoril3it0arcyorRonegavioirnusines2b0a0s3ed[28o]n. cRoemcepnlettlye, gSehnioemt iacl. reposrteeqduethnactesthaensaelqysuiesn[c4e7]s.imEpiliadreitmyiooflocgoircoanl ainvvireusstibgeattwioenesnhSaAveRSsh-CoowVn-2thaantdctihveetccoartosnianvitrhues wisioldlaltiefed frommRahrikneotlowpehruestahffie ndiisreisct96so.2u%rc,eaonfdSsAuRgSg-eCsoteVd[t4h8a].t Abamtsonmgatyhebefotuhre psoautiercnetsowf tihthe SvAirRuSs [d4i9sc].ovSeorfeadr, the idnuterrinmgetdhieatweihnotesrtsofo2f0S0A3-R20S0-C4,otVw-o2 wareereelwuasiivtreesasnesdaht aavreesbteaeunrarnetpionrGteudantogzbheosun, aCkheisn,am, ainndkso,noer variawbales aotchuesrtsom[5e0r,5w1h].oRaeteceinnttlhye, arersetaseuararcnht agsrohuorpt doifsStaonuctehfrCohminaacAivgetriccaugletu. Arall sUixnciviveertssitiyn trheipsocratgeed that wpearnegtoelsitnesd pmoasyitivbee forneSAoRfSt-hCeoVin[4te8r]m. ediate hosts for SARS-CoV-2, by analyzing more than",
            "1,000 metTaghennoemwicemsaemrgpinlegs,SbAeRcaSu-CseoVth-e2yshfoaurensdatbhoautt7800%%ooffpthaneggoelninesseaqreuepnocseitoivfeSAfoRr Sth-CeocVor, orenlaevaisreuds.",
            "Moreboyvtehre, MthielivtairryusMiesdolicaatel RfreosmearpchanIngsotliitnutsehoafrNedan9j9in%gsMeqiluiteanryceRseigmioinlairnit2y0w03it[h28t]h. Re eccuernrtelny,tSinhifeecttaeld. humraenpsotrrtaeidn SthAaRt Sth-CeosVe-q2u[e5n2c]e. Tsaimkiinlagrtithyisorfecceonrtorneasveiarrucshbinetwo ceoensSidAeRraSt-iCoonV, w-2eaangdreethdethcaotropnaanvgiorulisn is moisroelalitkeedlyfrotombRehoinnoeloopfhiunstearffmineisdiisa9te6.h2%os,tasnodf sSuAgRgSes-CteodVt-h2a.t bats may be the source of the virus [<a class=\"ref-link\" id=\"c49\" href=\"#r49\">49</a>].",
            "So far, the intermediate hosts of SARS-CoV-2 are elusive and have been reported to be snakes, 3.6. Rmeignikons,aol rDvisatrriiabbulteioonthers [<a class=\"ref-link\" id=\"c50\" href=\"#r50\">50</a>,<a class=\"ref-link\" id=\"c51\" href=\"#r51\">51</a>]. Recently, a research group of South China Agricultural University",
            "SARrtcSAheopwarconocenorr1taree,dv0drii0rne0tuphgsoma.ttroeMtpettaahodgnreeewgnWoooovlirHmenlrdsO,icwmthdsiaaedaymteva,bpirowelueniosst,nJhiuebsl7oe.o7lcaf3a4t1utedhtsheeefr,aiot2nthmh0tee0syr3pamanf[o2endud4g]ni2oa,d6ltaiencttohhosuaothatsnaltr7tsore0ifdf%eo8sr9,o0a9Sf9n%A6dpRscaSrelnei-qgnCguoiioceolViannnl-clss2ey,aasdbffrieyimeacapgitlnnoeaadsroiilstty(yieFzvdiiewngcgfuiaotrhsmreeotts2hhraoeee)f. Mostcucrarseenst wineferectiend Ahusima,aEnusrtorapine, SaAnRdSA-CmoeVr-i2ca[5. 2T].hTeamkianigntchoisurnetcreienst irnesAeasricahwinetroe cCohnisnidae(riantciolund, wineg mainalgarneded, Mthaact apoa,nHgoolinngisKmonorge, laiknedlyTtaoiwbeaonn),eSoifnignatepromreed, iaantedhsoostosno.f STAhReSt-oCtoaVl n-2u. mber of cases in mainland China was 5,327, with 349 deaths [<a class=\"ref-link\" id=\"c53\" href=\"#r53\">53</a>]. The cases were mainly concentrated in Beijing, Guan3.g6d. Roneggio, naanl dDiSsthraibnuxtio(nFigure 2b) [<a class=\"ref-link\" id=\"c54\" href=\"#r54\">54</a>]. In total, 2,102 patients were from Hong Kong, Macao, and Taiwan, with 336 deaths [<a class=\"ref-link\" id=\"c24\" href=\"#r24\">24</a>].",
            "FiguFreig2u.r(ea)2.C(oa)mCpoamripsaornisoofnthofetnhuemnubmerboerf SoAf SRASRaSnadnCdOCVOIVDID-1-919paptaiteinentstsininCChhininaa((iinncclluuddiinngg HHoonngg KongK, oMnagc, aMo aacnadoTaaniwd aTna)iawnadn)otahnedr cootuhnetrriceosu; (nbtr)itehse; n(bu)mtbheer nouf mSAbeRrS opfatSieAnRtsS inpadtiieffnetrsenint pdroifvfeinrecnets of Chpirnoav; i(ncc)easnoifncCrehainsead; (ncu) manbeirncorfeCasOeVd InDu-1m9bpeartioefnCtsOoVveIDr -t1im9 epwataiesnsthsoowveedr tinimaehwisatosgsrhaomw. eOdninFeab.",
            "11th, Hubei Province had added a \u201cclinical diagnosis case\u201d classification, and identified suspected cases with pneumonia imaging features as clinical diagnosis cases so that patients can receive standardized treatment as soon as possible. (d) The number of COVID-19 patients in different provinces of China.",
            "The time period shown in the picture was in the Spring Festival transportation.",
            "SARS were reported worldwide, with 774 deaths and 26 countries and regions affected (Figure 2a). Most cases were in Asia, Europe, and America. The main countries in Asia were China (including mainland, Macao, Hong Kong, and Taiwan), Singapore, and so on. The total number of cases in mainland China was 5,327, with 349 deaths [<a class=\"ref-link\" id=\"c53\" href=\"#r53\">53</a>]. The cases were mainly concentrated in Beijing, GViuruasnesg2d02o0n, 1g2,, a24n4d Shanxi (Figure 2b) [<a class=\"ref-link\" id=\"c54\" href=\"#r54\">54</a>]. In total, 2,102 patients were from Hong Kong, Macao,6aonf 1d7 Taiwan, with 336 deaths [<a class=\"ref-link\" id=\"c24\" href=\"#r24\">24</a>].",
            "According to the latest data on Feb. 14th, 2020 [<a class=\"ref-link\" id=\"c55\" href=\"#r55\">55</a>,<a class=\"ref-link\" id=\"c56\" href=\"#r56\">56</a>], there have been a total of 67,081 clinically diagnAocsceodrdcainsegstoofthCeOlaVtIeDst-1d9atianownoFreldbw. 1id4teh,,w20it2h01[,5552,656d],etahtherse. Ahatvoetableoenf 2a5tocotaulnotfri6e7s,0a8n1dclriengicioanllsy hdaiavgenionsfeecdtecdaspeseoopflCe.ODVuIeDt-o19thine wSporrilndgwFideest,iwvailthtr1a,n5s2p6odretaattihosn. pAetaokt,atlhoef d25isceoasuenthraiessbaenedn rsepgrieoands mhaovree rinapfeicdtleydapcreoospslCe.hDinuae(Ftoigtuhree S2pc)r.inAgs FtheestoivriaglintraanresapoorftCatOioVnIDpe-1a9k,,Hthuebdeiisperaosveinhcaes hbaesenbesepnrethade mmoosrtesreavpeidrellyyaicnrfoescsteCdhianraea(,Fwigiuthre524c,)4.0A6sctuhme uolraigtiivneadreiaagonfoCsiOs VcaIDse-s1.9W, Huuhbaeni pcirtoyvhinacse3h7a,9s1b4eecanstehse. Gmuoasntgsdevoenrge,lyHinenfeacnte, daanrdeaZ, wheijtihan5g4,4p0r6ocvuinmceulahtaivvee d1ia,2g9n4osciassceass, es1.,2W12uhcaansecs,ityanhdas 13,71,69214ccaasseess,. rGesupaencgtdivoenlyg,(HFiegnuarne, 2adn)d. ZAhtepjiraensgenptr,otvhiencCeOhVavIDe -11,299o4uctabsreesa,k1,h21a2s cbaeseens,sapnrdea1d,1t6o2 aclalspesa,rrtessopfecCtihvienlay a(Fnidguarreou2ndd). tAhet pwroesreldn,t,inthcleuCdiOnVg ItDhe-1U9 noiuttebdreSatkathesa,sTbheaeinlasnpdr,eaanddtoJaapllanp.arIttshoafsCbheiennanaontdiceadrotuhnadt mthoeswt oofrtldhe, sinecpluatdieinngtsthhaevUeneivteedr bSetaentesto, TWhauihlaanndo,racnodnJtaacptaend. wItithhaspeboepenlenwohtiocehdadthbaetemnoisntWofuthhaense. TphateiednitsstrhibauvetioevneorfbCeeOnVtoIDW-2u0h1a9npoarticeonntstaicnteCdhwinitah(pinecolpuldeinwghoHhoandg bKeoenngi,nMWauchaaona.nTdheTadiiwstarinb)uatinodn HofuCbOeiVPIrDov-2in01ce9 ipsasthieonwtsnininCFhiginuare(i3n.cluding Hong Kong, Macao and Taiwan) and Hubei Province is shown in Figure 3.",
            "FFiigguurree 33.. TThheeddiissttrriibbuuttiioonnooffCCOOVVIIDD--22001199ppaattiieennttssiinnCChhiinnaa((aa))aannddHHuubbeeiiPPrroovviinnccee((bb))..XXJJ,,XXiinnjijiaanngg;; XXZZ,, XXiizzaanngg;; GGSS,, GGaannssuu;;QQHH,,QQiningghhaai;i;SSCC, S, iScihcuhauna;nY; NYN, Y,uYnunnanna; nIM; I,MIn,nInernMeroMngoonlgiao;lNia;XN, NXi,nNgxiniag;xSiNa;, SSNha, aSnhxaia; nCxQi;, CCQho, nCghqoinngg;qGinZg,; GGuZi,zGhouuiz; hGoXu,;GGuXa,nGgxuia; nHgIx, iH; HaiIn,aHn;aSinXa,nS;hSaXn,xSi,hHanAx,iH, HenAa,nH; HenBa,nH; uHbBe,i; HHuNb,eHi; uHnaNn,; GHDun, Ganu;aGngDd,oGngu;aHngKd, oHnogn;gHKKo,ngH;oHnEg, HKoebnegi;; BHJ,EB, eHijienbge;i;TJB, JT,iaBnejiijnin; gS;DT, SJ,haTniadnojning;; SADH,, SAhnahnudio; nJXg,; JAiaHng, xAi;nJhS,uJii;aJnXg,sJui;aSnHgx,iS; hJSan, gJihaanig; sZuJ;, ZSHhe,jiSahnagn; gFhJ,aFi;uZjiaJ,nZ; ThWeji,aTnagiw; FaJn,;FHuLji,aHn;eTilWon,gTjiaaniwg;aJnL;, HJilLin, ;HLeNilo, Lnigajioannign;gJ.L, Jilin; LN, Liaoning. 3.7. Prevention, Diagnosis, and Treatment",
            "3.7.1. Prevention As the number of COVID-19 patients in China has been growing rapidly, preventing the spread of SARS-CoV-2 is the most important and urgent task [<a class=\"ref-link\" id=\"c57\" href=\"#r57\">57</a>]. It was shown that human-to-human transmission of SARS-CoV-2 has spread via droplets or close contacts [<a class=\"ref-link\" id=\"c58\" href=\"#r58\">58</a>,<a class=\"ref-link\" id=\"c59\" href=\"#r59\">59</a>], but aerosol and fecal-oral transmission still need further study [<a class=\"ref-link\" id=\"c60\" href=\"#r60\">60</a>,<a class=\"ref-link\" id=\"c61\" href=\"#r61\">61</a>]. To reduce virus transmission, early detection and isolation are essential. In addition, close monitoring in crowded places is also important [<a class=\"ref-link\" id=\"c62\" href=\"#r62\">62</a>]. The possible pathogens of SARS and COVID-19 are both derived from wild animals [<a class=\"ref-link\" id=\"c63\" href=\"#r63\">63</a>]. Therefore, hunting, selling, and eating wild animals not only seriously damage the ecosystem, but also lead to the spread of epidemic diseases [<a class=\"ref-link\" id=\"c64\" href=\"#r64\">64</a>]. Thus, banning all wildlife trade is an effective measure to prevent viral prevalence. Wearing level-D protective clothing can protect medical staff from infection of respiratory viruses [<a class=\"ref-link\" id=\"c65\" href=\"#r65\">65</a>]. A vaccine against SARS-CoV has not been described in any published articles [<a class=\"ref-link\" id=\"c66\" href=\"#r66\">66</a>]. However, on Jan. 26th, 2020, the China CDC started to develop a new vaccine for SARS-CoV-2. The virus has been successfully isolated and seed strains have been screened [<a class=\"ref-link\" id=\"c67\" href=\"#r67\">67</a>].",
            "3.7.2. Diagnosis The early symptoms of SARS and COVID-19 are very similar to winter influenza, and the most important way to distinguish flu and pneumonia is to take throat swabs for viral testing [<a class=\"ref-link\" id=\"c68\" href=\"#r68\">68</a>].",
            "Current diagnostic tests for coronavirus include RT-PCR, real-time reverse transcription PCR (rRT-PCR), reverse transcription loop-mediated isothermal amplification, as well as real-time RT-LAMP [<a class=\"ref-link\" id=\"c69\" href=\"#r69\">69</a>\u2013<a class=\"ref-link\" id=\"c72\" href=\"#r72\">72</a>]. National Medical Products Administration has approved seven new nucleic acid test reagents for coronavirus, which were developed based on fluorescence PCR by Feb. 1st, 2020 [<a class=\"ref-link\" id=\"c73\" href=\"#r73\">73</a>]. Suspected infections can be detected accurately and quickly for timely isolation and treatment to avoid infecting others by using these test reagents."
        ],
        "3.7.3. Treatment": [
            "Both SARS-CoV and SARS-CoV-2 are CoVs; hence, the treatment strategies of SARS could be relevant for COVID-19 [<a class=\"ref-link\" id=\"c74\" href=\"#r74\">74</a>]. In 2003, SARS was mainly treated by isolation of the patients, hormones treatment, antiviral and symptomatic treatments, and many drugs such as glucocorticoid [<a class=\"ref-link\" id=\"c29\" href=\"#r29\">29</a>] and interferon [<a class=\"ref-link\" id=\"c75\" href=\"#r75\">75</a>]. Now, isolation, antiviral, and symptomatic treatments are still mainly adopted for COVID-19 treatment. As effective drugs for SARS, hormones and interferons can also be used to treat COVID-19 [<a class=\"ref-link\" id=\"c74\" href=\"#r74\">74</a>]. Lopinavir is one kind of protease inhibitor used to treat HIV infection, with ritonavir as a booster. Lopinavir and/or ritonavir has anti coronavirus activity in vitro. Hong Kong scholars found that, compared with ribavirin alone, patients treated with lopinavir/ritonavir and ribavirin had lower risk of acute respiratory distress syndrome (ARDS) or death caused by SARS-CoV [<a class=\"ref-link\" id=\"c76\" href=\"#r76\">76</a>,<a class=\"ref-link\" id=\"c77\" href=\"#r77\">77</a>]. Lopinavir/ritonavir has also been clinically tested in treatment of COVID-19, and showed wonderfully effective treatment for some patients, but the general clinical effect has not been determined [<a class=\"ref-link\" id=\"c78\" href=\"#r78\">78</a>].",
            "More effective treatments are still under continuing exploration: On Jan. 25th, 2020, a joint research team from the Shanghai Institute of Materia Medica, Chinese Academy of Sciences, and Shanghai Tech University screened and identified 30 potential drugs that are reported to be effective against SARS-CoV-2 [<a class=\"ref-link\" id=\"c79\" href=\"#r79\">79</a>]. A high-resolution crystal structure of SARS-CoV-2 coronavirus 3CL hydrolase (Mpro) was announced after the outbreak of COVID-19 in the world [<a class=\"ref-link\" id=\"c80\" href=\"#r80\">80</a>], and human coronaviruses (HCoVs) have been treated as severe pathogens in respiratory tract infections. Nelfinavir was predicted to be a potential inhibitor of SARS-CoV-2 main protease [<a class=\"ref-link\" id=\"c81\" href=\"#r81\">81</a>]. The first patient in the US had been trial-treated with intravenous remdesivir (a novel nucleotide analogue prodrug in development) due to a severe infection [<a class=\"ref-link\" id=\"c82\" href=\"#r82\">82</a>,<a class=\"ref-link\" id=\"c83\" href=\"#r83\">83</a>]. No adverse reactions were observed during the administration, and the patient\u2019s condition was effectively improved [<a class=\"ref-link\" id=\"c84\" href=\"#r84\">84</a>]. Clinical trials of remdesivir for treatment of COVID-19 just started on Feb. 5th and 12th, 2020 in Wuhan and Beijing, respectively, and the experimental results remain unclear [<a class=\"ref-link\" id=\"c85\" href=\"#r85\">85</a>,<a class=\"ref-link\" id=\"c86\" href=\"#r86\">86</a>]."
        ],
        "3.8. Genomic Comparison": [
            "CoVs are RNA viruses and contain the largest genomes of all RNA viruses [<a class=\"ref-link\" id=\"c87\" href=\"#r87\">87</a>]. CoVs belong to the subfamily Coronavirinae in the family of Coronaviridae of the order Nidovirales, and this subfamily includes four genera: \u03b1-coronavirus, \u03b2-coronavirus, \u03b3-coronavirus, and \u03b4-coronavirus [<a class=\"ref-link\" id=\"c88\" href=\"#r88\">88</a>]. Both SARS-CoV-2 and SARS-CoV are in the coronavirus family, \u03b2-coronavirus genera [<a class=\"ref-link\" id=\"c89\" href=\"#r89\">89</a>]. The genome of SARS-CoV-2 is more than 85% similar to the genome of the SARS-like virus ZC45 (bat-SL-CoVZC45, MG772933.1), and together these types of viruses form a unique Orthocoronavirinae subfamily with another SARS-like virus ZXC21 in the sarbecovirus subgenus [<a class=\"ref-link\" id=\"c35\" href=\"#r35\">35</a>]. All the three viruses show typical \u03b2-coronavirus gene structure. Human SARS-CoV and a genetically similar bat coronavirus (bat-SL-CoVZXC21, MG772934) from southwest of China have formed another clade within the sarbecovirus [<a class=\"ref-link\" id=\"c35\" href=\"#r35\">35</a>].",
            "We also performed comparative genomic analyses of SARS-CoV-2 and SARS-CoV by zpicture. The results showed that the genomic sequences of SARS-CoV-2 and SARS-CoV have extremely high homology at the nucleotide level (Figure 4a,b). There are six regions of difference (RD) in the genome sequence between SARS-CoV and SARS-CoV-2, and the RDs are named according to the order of discovery. RD1, RD2, and RD3 (448nt, 55nt, and 278nt, respectively) are partial coding sequences of the orf lab gene; RD4 and RD5 (315nt and 80nt, respectively) are partial coding sequences of the S gene; RD6 is 214nt in size and is part of the coding sequence of the orf7b and orf8 genes. These RDs may sequences of the orf lab gene; RD4 and RD5 (315nt and 80nt, respectively) are partial coding sequences of the S gene; RD6 is 214nt in size and is part of the coding sequence of the orf7b and orf8 genes. These RDs may provide new molecular markers for the identification of SARS-CoV-2 and SARS-CoV, and also help to develop new drugs against SARS-CoV-2. ViruseTs o20a20n,a1l2y, z24e4the homogeneity of SARS-CoV, MERS-CoV, and SARS-CoV-2, an evolutionary8torfe1e7 was constructed based on the genomes of 35 SARS-CoV-2 strains from different data submission units, one SARS-CoV strain, and two MERS-CoV strains (Figure S1). Phylogenetic analysis showed tphraotvitdhee ndeiwstamnocelecouflaSrAmRaSrk-CerosVfor(AthYe2i7d4e1n1t9i)ficiastioclnosoefrSAtoRSS-ACRoVS--C2 oaVnd-2SAstRraSi-nCsoVth, aanndMalEsoRSh-eClpoVto (dKeCv1e6lo4p50n5e,wJXd86ru90g5s9a)g. ainst SARS-CoV-2.",
            "FFiigguurree44..((aa))GGeennoommicicsseeqquueenncceeaalilgignnmmeennttbbeetwtweeeennSSAARRSS-C-CooVV-2-2aannddSSAARRSS-C-CooVV;;((bb))DDoottpplolottmmaattrrixix ccaallccuullaatteeddffoorrtthheeccoommpplleetteeggeennoommeessooffSSAARRSS--CCooVV--22 aanndd SSAARRSS--CCooVV.. To analyze the homogeneity of SARS-CoV, MERS-CoV, and SARS-CoV-2, an evolutionary tree was constructed based on the genomes of 35 SARS-CoV-2 strains from different data submission units, one SARS-CoV strain, and two MERS-CoV strains (Figure S1). Phylogenetic analysis showed that the distance of SARS-CoV (AY274119) is closer to SARS-CoV-2 strains than MERS-CoV (KC164505, JX869059). 3.9. Proteomic Comparison To further explore whether all encoded proteins of SARS-CoV-2 are homologous to that of SARS-CoV, we performed a protein sequence alignment analysis using Blastp. The results showed that most of SARS-CoV-2 proteins are highly homologous (95%\u2013100%) to the proteins of SARS-CoV virus, indicating the evolutionary similarity between SARS-CoV and SARS-CoV-2 (Table 2). However, two proteins (orf8 and orf10) in SARS-CoV-2 have no homologous proteins in SARS-CoV. The amino acid sequence of orf8 in SARS-CoV-2 is different from sequences of conserved orf8 or orf8b derived from human SARS-CoV [<a class=\"ref-link\" id=\"c11\" href=\"#r11\">11</a>]. Orf8 protein of SARS-CoV-2 does not contain known functional domain or motif. An aggregation motif VLVVL (amino acid 75\u201379) has been found in SARS-CoV orf8b which was shown to trigger intracellular stress pathways and activate NOD-like receptor family pyrin domain-containing-3 (NLRP3) inflammasomes [<a class=\"ref-link\" id=\"c90\" href=\"#r90\">90</a>]. Therefore, it will be clinically meaningful to analyze the biological function of these two specific proteins (orf8 and orf10) in SARS-CoV-2.",
            "orf1a polyprotein orf1ab polyprotein orf3a protein orf6 protein orf7a protein orf7b protein orf8 protein orf10 protein",
            "3\u2019-to-5\u2019 exonuclease endoRNAse envelope protein helicase leader protein membrane glycoprotein nucleocapsid phosphoprotein"
        ],
        "27 RNA-dependent RNA polymerase surface glycoprotein": [
            "YP_009725298.1 YP_009725299.1 YP_009725300.1 YP_009725302.1 YP_009725303.1 YP_009725304.1 YP_009725305.1 YP_009725306.1 YP_009725312.1 YP_009725295.1 YP_009724389.1 YP_009724391.1 YP_009724394.1 YP_009724395.1 YP_009725296.1 YP_009724396.1 YP_009725255.1 YP_009725311.1 YP_009725301.1 YP_009725309.1 YP_009725310.1 YP_009724392.1 YP_009725308.1 YP_009725297.1 YP_009724393.1 YP_009724397.2 YP_009725307.1 YP_009724390.1 nonstructural polyprotein pp1a polyprotein orf1a polyprotein 1a nsp6-pp1a/pp1ab (TM3) Chain A, Replicase Polyprotein 1ab, Light Chain Chain E, Replicase Polyprotein 1ab, Heavy Chain nsp9-pp1a/pp1ab Chain A, Non-structural Protein 10",
            "nsp11-pp1a orf1a polyprotein (pp1a) orf1ab polyprotein (pp1ab) hypothetical protein sars3a hypothetical protein sars6 protein 8 hypothetical protein sars7b nsp16-pp1ab (2\u2019-o-MT) polyprotein 1a nsp14-pp1ab (nuclease ExoN homolog) nsp15-pp1ab (endoRNAse) E protein nsp13-pp1ab (ZD, NTPase/HEL) nsp1-pp1a/pp1ab matrix protein nucleocapsid protein nsp12-pp1ab (RdRp) spike glycoprotein",
            "5C8S_A NP_904321.1 NP_828850.1 NP_828849.2 NP_828852.2 NP_828856.1 ARO76387.1 NP_849175.1",
            "NP_828873.2 ARO76381.1 NP_828871.1 NP_828872.1 APO40581.1 NP_828870.1 NP_828860.2 NP_828855.1 ARO76389.1 NP_828869.1 ABD72985.1",
            "\u201c-\u201d represents no homologous protein. Query cover represents the percentage of the protein sequences that are participating in the comparison. Percent identity indicates the homology.",
            "As the most abundant protein in CoVs, nucleocapsid (N) protein is highly conserved across CoVs [<a class=\"ref-link\" id=\"c91\" href=\"#r91\">91</a>]. The N protein in SARS-CoV-2 shares ~90% amino acid identity with that in SARS-CoV [<a class=\"ref-link\" id=\"c28\" href=\"#r28\">28</a>], which indicates that antibodies against the N protein of SARS-CoV would likely recognize and bind the N protein of SARS-CoV-2 as well. N antibodies do not provide immunity to SARS-CoV-2 infection, but the antibodies have a cross reactivity with SARS-CoV N protein viruses, which would allow a serum-based assay to identify the asymptomatic SARS-CoV-2 infected-cases [<a class=\"ref-link\" id=\"c28\" href=\"#r28\">28</a>]. Although previous studies have found serum reactivity to group SARS-CoV N proteins in Chinese populations [<a class=\"ref-link\" id=\"c92\" href=\"#r92\">92</a>], exposure to SARS-CoV-2 should increase the dilution factor if the infection had occurred. This information has important implications for preventing the spread of asymptomatic infections.",
            "In addition, spike stalk S2 in SARS-CoV-2 is highly conserved and shares 99% identity with those of the two bat SARS-like CoVs (bat-SL-CoVZXC21 and bat-SL-CoVZC45) and human SARS-CoV [<a class=\"ref-link\" id=\"c11\" href=\"#r11\">11</a>]. Thus, the broad spectrum antiviral peptides against S2 has the potential to be effective treatment [<a class=\"ref-link\" id=\"c93\" href=\"#r93\">93</a>]."
        ],
        "3.10. Pathogenic Mechanisms": [
            "Many studies have been performed to study the pathogenesis of SARS-CoV [<a class=\"ref-link\" id=\"c94\" href=\"#r94\">94</a>\u2013<a class=\"ref-link\" id=\"c96\" href=\"#r96\">96</a>]. The spike (S) protein and N protein confer stability to the viral particle [<a class=\"ref-link\" id=\"c97\" href=\"#r97\">97</a>]. The N protein is a structural protein involved in virion assembly, and plays a pivotal role in virus transcription and assembly efficiency [<a class=\"ref-link\" id=\"c97\" href=\"#r97\">97</a>]. S protein can bind to the cellular receptors of sensitive cells and mediate infection of their target cells, after which it begins to replicate in the cytoplasm [<a class=\"ref-link\" id=\"c98\" href=\"#r98\">98</a>]. SARS-CoV mainly targets the lungs, immune organs, and small systemic blood vessels and causes systemic vasculitis and decrease of immune function [<a class=\"ref-link\" id=\"c99\" href=\"#r99\">99</a>]. More seriously, the infection leads to extensive pulmonary consolidation, diffuse alveolar damage, and the formation of a transparent membrane, finally deteriorating to respiratory distress [<a class=\"ref-link\" id=\"c100\" href=\"#r100\">100</a>].",
            "CoV can enter host cells through the interaction between CoV S protein and its host receptor angiotensin-converting enzyme 2 (ACE2), which is isolated from SARS-CoV\u2013permissive Vero-E6 cells. The receptor-binding motif (RBM) of S protein can directly contact ACE2 [<a class=\"ref-link\" id=\"c47\" href=\"#r47\">47</a>,<a class=\"ref-link\" id=\"c101\" href=\"#r101\">101</a>,<a class=\"ref-link\" id=\"c102\" href=\"#r102\">102</a>]. AEC2 have been identified to be key binding residues and functional receptor for SARS-CoV, and it can also protect alveolar cells [<a class=\"ref-link\" id=\"c103\" href=\"#r103\">103</a>]. The binding of spike protein to ACE2 and the subsequent downregulation of this receptor contribute to severe alveolar injury during SARS [<a class=\"ref-link\" id=\"c49\" href=\"#r49\">49</a>]. The downregulation of ACE2 results in the excessive production of angiotensin II by the related enzyme ACE, and the stimulation of type 1A angiotensin II receptor (AGTR1A) can lead to the increase of pulmonary vascular permeability, which potentially explains the increased lung pathology when the expression of ACE2 is decreased [<a class=\"ref-link\" id=\"c104\" href=\"#r104\">104</a>]. ACE2-transfected T cells form multinucleated syncytia with cells expressing S protein. The virus was shown to replicate effectively in ACE2-transfected, but not in mock-transfected T cells. Antibodies targeting ACE2 can block viral replication in Vero-E6 cells [<a class=\"ref-link\" id=\"c105\" href=\"#r105\">105</a>].",
            "Recently, Ji et al demonstrated that the receptor binding domain of SARS-CoV-2 was capable of binding ACE2 in the context of the SARS-CoV spike protein [<a class=\"ref-link\" id=\"c51\" href=\"#r51\">51</a>]. Among SRAS-CoV spike protein\u2019s fourteen residues predicted to interact directly with human ACE2 as the receptor for SARS-CoV, eight amino acids are well conserved in homology SARS-CoV-2 spike protein [<a class=\"ref-link\" id=\"c26\" href=\"#r26\">26</a>,<a class=\"ref-link\" id=\"c102\" href=\"#r102\">102</a>]. At the same time, Wan et al showed that SARS-CoV-2 uses ACE2 receptors to infect humans, bats, civets, monkeys, and swine, but not mice [<a class=\"ref-link\" id=\"c106\" href=\"#r106\">106</a>]. Compared to previously reported SARS-CoV strains, SARS-CoV-2 uses ACE2 receptors more efficiently than human SARS-CoV (year 2003), but less efficiently than human SARS-CoV (year 2002) [<a class=\"ref-link\" id=\"c106\" href=\"#r106\">106</a>]. The mutation of proteins determines two important characteristics of the SARS-CoV-2: A higher ability to infect and enhanced pathogenicity than the bat-like SARS-CoV, but a lower pathogenicity than SARS-CoV [<a class=\"ref-link\" id=\"c43\" href=\"#r43\">43</a>]."
        ],
        "4. Discussion": [
            "As a large number of people have left Wuhan, the control of the epidemic situation is extremely urgent, and the treatments of COVID-19 are imminent. On Feb. 14th, 2020, there were more than 54,000 confirmed patients in Hubei province, China [<a class=\"ref-link\" id=\"c55\" href=\"#r55\">55</a>]. Due to the lack of effective antiviral drugs, the prognosis of patients solely depends on their age and physical condition [<a class=\"ref-link\" id=\"c74\" href=\"#r74\">74</a>]. Although it was reported that the clinically recovered patients exceed the number of dead, the majority of the patients are still not cured in hospital. In addition, the potential adaptive mutation of SARS-CoV-2 makes it difficult for vaccine development. Therefore, it is urgent for us to develop more sensitive inspection methods and effective drugs.",
            "Seven type of CoVs have been identified to cause human disease [<a class=\"ref-link\" id=\"c107\" href=\"#r107\">107</a>]. The two highly pathogenic viruses, SARS-CoV and MERS-CoV, cause severe respiratory syndrome in humans. The other four human CoVs (HCoV-NL63, HCoV-229E, HCoV-OC43 and HKU1) induce only mild upper respiratory diseases, although some of them can cause severe infections in infants, young children, and elderly individuals [<a class=\"ref-link\" id=\"c4\" href=\"#r4\">4</a>,<a class=\"ref-link\" id=\"c108\" href=\"#r108\">108</a>]. The latest one is SARS-CoV-2. It has been reported that SARS-CoV-2 shared almost 80% of the genome with SARS-CoV [<a class=\"ref-link\" id=\"c11\" href=\"#r11\">11</a>]. Our results also showed that almost all encoded proteins of SARS-CoV-2 are homologous to SARS-CoV proteins (Table 2). Hence, clinical drugs and therapies for treating SARS may be used as a reference for COVID-19 treatment [<a class=\"ref-link\" id=\"c74\" href=\"#r74\">74</a>].",
            "In addition to the well-known SARS-CoV, MERS-CoV, as one Merbecovirus subgenus of \u03b2-CoVs, is also extremely invasive. MERS-CoV is the pathogen of the Middle East Respiratory Syndrome, which can infect both humans and animals, and can be transmitted through camels [109]. It mainly occurs in Saudi Arabia and has a high mortality rate [<a class=\"ref-link\" id=\"c66\" href=\"#r66\">66</a>]. Studies had demonstrated that the clinical course of SARS and MERS was highly similar, and SARS and MERS may have similar pathogenesis [<a class=\"ref-link\" id=\"c66\" href=\"#r66\">66</a>]. The genome sequence of SARS-CoV-2 also shows some similarities to that of MERS-CoV. It will be very interesting to study the relationship among SARS-CoV, MERS-CoV, and SARS-CoV-2 that may be exploited for future developing broad-spectrum antiviral therapies.",
            "Although more and more studies for SARS-CoV-2 have sprung up since the outbreak of this epidemic COVID-19, based on our comparison, we propose some key questions to be clarified in future studies (Table 3). In-depth understanding the underlying pathogenic mechanisms of SARS-CoV-2 will reveal more targets for better therapy of COVID-19.",
            "What is the effect of the surface epitope and receptor binding domain of S protein of SARS-CoV-2 on the virus\u2019 infectivity? Is there any effect of SARS-CoV vaccine designed according to S protein on SARS-CoV-2?",
            "Does SARS-CoV-2 orf8 and orf10 proteins, which have no homology proteins in SARS-CoV, play roles in the infectivity and pathogenicity of SARS-CoV-2?",
            "Can the susceptibility of asymptomatic carriers be judged by detecting the serum reactivity level of N protein?",
            "Apart from droplet transmission and contact transmission, are there other methods to transmit SARS-CoV-2?",
            "What is the percentage of COVID-19 patients have been infected with SARS and produced antibodies? Is there an effective specific anti-SARS-CoV-2 solution?",
            "Does traditional Chinese medicine have any effect on the treatment of COVID-19 caused by SARS-CoV-2? Do ethnic differences affect the transmissibility and pathogenicity of SARS-CoV-2?",
            "Do any environmental factors, such as regional conditions or climate, affect SARS-CoV-2 transmission?"
        ],
        "Supplementary": [
            "Materials: The following are available online at http://www.mdpi.com/1999-4915/12/2/244/s1, Figure S1: Phylogeny of SARS-CoV-2, SARS-CoV and MERS-CoV. Unrooted phylogenetic relationships are represented by constructing Neighbor-Joining tree. Table S1: The genomic information of latest SARS-CoV-2 strains",
            "Author Contributions: Conceptualization, L.X., Y.W. and X.G.; methodology, J.X. and W.Z.; software, S.Z. and W.Z.; validation, J.X., S.Z. and T.T.; formal analysis, J.X. and S.Z.; writing\u2014original draft preparation, J.X. and S.Z.; writing\u2014review and editing, L.X., Y.W., W.Z. and X.G.; visualization, J.X., S.Z., and A.E.A.; funding acquisition, L.X., Y.W. and X.G. All authors have read and agreed to the published version of the manuscript.",
            "Funding: This work was supported by the 2020 New Coronavirus Prevention and Control Emergency Project (grant no. 201100310300), the Program for Innovative Talents of Science and Technology in Henan Province (grant no. 18HASTIT048)."
        ],
        "Acknowledgments": [
            "All the genomic data of SARS-CoV-2 is from GISAID, NCBI/GenBank, NMDC, CNGB/CNGBdb and 2019nCoVR (Table S1). Here, we would like to express our gratitude to all units and individuals who are responsible for the sample collection and data submission.",
            "Conflicts of Interest: The authors declare no conflict of interest."
        ],
        "References": [
            "1. Wang, L.F.; Shi, Z.; Zhang, S.; Field, H.; Daszak, P.; Eaton, B.T. Review of bats and SARS. Emerg. Infect. Dis. 2006, 12, 1834. [CrossRef]",
            "2. Ge, X.-Y.; Li, J.; Yang, X.-L.; Chmura, A.; Zhu, G.; Epstein, J.H.; Mazet, J.K.; Hu, B.; Zhang, W.; Peng, C.; et al Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor. Nature 2013, 503, 535\u2013538. [CrossRef] [PubMed]",
            "3. Chen, Y.; Guo, D. Molecular mechanisms of coronavirus RNA capping and methylation. Virol. Sin. 2016, 31, 3\u201311. [CrossRef] [PubMed]",
            "4. Cui, J.; Li, F.; Shi, Z.L. Origin and evolution of pathogenic coronaviruses. Nat. Rev. Microbiol. 2019, 17, 181\u2013192. [CrossRef] [PubMed]",
            "5. Cauchemez, S.; Van Kerkhove, M.D.; Riley, S.; Donnelly, C.A.; Fraser, C.; Ferguson, N.M. Transmission scenarios for Middle East Respiratory Syndrome Coronavirus (MERS-CoV) and how to tell them apart. Euro Surveill. 2013, 18, 18.",
            "6. Gorbalenya, A.E.; Baker, S.C.; Baric, R.S.; de Groot, R.J.; Drosten, C.; Gulyaeva, A.A.; Haagmans, B.L.; Lauber, C.; Leontovich, A.M.; Neuman, B.W.; et al Severe acute respiratory syndrome-related coronavirus: The species and its viruses\u2014A statement of the Coronavirus Study Group. bioRxiv 2020. [CrossRef]",
            "7. WHO Named the New Pneumonia \u201cCOVID-19\u201d. Available online: http://www.xinhuanet.com/world/202002/12/c_1125561389.htm (accessed on 12 February 2020).",
            "8. Guan, Y.; Zheng, B.J.; He, Y.Q.; Liu, X.L.; Zhuang, Z.X.; Cheung, C.L.; Luo, S.W.; Li, P.H.; Zhang, L.J.; Butt, K.M.; et al Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China. Science 2003, 302, 276\u2013278. [CrossRef]",
            "9. Ki, M. 2015 MERS outbreak in Korea: Hospital-to-hospital transmission. Epidemiol. Health 2015, 37, 37. [CrossRef]",
            "10. Azhar, E.I.; El-Kafrawy, S.A.; Farraj, S.A.; Hassan, A.M.; Al-Saeed, M.S.; Hashem, A.M.; Madani, T.A. Evidence for camel-to-human transmission of MERS coronavirus. N. Engl. J. Med. 2014, 370, 2499\u20132505. [CrossRef]",
            "11. Chan, J.F.W.; Kok, K.H.; Zhu, Z.; Chu, H.; To, K.K.W.; Yuan, S.; Yuen, K.Y. Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerg. Microbes. Infect. 2020, 9, 221\u2013236. [CrossRef]",
            "12. Zhao, W.M.; Song, S.H.; Chen, M.L.; Zou, D.; Ma, L.N.; Ma, Y.K.; Li, R.J.; Hao, L.L.; Li, C.P.; Tian, D.M.; et al The 2019 Novel Coronavirus Resource. Hereditas 2020, 36, 1\u20139.",
            "13. NCBI Database. 2019-nCoV. Available online: https://www.ncbi.nlm.nih.gov/pubmed/?term=2019-nCoV (accessed on 14 February 2020).",
            "14. GSAID Database. 2020 Coronavirus. Available online: https://www.gisaid.org/CoV2020/ (accessed on 14 February 2020).",
            "15. NCBI Blast. Available online: https://blast.ncbi.nlm.nih.gov/Blast.cgi (accessed on 30 January 2020). 16. Zpicture. Available online: https://zpicture.dcode.org (accessed on 1 February 2020). 17. Kumar, S.; Stecher, G.; Tamura, K. MEGA7: Molecular evolutionary genetics analysis version 7.0 for bigger datasets. Mol. Biol. Evol. 2016, 33, 1870\u20131874. [CrossRef] [PubMed] 18. Tamura, K.; Nei, M.; Kumar, S. Prospects for inferring very large phylogenies by using the neighbor-joining method. Proc. Natl. Acad. Sci. USA 2004, 101, 11030\u201311035. [CrossRef] [PubMed] 19. Cheng, V.C.; Lau, S.K.; Woo, P.C.; Yuen, K.Y. Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection. Clin. Microbiol. Rev. 2007, 20, 660\u2013694. [CrossRef] [PubMed] 20. World Health Organization. Weekly Epidemiological Record, 2013, vol 88, 35 [full issue]. Wkly. Epidemiol. Rec.",
            "2013, 88, 365\u2013380.",
            "21. Lee, N.; Hui, D.S.; Wu, A.; Chan, P.K.S.; Cameron, P.; Joynt, G.; Ahuja, A.T.; Yung, M.Y.; Leung, C.; To, K.; et al A major outbreak of severe acute respiratory syndrome in Hong Kong. N. Engl. J. Med. 2003, 348, 1986\u20131994. [CrossRef]",
            "22. Poutanen, S.; Low, N.E.; Henry, B.; Finkelstein, S.; Rose, D.; Green, K.; Tellier, R.; Draker, R.; Adachi, D.; Ayers, M.; et al Identification of severe acute respiratory syndrome in Canada. N. Engl. J. Med. 2003, 348, 1995\u20132005. [CrossRef]",
            "23. Leo, Y.S.; Chen, M.; Heng, B.H.; Lee, C.C. Severe acute respiratory syndrome-Singapore, 2003. MMWR Morb. Mortal. Wkly. Rep. 2003, 52, 405.",
            "24. World Health Organization. Summary of Probable SARS Cases with Onset of Illness from 1 November 2002 to 31 July 2003. Available online: http://www.who.int/csr/sars/country/table2004_04_21/en/index.html. (accessed on 27 January 2020).",
            "25. Nuttall, I.; Dye, C. The SARS wake-up call. Science 2013, 339, 1287\u20131288. [CrossRef] 26. Al-Tawfiq, J.A.; Zumla, A.; Memish, Z.A. Travel implications of emerging coronaviruses: SARS and",
            "MERS-CoV. Travel. Med. Infect. Dis. 2014, 12, 422\u2013428. [CrossRef] 27. Chinese Center for Disease Control and Prevention. Epidemic Update and Risk Assessment of 2019",
            "Novel Coronavirus. Available online: http://www.chinacdc.cn/yyrdgz/202001/P020200128523354919292.pdf (accessed on 28 January 2020). 28. Gralinski, L.E.; Menachery, V.D. Return of the Coronavirus: 2019-nCoV. Viruses 2020, 12, 135. [CrossRef] [PubMed] 29. Wang, J.T.; Sheng, W.H.; Fang, C.T.; Chen, Y.C.; Wang, J.L.; Yu, C.J.; Yang, P.C. Clinical manifestations, laboratory findings, and treatment outcomes of SARS patients. Emerg. Infect. Dis. 2004, 10, 818. [CrossRef] [PubMed] 30. Fehr, A.R.; Channappanavar, R.; Perlman, S. Middle East respiratory syndrome: Emergence of a pathogenic human coronavirus. Annu. Rev. Med. 2017, 68, 387\u2013399. [CrossRef] [PubMed] 31. National Health Commission of the People\u2019s Republic of China. Diagnosis and Treatment of Pneumonia Caused by 2019-nCoV (Trial Version 4). Available online: http://www.nhc.gov.cn/jkj/ s3577/202002/573340613ab243b3a7f61df260551dd4/files/c791e5a7ea5149f680fdcb34dac0f54e.pdf (accessed on 6 February 2020). 32. Yang, F. Pulmonary rehabilitation guidelines in the principle of 4S for patients infected with 2019 novel coronavirus (2019-nCoV). Zhonghua Jie He He Hu Xi Za Zhi 2020, 43, E004. 33. Lessler, J.; Reich, N.G.; Brookmeyer, R.; Perl, T.M.; Nelson, K.E.; Cummings, D.A. Incubation periods of acute respiratory viral infections: A systematic review. Lancet. Infect. Dis. 2009, 9, 291\u2013300. [CrossRef] 34. Meltzer, M.I. Multiple contact dates and SARS incubation periods. Emerg. Infect. Dis. 2004, 10, 207. [CrossRef] 35. Zhu, N.; Zhang, D.; Wang, W.; Li, X.; Yang, B.; Song, J.; Zhao, X.; Huang, B.; Shi, W.; Lu, R.; et al A novel coronavirus from patients with pneumonia in China, 2019. N. Engl. J. Med. 2020, 382, 727\u2013733. [CrossRef] 36. Yang, Y.; Lu, Q.; Liu, M.; Wang, Y.; Zhang, A.; Jalali, N.; Dean, N.; Longini, I.; Halloran, M.E.; Xu, B.; et al Epidemiological and clinical features of the 2019 novel coronavirus outbreak in China. medRxiv 2020. [CrossRef] 37. Chan-Yeung, M.; Xu, R.H. SARS: Epidemiology. Respirology 2003, 8, S9\u2013S14. [CrossRef] 38. Wang, C.; Horby, P.W.; Hayden, F.G.; Gao, G.F. A novel coronavirus outbreak of global health concern. Lancet 2020, 395, 470\u2013473. [CrossRef] 39. Peiris, J.S.; Yuen, K.Y.; Osterhaus, A.D.; St\u00f6hr, K. The severe acute respiratory syndrome. N. Engl. J. Med. 2003, 349, 2431\u20132441. [CrossRef] [PubMed] 40. Leung, G.M.; Hedley, A.J.; Ho, L.-M.; Chau, P.; Wong, I.O.; Thach, T.Q.; Ghani, A.C.; Donnelly, C.; Fraser, C.; Riley, S.; et al The epidemiology of severe acute respiratory syndrome in the 2003 Hong Kong epidemic: An analysis of all 1755 patients. Ann. Intern. Med. 2004, 141, 662\u2013673. [CrossRef] [PubMed] 41. Infectious Disease Expert Li Lanjuan Responded to Six Questions of 2019-nCoV. Available online: http: //m.news.cctv.com/2020/01/23/ARTIEw78LIxqpgx6Ilm7NkBo200123.shtml (accessed on 23 January 2020). 42. Li, Q.; Guan, X.; Wu, P.; Wang, X.; Zhou, L.; Tong, Y.; Ren, R.; Leung, K.S.; Lau, E.H.; Wong, J.Y.; et al Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia. N. Engl. J. Med. 2020. [CrossRef] [PubMed] 43. Huang, C.; Wang, Y.; Li, X.; Ren, L.; Zhao, J.; Hu, Y.; Zhang, L.; Fan, G.; Xu, J.; Gu, X.; et al Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020, 395, 497\u2013506. [CrossRef]",
            "44. Chen, N.; Zhou, M.; Dong, X.; Qu, J.; Gong, F.; Han, Y.; Qiu, Y.; Wang, J.; Liu, Y.; Wei, Y.; et al Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study. Lancet 2020, 395, 507\u2013513. [CrossRef]",
            "45. Press Conference of the National Health Commission of the People\u2019s Republic of China on 3 February 2020. Available online: http://www.nhc.gov.cn/wjw/xwfbh/xwzb.shtml (accessed on 4 February 2020).",
            "46. Yuan, J.; Hon, C.-C.; Li, Y.; Wang, D.; Xu, G.; Zhang, H.; Zhou, P.; Poon, L.; Lam, T.Y.; Leung, F.C.-C.; et al Intraspecies diversity of SARS-like coronaviruses in Rhinolophus sinicus and its implications for the origin of SARS coronaviruses in humans. J. Gen. Virol. 2010, 91, 1058\u20131062. [CrossRef] [PubMed]",
            "47. Phan, T. Novel coronavirus: From discovery to clinical diagnostics. Infect. Genet. Evol. 2020, 79, 104211. [CrossRef]",
            "48. Wang, M.; Yan, M.; Xu, H.; Liang, W.; Kan, B.; Zheng, B.; Chen, H.; Zheng, H.; Xu, Y.; Zhang, E.; et al SARS-CoV infection in a restaurant from palm civet. Emerg. Infect. Dis. 2005, 11, 1860. [CrossRef]",
            "49. Zhou, P.; Yang, X.-L.; Wang, X.-G.; Hu, B.; Zhang, L.; Zhang, W.; Si, H.-R.; Zhu, Y.; Li, B.; Huang, C.-L.; et al Discovery of a novel coronavirus associated with the recent pneumonia outbreak in humans and its potential bat origin. bioRxiv 2020. [CrossRef]",
            "50. Guo, Q.; Li, M.; Wang, C.; Wang, P.; Fang, Z.; Tan, J.; Wu, S.; Xiao, Y.; Zhu, H. Host and infectivity prediction of Wuhan 2019 novel coronavirus using deep learning algorithm. bioRxiv 2020. [CrossRef]",
            "51. Ji, W.; Wang, W.; Zhao, X.; Zai, J.; Li, X. Homologous recombination within the spike glycoprotein of the newly identified coronavirus may boost cross-species transmission from snake to human. J. Med. Virol. 2020, 92, 433\u2013440. [CrossRef]",
            "52. South China Agricultural University: Pangolin May Be a Potential Intermediate Host of New Coronavirus. Available online: http://www.chinanews.com/sh/2020/02-07/9082279.shtml (accessed on 7 February 2020).",
            "53. Chowell, G.; Castillo-Chavez, C.; Fenimore, P.W.; Kribs-Zaleta, C.M.; Arriola, L.; Hyman, J.M. Model parameters and outbreak control for SARS. Emerg. Infect. Dis. 2004, 10, 1258. [CrossRef] [PubMed]",
            "54. Lau, E.H.Y.; Hsiung, C.A.; Cowling, B.J.; Chen, C.-H.; Ho, L.-M.; Tsang, T.; Chang, C.-W.; Donnelly, C.; Leung, G.M. A comparative epidemiologic analysis of SARS in Hong Kong, Beijing and Taiwan. BMC Infect. Dis. 2010, 10, 50. [CrossRef] [PubMed]",
            "55. Chinese Center for Disease Control and Prevention. Distribution of Pneumonia Infected by 2019-nCoV. Available online: http://2019ncov.chinacdc.cn/2019-nCoV/ (accessed on 15 February 2020).",
            "56. Real-time Updates of COVID-19 Epidemic in China. Available online: https://ncov.dxy.cn/ncovh5/view/ pneumonia (accessed on 15 February 2020).",
            "57. Nishiura, H.; Jung, S.-M.; Linton, N.; Kinoshita, R.; Yang, Y.; Hayashi, K.; Kobayashi, T.; Yuan, B.; Akhmetzhanov, A.R. The extent of transmission of novel coronavirus in Wuhan, China, 2020. J. Clin. Med. 2020, 9, 330. [CrossRef]",
            "58. Li, X.; Zai, J.; Wang, X.; Li, Y. Potential of large \u2018first generation\u2019 human-to-human transmission of 2019-nCoV. J. Med. Virol. 2020, 92, 448\u2013454. [CrossRef]",
            "59. Carlos, W.G.; Dela Cruz, C.S.; Cao, B.; Pasnick, S.; Jamil, S. Novel Wuhan (2019-nCoV) Coronavirus. Am. J. Respir. Crit. Care Med. 2020, 201, 7\u20138. [CrossRef]",
            "60. National Health Commission of the People\u2019s Republic of China. The Role of Fecal-Oral Transmission in All transmission Still Need Further Observation and Research. Available online: http://news.cctv.com/2020/02/ 13/ARTISJWExxLSLWoL8mtJos97200213.shtml (accessed on 13 February 2020).",
            "61. Chinese Center for Disease Control and Prevention. There Is No Evidence That the New Coronavirus Can Be Transmitted through Aerosol. Available online: http://news.cctv.com/2020/02/09/ ARTIiVFnLC1ww5sTSMqbcXlz200209.shtml (accessed on 9 February 2020).",
            "62. Lau, J.T.; Tsui, H.; Lau, M.; Yang, X. SARS transmission, risk factors, and prevention in Hong Kong. Emerg. Infect. Dis. 2004, 10, 587. [CrossRef]",
            "63. Lu, H.; Stratton, C.W.; Tang, Y.W. Outbreak of Pneumonia of Unknown Etiology in Wuhan China: The Mystery and the Miracle. J. Med. Virol. 2020, 92, 401\u2013402. [CrossRef]",
            "64. Rouquet, P.; Froment, J.-M.; Bermejo, M.; Kilbourn, A.; Karesh, W.; Reed, P.; Kumulungui, B.; Yaba, P.; Delicat, A.; Rollin, P.E.; et al Wild animal mortality monitoring and human Ebola outbreaks, Gabon and Republic of Congo, 2001\u20132003. Emerg. Infect. Dis. 2005, 11, 283. [CrossRef]",
            "65. Yoo, J.H. The Fight against the 2019-nCoV Outbreak: An Arduous March Has Just Begun. J. Korean Med. Sci. 2020, 35, e56. [CrossRef]",
            "66. De Wit, E.; van Doremalen, N.; Falzarano, D.; Munster, V.J. SARS and MERS: Recent insights into emerging coronaviruses. Nat. Rev. Microbiol. 2016, 14, 523. [CrossRef] [PubMed]",
            "67. Chinese Center for Disease Control and Prevention. The First New Coronavirus Species Information Was Published by the National Pathogen Microorganism Resource Bank. Available online: http://www.chinacdc. cn/yw_9324/202001/t20200124_211413.html (accessed on 1 February 2020).",
            "68. Zeng, Q.; Khan, K.; Wu, J.; Zhu, H. The utility of preemptive mass influenza vaccination in controlling a SARS outbreak during flu season. Math. Biosci. Eng. 2007, 4, 739. [PubMed]",
            "69. Wang, N.; Luo, C.; Liu, H.; Yang, X.-L.; Hu, B.; Zhang, W.; Li, B.; Zhu, Y.; Zhu, G.; Shen, X.; et al Characterization of a New Member of Alphacoronavirus with Unique Genomic Features in Rhinolophus Bats. Viruses 2019, 11, 379. [CrossRef] [PubMed]",
            "70. Bhadra, S.; Jiang, Y.S.; Kumar, M.R.; Johnson, R.F.; Hensley, L.E.; Ellington, A.D. Real-time sequence-validated loop-mediated isothermal amplification assays for detection of Middle East respiratory syndrome coronavirus (MERS-CoV). PLoS ONE 2015, 10, e0123126. [CrossRef] [PubMed]",
            "71. Chan, J.F.-W.; Choi, G.K.-Y.; Tsang, A.K.-L.; Tee, K.-M.; Lam, H.-Y.; Yip, C.C.-Y.; To, K.K.-W.; Cheng, V.C.-C.; Yeung, M.L.; Lau, S.K.; et al Development and evaluation of novel real-time reverse transcription-PCR assays with locked nucleic acid probes targeting leader sequences of human-pathogenic coronaviruses. J. Clin. Microbiol. 2015, 53, 2722\u20132726. [CrossRef]",
            "72. Wu, P.; Hao, X.; Lau, E.H.Y.; Wong, J.Y.; Leung, K.S.M.; Wu, J.T.; Cowling, B.J.; Leung, G.M. Real-time tentative assessment of the epidemiological characteristics of novel coronavirus infections in Wuhan, China, as at 22 January 2020. Euro. Surveill. 2020, 25, 2000044. [CrossRef]",
            "73. National Medical Products Administration. National Medical Products Administration Examined and Approved the New Nucleic Acid Test Reagent of Coronavirus Again. Available online: http://www.nmpa. gov.cn/WS04/CL2056/374398.html (accessed on 28 January 2020).",
            "74. Chen, Y.; Liu, Q.; Guo, D. Emerging coronaviruses: Genome structure, replication, and pathogenesis. J. Med. Virol. 2020, 92, 418\u2013423. [CrossRef]",
            "75. Cinatl, J.; Morgenstern, B.; Bauer, G.; Chandra, P.; Rabenau, H.; Doerr, H.W. Treatment of SARS with human interferons. Lancet 2003, 362, 293\u2013294. [CrossRef]",
            "76. Chu, C.M.; Cheng, V.C.C.; Hung, I.F.N.; Wong, M.M.L.; Chan, K.; Kao, R.Y.; Poon, L.; Wong, C.L.P.; Guan, Y.; Peiris, J.S.M.; et al Role of lopinavir/ritonavir in the treatment of SARS: Initial virological and clinical findings. Thorax 2004, 59, 252\u2013256. [CrossRef]",
            "77. Lu, H. Drug treatment options for the 2019-new coronavirus (2019-nCoV). Biosci. Trends 2020. [CrossRef] 78. Beijing Municipal Health Commission. Explanation on the Situation that Drugs for AIDS Can Be Tried to",
            "Treat Pneumonia Caused by 2019-nCoV Infection. Available online: http://wjw.beijing.gov.cn/wjwh/ztzl/ xxgzbd/202001/t20200126_1621354.html (accessed on 26 January 2020). 79. The Joint Research Team of Shanghai Institute of Materia Medica, Chinese Academy of Sciences, and ShanghaiTech University Discovered a Batch of Old Drugs and Traditional Chinese Medicines with Therapeutic Potential for COVID-19. Available online: http://www.shanghaitech.edu.cn/2020/0125/ c1001a50141/page.htm (accessed on 25 January 2020). 80. High-Resolution Crystal Structure of 2019-nCoV Coronavirus 3CL Hydrolase (Mpro) was Announced by the Joint Research Team of Shanghai Institute of Materia Medica, Chinese Academy of Sciences, and ShanghaiTech University. Available online: http://www.shanghaitech.edu.cn/2020/0126/c1001a50145/page.htm (accessed on 26 January 2020). 81. Xu, Z.; Peng, C.; Shi, Y.; Zhu, Z.; Mu, K.; Wang, X.; Zhu, W. Nelfinavir was predicted to be a potential inhibitor of 2019 nCov main protease by an integrative approach combining homology modelling, molecular docking and binding free energy calculation. bioRxiv 2020. [CrossRef] 82. Sheahan, T.P.; Sims, A.C.; Leist, S.R.; Sch\u00e4fer, A.; Won, J.; Brown, A.J.; Montgomery, S.A.; Hogg, A.; Babusis, D.; Clarke, M.O.; et al Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV. Nat. Commun. 2020, 11, 222. [CrossRef] [PubMed] 83. Mulangu, S.; Dodd, L.E.; Davey, R.T.; Mbaya, O.T.; Proschan, M.; Mukadi, D.; Manzo, M.L.; Nzolo, D.; Oloma, A.T.; Ibanda, A.; et al A randomized, controlled trial of Ebola virus disease therapeutics. N. Engl. J. Med. 2019, 381, 2293\u20132303. [CrossRef] [PubMed]",
            "84. Holshue, M.L.; DeBolt, C.; Lindquist, S.; Lofy, K.H.; Wiesman, J.; Bruce, H.; Spitters, C.; Ericson, K.; Wilkerson, S.; Tural, A.; et al First Case of 2019 Novel Coronavirus in the United States. N. Engl. J. Med. 2020. [CrossRef]",
            "85. Song, G.; Cheng, M.Q.; Wei, X.W. Research progress on novel coronavirus (2019-nCoV) related drugs in vitro/vivo. Bing Du Xue Bao 2020. [CrossRef]",
            "86. China-Japan Friendship Hospital: Clinical Experimental Research Work Is Being Carried Out on Remdesivir. Available online: http://www.chinanews.com/sh/shipin/cns-d/2020/02-12/news847712.shtml (accessed on 12 February 2020).",
            "87. Lai, M.M. Recombination in large RNA viruses: Coronaviruses. Semin. Virol. 1996, 7, 381\u2013388. [CrossRef] 88. Woo, P.C.Y.; Lau, S.K.; Lam, C.S.F.; Lau, C.C.Y.; Tsang, A.K.L.; Lau, J.H.N.; Bai, R.; Teng, J.L.L.; Tsang, C.C.C.; Wang, M.; et al Discovery of seven novel Mammalian and avian coronaviruses in the genus deltacoronavirus supports bat coronaviruses as the gene source of alphacoronavirus and betacoronavirus and avian coronaviruses as the gene source of gammacoronavirus and deltacoronavirus. J. Virol. 2012, 86, 3995\u20134008. 89. Lu, R.; Zhao, X.; Li, J.; Niu, P.; Yang, B.; Wu, H.; Wang, W.; Song, H.; Huang, B.; Zhu, N.; et al Genomic characterisation and epidemiology of 2019 novel coronavirus: Implications for virus origins and receptor binding. Lancet 2020, 395, 565\u2013574. [CrossRef] 90. Shi, C.S.; Nabar, N.R.; Huang, N.N.; Kehrl, J.H. SARS-Coronavirus Open Reading Frame-8b triggers intracellular stress pathways and activates NLRP3 inflammasomes. Cell Death Discov. 2019, 5, 101. [CrossRef] 91. Menachery, V.D.; Graham, R.L.; Baric, R.S. Jumping species\u2014A mechanism for coronavirus persistence and survival. Curr. Opin. Virol. 2017, 23, 1\u20137. [CrossRef] 92. Wang, N.; Li, S.-Y.; Yang, X.-L.; Huang, H.-M.; Zhang, Y.-J.; Guo, H.; Luo, C.-M.; Miller, M.; Zhu, G.; Chmura, A.; et al Serological evidence of bat SARS-related coronavirus infection in humans, China. Virol. Sin. 2018, 33, 104\u2013107. [CrossRef] [PubMed] 93. Xia, S.; Yan, L.; Xu, W.; Agrawal, A.S.; Algaissi, A.; Tseng, C.-T.K.; Wang, Q.; Du, L.; Tan, W.; Wilson, I.A.; et al A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike. Sci. Adv. 2019, 5, eaav4580. [CrossRef] [PubMed] 94. Nicholls, J.; DONG, X.P.; Jiang, G.; Peiris, M. SARS: Clinical virology and pathogenesis. Respirology 2003, 8, S6\u2013S8. [CrossRef] [PubMed] 95. He, L.; Ding, Y.; Zhang, Q.; Che, X.; He, Y.; Shen, H.; Wang, H.; Li, Z.; Zhao, L.; Geng, J.; et al Expression of elevated levels of pro-inflammatory cytokines in SARS-CoV-infected ACE2+ cells in SARS patients: Relation to the acute lung injury and pathogenesis of SARS. J. Pathol. 2006, 210, 288\u2013297. [CrossRef] [PubMed] 96. Hamming, I.; Timens, W.; Bulthuis, M.L.C.; Lely, A.T.; Navis, G.J.; van Goor, H. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J. Pathol. 2004, 203, 631\u2013637. [CrossRef] [PubMed] 97. Perlman, S.; Netland, J. Coronaviruses post-SARS: Update on replication and pathogenesis. Nat. Rev. Microbiol. 2009, 7, 439\u2013450. [CrossRef] 98. Ding, Y.; Wang, H.; Shen, H.; Li, Z.; Geng, J.; Han, H.; Cai, J.; Li, X.; Kang, W.; Weng, D.; et al The clinical pathology of severe acute respiratory syndrome (SARS): A report from China. J. Pathol. 2003, 200, 282\u2013289. [CrossRef] 99. Ding, Y.; He, L.; Zhang, Q.; Huang, Z.; Che, X.-Y.; Hou, J.-L.; Wang, H.; Shen, H.; Qiu, L.; Li, Z.; et al Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: Implications for pathogenesis and virus transmission pathways. J. Pathol. 2004, 203, 622\u2013630. [CrossRef] 100. HUI, D.S.C.; WONG, P.C.; Wang, C. SARS: Clinical features and diagnosis. Respirology 2003, 8, S20\u2013S24. [CrossRef] 101. Millet, J.K.; Whittaker, G.R. Host cell proteases: Critical determinants of coronavirus tropism and pathogenesis. Virus. Res. 2015, 202, 120\u2013134. [CrossRef] 102. Zhou, P.; Yang, X.-L.; Wang, X.-G.; Hu, B.; Zhang, L.; Zhang, W.; Si, H.-R.; Zhu, Y.; Li, B.; Huang, C.-L.; et al A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 2020. [CrossRef] [PubMed] 103. Kuba, K.; Imai, Y.; Rao, S.; Gao, H.; Guo, F.; Guan, B.; Huan, Y.; Yang, P.; Zhang, Y.; Deng, W.; et al A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus\u2013induced lung injury. Nat. Med. 2005, 11, 875\u2013879. [CrossRef] [PubMed]",
            "104. Imai, Y.; Kuba, K.; Rao, S.; Huan, Y.; Guo, F.; Guan, B.; Yang, P.; Sarao, R.; Wada, T.; Leong-Poi, H.; et al Angiotensin-converting enzyme 2 protects from severe acute lung failure. Nature 2005, 436, 112\u2013116. [CrossRef] [PubMed]",
            "105. Li, W.; Moore, M.J.; Vasilieva, N.; Sui, J.; Wong, S.K.; Berne, M.A.; Somasundaran, M.; Sullivan, J.L.; Luzuriaga, K.; Greenough, T.C.; et al Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 2003, 426, 450\u2013454. [CrossRef]",
            "106. Wan, Y.; Shang, J.; Graham, R.; Baric, R.S.; Li, F. Receptor recognition by novel coronavirus from Wuhan: An analysis based on decade-long structural studies of SARS. J. Virol. 2020. [CrossRef]",
            "107. Bassetti, M.; Vena, A.; Roberto Giacobbe, D. The Novel Chinese Coronavirus (2019-nCoV) Infections: Challenges for fighting the storm. Eur. J. Clin. Investig. 2020. [CrossRef]",
            "108. Su, S.; Wong, G.; Shi, W.; Liu, J.; Lai, A.C.; Zhou, J.; Liu, W.; Bi, Y.; Gao, G.F. Epidemiology, genetic recombination, and pathogenesis of coronaviruses. Trends. Microbiol. 2016, 24, 490\u2013502. [CrossRef]",
            "109. Chu, D.K.W.; Poon, L.; Gomaa, M.; Shehata, M.; Perera, R.A.; Abu Zeid, D.; El Rifay, A.S.; Siu, L.Y.; Guan, Y.; Webby, R.J.; et al MERS coronaviruses in dromedary camels, Egypt. Emerg. Infect. Dis. 2014, 20, 1049. [CrossRef]"
        ]
    },
    "participants": [
        {
            "participant": "proteins",
            "number": 28,
            "context": "The genomic information of latest SARS-CoV-2 strains is shown in Table S1.<br/><br/>2.2. <mark class=\"stats\">Homology Analysis<br/><br/>The amino acid sequences of 28 proteins in SARS-CoV-2 were compared with those of SARS-CoV to analyze protein homology by using NCBI Blastp [<a class=\"ref-link\" id=\"c15\" href=\"#r15\">15</a>]</mark>. Proteins from SARS and SARS-CoV-2 were treated as homologous: identity value \u2265 65%, query coverage \u2265 95%"
        },
        {
            "participant": "proteins",
            "number": 28,
            "context": "Homology Analysis. <mark class=\"stats\">The amino acid sequences of 28 proteins in SARS-CoV-2 were compared with those of SARS-CoV to analyze protein homology by using NCBI Blastp [<a class=\"ref-link\" id=\"c15\" href=\"#r15\">15</a>]</mark>. Proteins from SARS and SARS-CoV-2 were treated as homologous: identity value \u2265 65%, query coverage \u2265 95%"
        },
        {
            "participant": "cases",
            "number": 305,
            "context": "3.1. <mark class=\"stats\">COVID-19 and SARS\u2014the Initial Events the COhMnindaNeijssooterrviM.rbe2ugi7ntiitoiohsnnt,ar2yl00o2f,HaeraelstBpheiraijanitnnogro,yuGniullcaneCnedgshstdihneoaarntugtp,htSieshdaanicnuxiGteinuraenspgdiroantHoguryPbresoiy,vneisndpcreoec,miCaelhlhyinaWad[ut1hh9ua].nsIfinnarFCrehebsi,nu2al0t0e3d, in 305 cases and five deaths R[2T0-]P</mark>. CTRh,erRfoTl-lPoCwRin, gRTm-LoAnMthP, ,there werReTc-lPuCsRte,rrsRoTf-PaCtyRp,iRcaTl-LpAnMeuPm, onia repoDritaegdnionstoicthmeretphaordtss of mrRaTin-lLaAnMd PC,hCinoaro, nHaovnirgusKdoentgec[t2io1n], CanraRdTa-L[A22M],Pa,nCdoSroinngavapiroursed[e2t3e]c.tiIonnJul, 2003, SATRrSe-aCtmoVenstpread acrossG2lu6ccoocuonrttircioeisdkiinat nsdixincotenrtfienreonnts, and caLuospeidnaavciur/mrituolknaiattivvier (8i,n09te6sctiansge)s and 774 deaths (9.6%) [<a class=\"ref-link\" id=\"c24\" href=\"#r24\">24</a>]"
        },
        {
            "participant": "employees",
            "number": 4,
            "context": "In particular, a higher mortality (21%) was found in hospital personnel [<a class=\"ref-link\" id=\"c25\" href=\"#r25\">25</a>,<a class=\"ref-link\" id=\"c26\" href=\"#r26\">26</a>]. <mark class=\"stats\">3.1O. nCODVeIcD. -1299atnhd, S2A01R9S,\u2014ththee hIneiatilathl Edveenptasrtments of Hubei Province received a report that four employees of the South China Seafood Wholesale Market were diagnosed with unknown-caused pneumoOnniaNinova. 2lo7ctha,l 2h0o0s2p, iatarle, swpihriacthorwy ailslntehses fierrustptreedpoinrtGouf aSnAgRdoSn-CgoPVr-o2vi[n2c7e],</mark>. COhninDa e[c1.9]3. 1Inst,F2e0b1, 9, the2N00a3t,iotnhealCHheinaeltshe CMoimnimstrisysioofnHoefaPltehoapnlenoRuenpcuebdlitchoaft CthhisinaacuantedrCeshpiinraetsoerCy esnytnedrrfoomr De ihsaedastehuCsonfatrrol andrePsureltveedntiinon30(5ChcainseasCaDndC)fipvaertdiceiapthatsed[20in]. tThheeinfvoellsotwigiantgiomn oanntdh,cathseer-esewarecrheincgluwsteorrsko[2f 7a]t.yOpincatlhe sNaomp[8w2e,n03ae9d]du.6aaImycny,aostsJ,nhuetieslha, age2rnoe0ndpv0u3oe7m,rr7tnSe4bmAdedRreiennSoa-ttfoChoptsohfaVe(Wt9rie.sp6unp%ahtrrsea)tasni[nd2or4ffeae]lm.ccerItaaneosidsnepsdlwaa2rn6iitntidhccfuooCSlurhaAmnrinR,taraaStie,i-hosHCingioonhaVnebsg-rio2xKmuccotooontnrnhgtttaeii[nln2idute1yin]es,est(Cs2at,1saoa%enncao)lddiuwmactabab[su2rew2fsoa]eo,kudarsnlnaddtdocwiuSnsimiodnhceugoi.ealsatBppytioyitv[ra2teelh8e]. datpeeorsfotnhniselp[2a5p,e2r6\u2019]s. submission, a cumulative 67,081 cases and 1,526 deaths (2.1%) were reported worldwide"
        },
        {
            "participant": "cases",
            "number": 67081,
            "context": "3.1O. nCODVeIcD. -1299atnhd, S2A01R9S,\u2014ththee hIneiatilathl Edveenptasrtments of Hubei Province received a report that four employees of the South China Seafood Wholesale Market were diagnosed with unknown-caused pneumoOnniaNinova. 2lo7ctha,l 2h0o0s2p, iatarle, swpihriacthorwy ailslntehses fierrustptreedpoinrtGouf aSnAgRdoSn-CgoPVr-o2vi[n2c7e],. <mark class=\"stats\">COhninDa e[c1.9]3. 1Inst,F2e0b1, 9, the2N00a3t,iotnhealCHheinaeltshe CMoimnimstrisysioofnHoefaPltehoapnlenoRuenpcuebdlitchoaft CthhisinaacuantedrCeshpiinraetsoerCy esnytnedrrfoomr De ihsaedastehuCsonfatrrol andrePsureltveedntiinon30(5ChcainseasCaDndC)fipvaertdiceiapthatsed[20in]. tThheeinfvoellsotwigiantgiomn oanntdh,cathseer-esewarecrheincgluwsteorrsko[2f 7a]t.yOpincatlhe sNaomp[8w2e,n03ae9d]du.6aaImycny,aostsJ,nhuetieslha, age2rnoe0ndpv0u3oe7m,rr7tnSe4bmAdedRreiennSoa-ttfoChoptsohfaVe(Wt9rie.sp6unp%ahtrrsea)tasni[nd2or4ffeae]lm.ccerItaaneosidsnepsdlwaa2rn6iitntidhccfuooCSlurhaAmnrinR,taraaStie,i-hosHCingioonhaVnebsg-rio2xKmuccotooontnrnhgtttaeii[nln2idute1yin]es,est(Cs2at,1saoa%enncao)lddiuwmactabab[su2rew2fsoa]eo,kudarsnlnaddtdocwiuSnsimiodnhceugoi.ealsatBppytioyitv[ra2teelh8e]. datpeeorsfotnhniselp[2a5p,e2r6\u2019]s. submission, a cumulative 67,081 cases and 1,526 deaths (2.1%) were reported worldwide</mark>. In Wuhan, China, the number is 37,914"
        },
        {
            "participant": "patients with SARS discovered during the winter of 2003-2004",
            "number": 4,
            "context": "Epidemiological investigations have shown that civet cats in the wildlife market were the direct source of SARS-CoV [<a class=\"ref-link\" id=\"c48\" href=\"#r48\">48</a>]. <mark class=\"stats\">Among the four patients with SARS discovered during the winter of 2003-2004, two were waitresses at a restaurant in Guangzhou, China, and one was a customer who</mark>. Virusebs a2s0i2c0,d1i2s,e2a4s4es, such as heart disease and hypertension [<a class=\"ref-link\" id=\"c43\" href=\"#r43\">43</a>,<a class=\"ref-link\" id=\"c44\" href=\"#r44\">44</a>]"
        },
        {
            "participant": "patients",
            "number": 2102,
            "context": "Roneggio, naanl dDiSsthraibnuxtio(nFigure 2b) [<a class=\"ref-link\" id=\"c54\" href=\"#r54\">54</a>]. <mark class=\"stats\">In total, 2,102 patients were from Hong Kong, Macao, and Taiwan, with 336 deaths [<a class=\"ref-link\" id=\"c24\" href=\"#r24\">24</a>]</mark>. FiguFreig2u.r(ea)2.C(oa)mCpoamripsaornisoofnthofetnhuemnubmerboerf SoAf SRASRaSnadnCdOCVOIVDID-1-919paptaiteinentstsininCChhininaa((iinncclluuddiinngg HHoonngg KongK, oMnagc, aMo aacnadoTaaniwd aTna)iawnadn)otahnedr cootuhnetrriceosu; (nbtr)itehse; n(bu)mtbheer nouf mSAbeRrS opfatSieAnRtsS inpadtiieffnetrsenint pdroifvfeinrecnets of Chpirnoav; i(ncc)easnoifncCrehainsead; (ncu) manbeirncorfeCasOeVd InDu-1m9bpeartioefnCtsOoVveIDr -t1im9 epwataiesnsthsoowveedr tinimaehwisatosgsrhaomw. eOdninFeab"
        },
        {
            "participant": "patients",
            "number": 2102,
            "context": "The cases were mainly concentrated in Beijing, GViuruasnesg2d02o0n, 1g2,, a24n4d Shanxi (Figure 2b) [<a class=\"ref-link\" id=\"c54\" href=\"#r54\">54</a>]. <mark class=\"stats\">In total, 2,102 patients were from Hong Kong, Macao,6aonf 1d7 Taiwan, with 336 deaths [<a class=\"ref-link\" id=\"c24\" href=\"#r24\">24</a>]</mark>. According to the latest data on Feb. 14th, 2020 [<a class=\"ref-link\" id=\"c55\" href=\"#r55\">55</a>,<a class=\"ref-link\" id=\"c56\" href=\"#r56\">56</a>], there have been a total of 67,081 clinically diagnAocsceodrdcainsegstoofthCeOlaVtIeDst-1d9atianownoFreldbw. 1id4teh,,w20it2h01[,5552,656d],etahtherse"
        },
        {
            "participant": "proteins",
            "number": 2,
            "context": "The results showed that most of SARS-CoV-2 proteins are highly homologous (95%\u2013100%) to the proteins of SARS-CoV virus, indicating the evolutionary similarity between SARS-CoV and SARS-CoV-2 (Table 2). <mark class=\"stats\">However, two proteins (orf8 and orf10) in SARS-CoV-2 have no homologous proteins in SARS-CoV</mark>. The amino acid sequence of orf8 in SARS-CoV-2 is different from sequences of conserved orf8 or orf8b derived from human SARS-CoV [<a class=\"ref-link\" id=\"c11\" href=\"#r11\">11</a>]"
        },
        {
            "participant": "specific proteins",
            "number": 2,
            "context": "An aggregation motif VLVVL (amino acid 75\u201379) has been found in SARS-CoV orf8b which was shown to trigger intracellular stress pathways and activate NOD-like receptor family pyrin domain-containing-3 (NLRP3) inflammasomes [<a class=\"ref-link\" id=\"c90\" href=\"#r90\">90</a>]. <mark class=\"stats\">Therefore, it will be clinically meaningful to analyze the biological function of these two specific proteins (orf8 and orf10) in SARS-CoV-2</mark>. SARS-CoV-2"
        },
        {
            "participant": "confirmed patients",
            "number": 54000,
            "context": "As a large number of people have left Wuhan, the control of the epidemic situation is extremely urgent, and the treatments of COVID-19 are imminent. <mark class=\"stats\">On Feb. 14th, 2020, there were more than 54,000 confirmed patients in Hubei province, China [<a class=\"ref-link\" id=\"c55\" href=\"#r55\">55</a>]</mark>. Due to the lack of effective antiviral drugs, the prognosis of patients solely depends on their age and physical condition [<a class=\"ref-link\" id=\"c74\" href=\"#r74\">74</a>]"
        }
    ],
    "statistics": [
        {
            "tests": {
                "context": "<mark class=\"stats\">The evolutionary distances were calculated using the Maximum Composite Likelihood method [18]</mark>",
                "tests": [
                    {
                        "test": "Maximum Composite Likelihood method"
                    }
                ]
            }
        }
    ],
    "keywords": [
        "clinical feature",
        "NOD-like receptor family pyrin domain-containing-3",
        "clinical manifestations",
        "chest compfouutnedd toonmtohgeracphhesyt",
        "severe acute respiratory syndrome",
        "receptor-binding motif",
        "human coronaviruses",
        "pathogenic mechanism",
        "coronaviruses",
        "coronavirus",
        "aspartate transaminase",
        "SARS-CoV-2",
        "lactic dehydrogenase",
        "epidemiology",
        "COVID-19",
        "epithelium",
        "SARS-CoV",
        "new coronavirus",
        "proteomic comparison",
        "genomic comparison",
        "Rhinolophus sinicus",
        "novel coronavirus",
        "sars cov",
        "East Respiratory syndrome",
        "respiratory syndrome coronavirus",
        "acute respiratory distress syndrome",
        "regions of difference",
        "National Center for Biotechnology Information",
        "reverse transcription PCR",
        "pneumonia",
        "middle east respiratory syndrome",
        "pathogenesis",
        "angiotensin-converting enzyme 2",
        "Global Initiative on Sharing All Influenza Data",
        "pathogenic",
        "C-reactive protein"
    ],
    "keyword_relevance": {
        "severe acute respiratory syndrome": 0.2925824175824176,
        "SARS-CoV": 0.19642857142857142,
        "SARS-CoV-2": 0.11126373626373626,
        "coronavirus": 0.10714285714285714,
        "COVID-19": 0.042582417582417584,
        "Middle East respiratory syndrome": 0.03159340659340659,
        "angiotensin-converting enzyme 2": 0.024725274725274724,
        "coronaviruses": 0.023351648351648352,
        "regions of difference": 0.020604395604395604,
        "novel coronavirus": 0.017857142857142856,
        "pathogenic": 0.016483516483516484,
        "pneumonia": 0.013736263736263736,
        "pathogenesis": 0.013736263736263736,
        "human coronaviruses": 0.01098901098901099,
        "National Center for Biotechnology Information": 0.008241758241758242,
        "lactic dehydrogenase": 0.005494505494505495,
        "new coronavirus": 0.005494505494505495,
        "reverse transcription PCR": 0.005494505494505495,
        "C-reactive protein": 0.005494505494505495,
        "NOD-like receptor family pyrin domain-containing-3": 0.004120879120879121,
        "pathogenic mechanism": 0.004120879120879121,
        "aspartate transaminase": 0.004120879120879121,
        "epidemiology": 0.004120879120879121,
        "Rhinolophus sinicus": 0.004120879120879121,
        "respiratory syndrome coronavirus": 0.004120879120879121,
        "Global Initiative on Sharing All Influenza Data": 0.004120879120879121,
        "clinical feature": 0.0027472527472527475,
        "chest compfouutnedd toonmtohgeracphhesyt": 0.0027472527472527475,
        "receptor-binding motif": 0.0027472527472527475,
        "epithelium": 0.0027472527472527475,
        "acute respiratory distress syndrome": 0.0027472527472527475,
        "clinical manifestations": 0.0013736263736263737,
        "proteomic comparison": 0.0013736263736263737,
        "genomic comparison": 0.0013736263736263737,
        "sars cov": 0.0,
        "East Respiratory syndrome": 0.0,
        "middle east respiratory syndrome": 0.0
    },
    "species": [
        "Rhinolophus sinicus"
    ],
    "summary": [
        "<h2 style=\"display: inline\">Introduction:</h2> Coronaviruses (CoVs) are a group of viruses that co-infect humans and other vertebrate animals.",
        "The source of unexplained pneumonia was first discovered in Wuhan in Dec, 2019, and SARS-CoV-2, a new coronavirus, was isolated from the respiratory epithelium of patients.",
        "It belongs to a new evolutionary branch within the CoV.",
        "<h2 style=\"display: inline\">Objectives:</h2> The goal of this work is to systematically review and compare between SARS-CoV and SARS-CoV-2 in the context of their virus incubation, originations, diagnosis and treatment methods, genomic and proteomic sequences, and pathogenic mechanisms.",
        "<h2 style=\"display: inline\">Methods:</h2> The complete genomic sequences of SARS-CoV-2 were obtained from 2019 Novel Coronavirus Resource (2019nCoVR) [<a class=\"ref-link\" id=\"c12\" href=\"#r12\">12</a>] and two databases, including the National Center for Biotechnology Information (NCBI) [<a class=\"ref-link\" id=\"c13\" href=\"#r13\">13</a>] and Global Initiative on Sharing All Influenza Data (GISAID) [<a class=\"ref-link\" id=\"c14\" href=\"#r14\">14</a>].",
        "The amino acid sequences of 28 proteins in SARS-CoV-2 were compared with those of SARS-CoV to analyze protein homology by using NCBI Blastp [<a class=\"ref-link\" id=\"c15\" href=\"#r15\">15</a>].",
        "29,751 1\u20134 days on average Young adults.",
        "1:1.25 9.60% Fever, cough, myalgia, dyspnea, and diarrhea Droplets or close contacts Beijing, Guangdong, Shanxi in China RT-PCR, rRT-PCR, RT-LAMP, rRT-LAMP, Coronavirus detection kit Glucocorticoid and interferon",
        "<h2 style=\"display: inline\">Results:</h2> The differences and similarities of clinical characteristics between COVID-19 and SARS were summarized in Table 1.<br/><br/>Items First occurrence<br/><br/>Pathogen Intermediate host<br/><br/>Definitive host Virus type<br/><br/>Species pathogen Total DNA sequence length of pathogen Latency<br/><br/>Susceptible people<br/><br/>Male\u2013female patient ratio Mortality<br/><br/>Clinical symptoms<br/><br/>Propagation mode Major regional distribution.",
        "The differences and similarities of clinical characteristics between COVID-19 and SARS were summarized in Table 1.",
        "Species pathogen Total DNA sequence length of pathogen Latency.",
        "Propagation mode Major regional distribution",
        "<h2 style=\"display: inline\">Conclusion:</h2> As a large number of people have left Wuhan, the control of the epidemic situation is extremely urgent, and the treatments of COVID-19 are imminent.",
        "On Feb. 14th, 2020, there were more than 54,000 confirmed patients in Hubei province, China [<a class=\"ref-link\" id=\"c55\" href=\"#r55\">55</a>].",
        "Due to the lack of effective antiviral drugs, the prognosis of patients solely depends on their age and physical condition [<a class=\"ref-link\" id=\"c74\" href=\"#r74\">74</a>].",
        "It is urgent for them to develop more sensitive inspection methods and effective drugs"
    ],
    "structured_summary": {
        "Introduction": [
            "Coronaviruses (CoVs) are a group of viruses that co-infect humans and other vertebrate animals.",
            "The source of unexplained pneumonia was first discovered in Wuhan in Dec, 2019, and SARS-CoV-2, a new coronavirus, was isolated from the respiratory epithelium of patients.",
            "It belongs to a new evolutionary branch within the CoV."
        ],
        "Objectives": [
            "The goal of this work is to systematically review and compare between SARS-CoV and SARS-CoV-2 in the context of their virus incubation, originations, diagnosis and treatment methods, genomic and proteomic sequences, and pathogenic mechanisms."
        ],
        "Methods": [
            "The complete genomic sequences of SARS-CoV-2 were obtained from 2019 Novel Coronavirus Resource (2019nCoVR) [<a class=\"ref-link\" id=\"c12\" href=\"#r12\">12</a>] and two databases, including the National Center for Biotechnology Information (NCBI) [<a class=\"ref-link\" id=\"c13\" href=\"#r13\">13</a>] and Global Initiative on Sharing All Influenza Data (GISAID) [<a class=\"ref-link\" id=\"c14\" href=\"#r14\">14</a>].",
            "The amino acid sequences of 28 proteins in SARS-CoV-2 were compared with those of SARS-CoV to analyze protein homology by using NCBI Blastp [<a class=\"ref-link\" id=\"c15\" href=\"#r15\">15</a>].",
            "29,751 1\u20134 days on average Young adults.",
            "1:1.25 9.60% Fever, cough, myalgia, dyspnea, and diarrhea Droplets or close contacts Beijing, Guangdong, Shanxi in China RT-PCR, rRT-PCR, RT-LAMP, rRT-LAMP, Coronavirus detection kit Glucocorticoid and interferon"
        ],
        "Results": [
            "The differences and similarities of clinical characteristics between COVID-19 and SARS were summarized in Table 1.<br/><br/>Items First occurrence<br/><br/>Pathogen Intermediate host<br/><br/>Definitive host Virus type<br/><br/>Species pathogen Total DNA sequence length of pathogen Latency<br/><br/>Susceptible people<br/><br/>Male\u2013female patient ratio Mortality<br/><br/>Clinical symptoms<br/><br/>Propagation mode Major regional distribution.",
            "The differences and similarities of clinical characteristics between COVID-19 and SARS were summarized in Table 1.",
            "Species pathogen Total DNA sequence length of pathogen Latency.",
            "Propagation mode Major regional distribution"
        ],
        "Conclusion": [
            "As a large number of people have left Wuhan, the control of the epidemic situation is extremely urgent, and the treatments of COVID-19 are imminent.",
            "On Feb. 14th, 2020, there were more than 54,000 confirmed patients in Hubei province, China [<a class=\"ref-link\" id=\"c55\" href=\"#r55\">55</a>].",
            "Due to the lack of effective antiviral drugs, the prognosis of patients solely depends on their age and physical condition [<a class=\"ref-link\" id=\"c74\" href=\"#r74\">74</a>].",
            "It is urgent for them to develop more sensitive inspection methods and effective drugs"
        ]
    },
    "reference_links": [
        {
            "id": "1",
            "alt_id": "Wang_et+al_2006_a",
            "entry": "1. Wang, L.F.; Shi, Z.; Zhang, S.; Field, H.; Daszak, P.; Eaton, B.T. Review of bats and SARS. Emerg. Infect. Dis. 2006, 12, 1834. [CrossRef]",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Wang%2C%20L.F.%20Shi%2C%20Z.%20Zhang%2C%20S.%20Field%2C%20H.%20Review%20of%20bats%20and%20SARS%202006",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Wang%2C%20L.F.%20Shi%2C%20Z.%20Zhang%2C%20S.%20Field%2C%20H.%20Review%20of%20bats%20and%20SARS%202006",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Wang%2C%20L.F.%20Shi%2C%20Z.%20Zhang%2C%20S.%20Field%2C%20H.%20Review%20of%20bats%20and%20SARS%202006"
        },
        {
            "id": "2",
            "alt_id": "Ge_et+al_2013_a",
            "entry": "2. Ge, X.-Y.; Li, J.; Yang, X.-L.; Chmura, A.; Zhu, G.; Epstein, J.H.; Mazet, J.K.; Hu, B.; Zhang, W.; Peng, C.; et al. Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor. Nature 2013, 503, 535\u2013538. [CrossRef] [PubMed]",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Ge%2C%20X.-Y.%20Li%2C%20J.%20Yang%2C%20X.-L.%20Chmura%2C%20A.%20Isolation%20and%20characterization%20of%20a%20bat%20SARS-like%20coronavirus%20that%20uses%20the%20ACE2%20receptor%202013",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Ge%2C%20X.-Y.%20Li%2C%20J.%20Yang%2C%20X.-L.%20Chmura%2C%20A.%20Isolation%20and%20characterization%20of%20a%20bat%20SARS-like%20coronavirus%20that%20uses%20the%20ACE2%20receptor%202013",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Ge%2C%20X.-Y.%20Li%2C%20J.%20Yang%2C%20X.-L.%20Chmura%2C%20A.%20Isolation%20and%20characterization%20of%20a%20bat%20SARS-like%20coronavirus%20that%20uses%20the%20ACE2%20receptor%202013"
        },
        {
            "id": "3",
            "alt_id": "Chen_2016_a",
            "entry": "3. Chen, Y.; Guo, D. Molecular mechanisms of coronavirus RNA capping and methylation. Virol. Sin. 2016, 31, 3\u201311. [CrossRef] [PubMed]",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Chen%2C%20Y.%20Guo%2C%20D.%20Molecular%20mechanisms%20of%20coronavirus%20RNA%20capping%20and%20methylation%202016",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Chen%2C%20Y.%20Guo%2C%20D.%20Molecular%20mechanisms%20of%20coronavirus%20RNA%20capping%20and%20methylation%202016",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Chen%2C%20Y.%20Guo%2C%20D.%20Molecular%20mechanisms%20of%20coronavirus%20RNA%20capping%20and%20methylation%202016"
        },
        {
            "id": "4",
            "alt_id": "Cui_et+al_2019_a",
            "entry": "4. Cui, J.; Li, F.; Shi, Z.L. Origin and evolution of pathogenic coronaviruses. Nat. Rev. Microbiol. 2019, 17, 181\u2013192. [CrossRef] [PubMed]",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Cui%2C%20J.%20Li%2C%20F.%20Shi%2C%20Z.L.%20Origin%20and%20evolution%20of%20pathogenic%20coronaviruses%202019",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Cui%2C%20J.%20Li%2C%20F.%20Shi%2C%20Z.L.%20Origin%20and%20evolution%20of%20pathogenic%20coronaviruses%202019",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Cui%2C%20J.%20Li%2C%20F.%20Shi%2C%20Z.L.%20Origin%20and%20evolution%20of%20pathogenic%20coronaviruses%202019"
        },
        {
            "id": "5",
            "alt_id": "Cauchemez_et+al_2013_a",
            "entry": "5. Cauchemez, S.; Van Kerkhove, M.D.; Riley, S.; Donnelly, C.A.; Fraser, C.; Ferguson, N.M. Transmission scenarios for Middle East Respiratory Syndrome Coronavirus (MERS-CoV) and how to tell them apart. Euro Surveill. 2013, 18, 18.",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Cauchemez%2C%20S.%20Van%20Kerkhove%2C%20M.D.%20Riley%2C%20S.%20Donnelly%2C%20C.A.%20Transmission%20scenarios%20for%20Middle%20East%20Respiratory%20Syndrome%20Coronavirus%20%28MERS-CoV%29%20and%20how%20to%20tell%20them%20apart%202013",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Cauchemez%2C%20S.%20Van%20Kerkhove%2C%20M.D.%20Riley%2C%20S.%20Donnelly%2C%20C.A.%20Transmission%20scenarios%20for%20Middle%20East%20Respiratory%20Syndrome%20Coronavirus%20%28MERS-CoV%29%20and%20how%20to%20tell%20them%20apart%202013",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Cauchemez%2C%20S.%20Van%20Kerkhove%2C%20M.D.%20Riley%2C%20S.%20Donnelly%2C%20C.A.%20Transmission%20scenarios%20for%20Middle%20East%20Respiratory%20Syndrome%20Coronavirus%20%28MERS-CoV%29%20and%20how%20to%20tell%20them%20apart%202013"
        },
        {
            "id": "6",
            "alt_id": "Gorbalenya_et+al_2020_a",
            "entry": "6. Gorbalenya, A.E.; Baker, S.C.; Baric, R.S.; de Groot, R.J.; Drosten, C.; Gulyaeva, A.A.; Haagmans, B.L.; Lauber, C.; Leontovich, A.M.; Neuman, B.W.; et al. Severe acute respiratory syndrome-related coronavirus: The species and its viruses\u2014A statement of the Coronavirus Study Group. bioRxiv 2020. [CrossRef]",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Gorbalenya%20AE%20Baker%20SC%20Baric%20RS%20de%20Groot%20RJ%20Drosten%20C%20Gulyaeva%20AA%20Haagmans%20BL%20Lauber%20C%20Leontovich%20AM%20Neuman%20BW%20et%20al%20Severe%20acute%20respiratory%20syndromerelated%20coronavirus%20The%20species%20and%20its%20virusesA%20statement%20of%20the%20Coronavirus%20Study%20Group%20bioRxiv%202020%20CrossRef"
        },
        {
            "id": "7",
            "alt_id": "7._0000_a",
            "entry": "7. WHO Named the New Pneumonia \u201cCOVID-19\u201d. Available online: http://www.xinhuanet.com/world/202002/12/c_1125561389.htm (accessed on 12 February 2020).",
            "url": "http://www.xinhuanet.com/world/202002/12/c_1125561389.htm"
        },
        {
            "id": "8",
            "alt_id": "Guan_et+al_2003_a",
            "entry": "8. Guan, Y.; Zheng, B.J.; He, Y.Q.; Liu, X.L.; Zhuang, Z.X.; Cheung, C.L.; Luo, S.W.; Li, P.H.; Zhang, L.J.; Butt, K.M.; et al. Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China. Science 2003, 302, 276\u2013278. [CrossRef]",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Guan%2C%20Y.%20Zheng%2C%20B.J.%20He%2C%20Y.Q.%20Liu%2C%20X.L.%20Isolation%20and%20characterization%20of%20viruses%20related%20to%20the%20SARS%20coronavirus%20from%20animals%20in%20southern%20China%202003",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Guan%2C%20Y.%20Zheng%2C%20B.J.%20He%2C%20Y.Q.%20Liu%2C%20X.L.%20Isolation%20and%20characterization%20of%20viruses%20related%20to%20the%20SARS%20coronavirus%20from%20animals%20in%20southern%20China%202003",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Guan%2C%20Y.%20Zheng%2C%20B.J.%20He%2C%20Y.Q.%20Liu%2C%20X.L.%20Isolation%20and%20characterization%20of%20viruses%20related%20to%20the%20SARS%20coronavirus%20from%20animals%20in%20southern%20China%202003"
        },
        {
            "id": "9",
            "alt_id": "Ki_2015_a",
            "entry": "9. Ki, M. 2015 MERS outbreak in Korea: Hospital-to-hospital transmission. Epidemiol. Health 2015, 37, 37. [CrossRef]",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Ki%2C%20M.%20MERS%20outbreak%20in%20Korea%3A%20Hospital-to-hospital%20transmission%202015",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Ki%2C%20M.%20MERS%20outbreak%20in%20Korea%3A%20Hospital-to-hospital%20transmission%202015",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Ki%2C%20M.%20MERS%20outbreak%20in%20Korea%3A%20Hospital-to-hospital%20transmission%202015"
        },
        {
            "id": "10",
            "alt_id": "Azhar_et+al_2014_a",
            "entry": "10. Azhar, E.I.; El-Kafrawy, S.A.; Farraj, S.A.; Hassan, A.M.; Al-Saeed, M.S.; Hashem, A.M.; Madani, T.A. Evidence for camel-to-human transmission of MERS coronavirus. N. Engl. J. Med. 2014, 370, 2499\u20132505. [CrossRef]",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Azhar%2C%20E.I.%20El-Kafrawy%2C%20S.A.%20Farraj%2C%20S.A.%20Hassan%2C%20A.M.%20Evidence%20for%20camel-to-human%20transmission%20of%20MERS%20coronavirus%202014",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Azhar%2C%20E.I.%20El-Kafrawy%2C%20S.A.%20Farraj%2C%20S.A.%20Hassan%2C%20A.M.%20Evidence%20for%20camel-to-human%20transmission%20of%20MERS%20coronavirus%202014",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Azhar%2C%20E.I.%20El-Kafrawy%2C%20S.A.%20Farraj%2C%20S.A.%20Hassan%2C%20A.M.%20Evidence%20for%20camel-to-human%20transmission%20of%20MERS%20coronavirus%202014"
        },
        {
            "id": "11",
            "alt_id": "Chan_et+al_2019_a",
            "entry": "11. Chan, J.F.W.; Kok, K.H.; Zhu, Z.; Chu, H.; To, K.K.W.; Yuan, S.; Yuen, K.Y. Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerg. Microbes. Infect. 2020, 9, 221\u2013236. [CrossRef]",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Chan%20JFW%20Kok%20KH%20Zhu%20Z%20Chu%20H%20To%20KKW%20Yuan%20S%20Yuen%20KY%20Genomic%20characterization%20of%20the%202019%20novel%20humanpathogenic%20coronavirus%20isolated%20from%20a%20patient%20with%20atypical%20pneumonia%20after%20visiting%20Wuhan%20Emerg%20Microbes%20Infect%202020%209%20221236%20CrossRef",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Chan%20JFW%20Kok%20KH%20Zhu%20Z%20Chu%20H%20To%20KKW%20Yuan%20S%20Yuen%20KY%20Genomic%20characterization%20of%20the%202019%20novel%20humanpathogenic%20coronavirus%20isolated%20from%20a%20patient%20with%20atypical%20pneumonia%20after%20visiting%20Wuhan%20Emerg%20Microbes%20Infect%202020%209%20221236%20CrossRef",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Chan%20JFW%20Kok%20KH%20Zhu%20Z%20Chu%20H%20To%20KKW%20Yuan%20S%20Yuen%20KY%20Genomic%20characterization%20of%20the%202019%20novel%20humanpathogenic%20coronavirus%20isolated%20from%20a%20patient%20with%20atypical%20pneumonia%20after%20visiting%20Wuhan%20Emerg%20Microbes%20Infect%202020%209%20221236%20CrossRef"
        },
        {
            "id": "12",
            "alt_id": "Zhao_et+al_2019_a",
            "entry": "12. Zhao, W.M.; Song, S.H.; Chen, M.L.; Zou, D.; Ma, L.N.; Ma, Y.K.; Li, R.J.; Hao, L.L.; Li, C.P.; Tian, D.M.; et al. The 2019 Novel Coronavirus Resource. Hereditas 2020, 36, 1\u20139.",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Zhao%2C%20W.M.%20Song%2C%20S.H.%20Chen%2C%20M.L.%20Zou%2C%20D.%20Novel%20Coronavirus%20Resource%202019",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Zhao%2C%20W.M.%20Song%2C%20S.H.%20Chen%2C%20M.L.%20Zou%2C%20D.%20Novel%20Coronavirus%20Resource%202019",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Zhao%2C%20W.M.%20Song%2C%20S.H.%20Chen%2C%20M.L.%20Zou%2C%20D.%20Novel%20Coronavirus%20Resource%202019"
        },
        {
            "id": "13",
            "alt_id": "13._0000_b",
            "entry": "13. NCBI Database. 2019-nCoV. Available online: https://www.ncbi.nlm.nih.gov/pubmed/?term=2019-nCoV (accessed on 14 February 2020).",
            "url": "https://www.ncbi.nlm.nih.gov/pubmed/?term=2019-nCoV"
        },
        {
            "id": "14",
            "alt_id": "Database_2020_a",
            "entry": "14. GSAID Database. 2020 Coronavirus. Available online: https://www.gisaid.org/CoV2020/ (accessed on 14 February 2020).",
            "url": "https://www.gisaid.org/CoV2020/"
        },
        {
            "id": "15",
            "alt_id": "15._0000_c",
            "entry": "15. NCBI Blast. Available online: https://blast.ncbi.nlm.nih.gov/Blast.cgi (accessed on 30 January 2020).",
            "url": "https://blast.ncbi.nlm.nih.gov/Blast.cgi"
        },
        {
            "id": "16",
            "alt_id": "Zpicture_0000_a",
            "entry": "16. Zpicture. Available online: https://zpicture.dcode.org (accessed on 1 February 2020).",
            "url": "https://zpicture.dcode.org"
        },
        {
            "id": "17",
            "alt_id": "Kumar_et+al_2016_a",
            "entry": "17. Kumar, S.; Stecher, G.; Tamura, K. MEGA7: Molecular evolutionary genetics analysis version 7.0 for bigger datasets. Mol. Biol. Evol. 2016, 33, 1870\u20131874. [CrossRef] [PubMed] 18. Tamura, K.; Nei, M.; Kumar, S. Prospects for inferring very large phylogenies by using the neighbor-joining method. Proc. Natl. Acad. Sci. USA 2004, 101, 11030\u201311035. [CrossRef] [PubMed] 19.",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Kumar%2C%20S.%20Stecher%2C%20G.%20Tamura%2C%20K.%20MEGA7%3A%20Molecular%20evolutionary%20genetics%20analysis%20version%207.0%20for%20bigger%20datasets%202016",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Kumar%2C%20S.%20Stecher%2C%20G.%20Tamura%2C%20K.%20MEGA7%3A%20Molecular%20evolutionary%20genetics%20analysis%20version%207.0%20for%20bigger%20datasets%202016",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Kumar%2C%20S.%20Stecher%2C%20G.%20Tamura%2C%20K.%20MEGA7%3A%20Molecular%20evolutionary%20genetics%20analysis%20version%207.0%20for%20bigger%20datasets%202016"
        },
        {
            "id": "Cheng_et+al_2007_a",
            "alt_id": "18",
            "entry": "Cheng, V.C.; Lau, S.K.; Woo, P.C.; Yuen, K.Y. Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection. Clin. Microbiol. Rev. 2007, 20, 660\u2013694. [CrossRef] [PubMed] 20. World Health Organization. Weekly Epidemiological Record, 2013, vol. 88, 35 [full issue]. Wkly. Epidemiol. Rec.",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Cheng%2C%20V.C.%20Lau%2C%20S.K.%20Woo%2C%20P.C.%20Yuen%2C%20K.Y.%20Severe%20acute%20respiratory%20syndrome%20coronavirus%20as%20an%20agent%20of%20emerging%20and%20reemerging%20infection%202007",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Cheng%2C%20V.C.%20Lau%2C%20S.K.%20Woo%2C%20P.C.%20Yuen%2C%20K.Y.%20Severe%20acute%20respiratory%20syndrome%20coronavirus%20as%20an%20agent%20of%20emerging%20and%20reemerging%20infection%202007",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Cheng%2C%20V.C.%20Lau%2C%20S.K.%20Woo%2C%20P.C.%20Yuen%2C%20K.Y.%20Severe%20acute%20respiratory%20syndrome%20coronavirus%20as%20an%20agent%20of%20emerging%20and%20reemerging%20infection%202007"
        },
        {
            "id": "Lee_et+al_2003_a",
            "alt_id": "19",
            "entry": "2013, 88, 365\u2013380.",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Lee%2C%20N.%20Hui%2C%20D.S.%20Wu%2C%20A.%20Chan%2C%20P.K.S.%20A%20major%20outbreak%20of%20severe%20acute%20respiratory%20syndrome%20in%20Hong%20Kong%202003",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Lee%2C%20N.%20Hui%2C%20D.S.%20Wu%2C%20A.%20Chan%2C%20P.K.S.%20A%20major%20outbreak%20of%20severe%20acute%20respiratory%20syndrome%20in%20Hong%20Kong%202003",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Lee%2C%20N.%20Hui%2C%20D.S.%20Wu%2C%20A.%20Chan%2C%20P.K.S.%20A%20major%20outbreak%20of%20severe%20acute%20respiratory%20syndrome%20in%20Hong%20Kong%202003"
        },
        {
            "id": "21",
            "alt_id": "Poutanen_et+al_2003_a",
            "entry": "21. Lee, N.; Hui, D.S.; Wu, A.; Chan, P.K.S.; Cameron, P.; Joynt, G.; Ahuja, A.T.; Yung, M.Y.; Leung, C.; To, K.; et al. A major outbreak of severe acute respiratory syndrome in Hong Kong. N. Engl. J. Med. 2003, 348, 1986\u20131994. [CrossRef]",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Poutanen%2C%20S.%20Low%2C%20N.E.%20Henry%2C%20B.%20Finkelstein%2C%20S.%20Identification%20of%20severe%20acute%20respiratory%20syndrome%20in%20Canada%202003",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Poutanen%2C%20S.%20Low%2C%20N.E.%20Henry%2C%20B.%20Finkelstein%2C%20S.%20Identification%20of%20severe%20acute%20respiratory%20syndrome%20in%20Canada%202003",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Poutanen%2C%20S.%20Low%2C%20N.E.%20Henry%2C%20B.%20Finkelstein%2C%20S.%20Identification%20of%20severe%20acute%20respiratory%20syndrome%20in%20Canada%202003"
        },
        {
            "id": "22",
            "alt_id": "Leo_et+al_2003_a",
            "entry": "22. Poutanen, S.; Low, N.E.; Henry, B.; Finkelstein, S.; Rose, D.; Green, K.; Tellier, R.; Draker, R.; Adachi, D.; Ayers, M.; et al. Identification of severe acute respiratory syndrome in Canada. N. Engl. J. Med. 2003, 348, 1995\u20132005. [CrossRef]",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Poutanen%20S%20Low%20NE%20Henry%20B%20Finkelstein%20S%20Rose%20D%20Green%20K%20Tellier%20R%20Draker%20R%20Adachi%20D%20Ayers%20M%20et%20al%20Identification%20of%20severe%20acute%20respiratory%20syndrome%20in%20Canada%20N%20Engl%20J%20Med%202003%20348%2019952005%20CrossRef",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Poutanen%20S%20Low%20NE%20Henry%20B%20Finkelstein%20S%20Rose%20D%20Green%20K%20Tellier%20R%20Draker%20R%20Adachi%20D%20Ayers%20M%20et%20al%20Identification%20of%20severe%20acute%20respiratory%20syndrome%20in%20Canada%20N%20Engl%20J%20Med%202003%20348%2019952005%20CrossRef",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Poutanen%20S%20Low%20NE%20Henry%20B%20Finkelstein%20S%20Rose%20D%20Green%20K%20Tellier%20R%20Draker%20R%20Adachi%20D%20Ayers%20M%20et%20al%20Identification%20of%20severe%20acute%20respiratory%20syndrome%20in%20Canada%20N%20Engl%20J%20Med%202003%20348%2019952005%20CrossRef"
        },
        {
            "id": "23",
            "alt_id": "Organization_2002_a",
            "entry": "23. Leo, Y.S.; Chen, M.; Heng, B.H.; Lee, C.C. Severe acute respiratory syndrome-Singapore, 2003. MMWR Morb. Mortal. Wkly. Rep. 2003, 52, 405.",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Leo%20YS%20Chen%20M%20Heng%20BH%20Lee%20CC%20Severe%20acute%20respiratory%20syndromeSingapore%202003%20MMWR%20Morb%20Mortal%20Wkly%20Rep%202003%2052%20405"
        },
        {
            "id": "24",
            "alt_id": "Nuttall_2013_a",
            "entry": "24. World Health Organization. Summary of Probable SARS Cases with Onset of Illness from 1 November 2002 to 31 July 2003. Available online: http://www.who.int/csr/sars/country/table2004_04_21/en/index.html. (accessed on 27 January 2020).",
            "url": "http://www.who.int/csr/sars/country/table2004_04_21/en/index.html"
        },
        {
            "id": "25",
            "alt_id": "25._0000_d",
            "entry": "25. Nuttall, I.; Dye, C. The SARS wake-up call. Science 2013, 339, 1287\u20131288. [CrossRef] 26. MERS-CoV. Travel. Med. Infect. Dis. 2014, 12, 422\u2013428. [CrossRef] 27. Chinese Center for Disease Control and Prevention. Epidemic Update and Risk Assessment of 2019",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Nuttall%20I%20Dye%20C%20The%20SARS%20wakeup%20call%20Science%202013%20339%2012871288%20CrossRef%2026%20MERSCoV%20Travel%20Med%20Infect%20Dis%202014%2012%20422428%20CrossRef%2027%20Chinese%20Center%20for%20Disease%20Control%20and%20Prevention%20Epidemic%20Update%20and%20Risk%20Assessment%20of%202019"
        },
        {
            "id": "Gralinski_2004_a",
            "alt_id": "25",
            "entry": "Novel Coronavirus. Available online: http://www.chinacdc.cn/yyrdgz/202001/P020200128523354919292.pdf (accessed on 28 January 2020).",
            "url": "http://www.chinacdc.cn/yyrdgz/202001/P020200128523354919292.pdf",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Novel%20Coronavirus%20Available%20online%20httpwwwchinacdccnyyrdgz202001P020200128523354919292pdf%20accessed%20on%2028%20January%202020",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Novel%20Coronavirus%20Available%20online%20httpwwwchinacdccnyyrdgz202001P020200128523354919292pdf%20accessed%20on%2028%20January%202020"
        },
        {
            "id": "28",
            "alt_id": "Fehr_et+al_2017_a",
            "entry": "28. Gralinski, L.E.; Menachery, V.D. Return of the Coronavirus: 2019-nCoV. Viruses 2020, 12, 135. [CrossRef] [PubMed] 29. Wang, J.T.; Sheng, W.H.; Fang, C.T.; Chen, Y.C.; Wang, J.L.; Yu, C.J.; Yang, P.C. Clinical manifestations, laboratory findings, and treatment outcomes of SARS patients. Emerg. Infect. Dis. 2004, 10, 818. [CrossRef] [PubMed] 30.",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Fehr%2C%20A.R.%20Channappanavar%2C%20R.%20Perlman%2C%20S.%20Middle%20East%20respiratory%20syndrome%3A%20Emergence%20of%20a%20pathogenic%20human%20coronavirus%202017",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Fehr%2C%20A.R.%20Channappanavar%2C%20R.%20Perlman%2C%20S.%20Middle%20East%20respiratory%20syndrome%3A%20Emergence%20of%20a%20pathogenic%20human%20coronavirus%202017",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Fehr%2C%20A.R.%20Channappanavar%2C%20R.%20Perlman%2C%20S.%20Middle%20East%20respiratory%20syndrome%3A%20Emergence%20of%20a%20pathogenic%20human%20coronavirus%202017"
        },
        {
            "id": "Yang_2019_a",
            "alt_id": "27",
            "entry": "Fehr, A.R.; Channappanavar, R.; Perlman, S. Middle East respiratory syndrome: Emergence of a pathogenic human coronavirus. Annu. Rev. Med. 2017, 68, 387\u2013399. [CrossRef] [PubMed] 31. National Health Commission of the People\u2019s Republic of China. Diagnosis and Treatment of Pneumonia Caused by 2019-nCoV (Trial Version 4). Available online: http://www.nhc.gov.cn/jkj/s3577/202002/573340613ab243b3a7f61df260551dd4/files/c791e5a7ea5149f680fdcb34dac0f54e.pdf (accessed on 6 February 2020).",
            "url": "http://www.nhc.gov.cn/jkj/s3577/202002/573340613ab243b3a7f61df260551dd4/files/c791e5a7ea5149f680fdcb34dac0f54e.pdf",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Fehr%20AR%20Channappanavar%20R%20Perlman%20S%20Middle%20East%20respiratory%20syndrome%20Emergence%20of%20a%20pathogenic%20human%20coronavirus%20Annu%20Rev%20Med%202017%2068%20387399%20CrossRef%20PubMed%2031%20National%20Health%20Commission%20of%20the%20Peoples%20Republic%20of%20China%20Diagnosis%20and%20Treatment%20of%20Pneumonia%20Caused%20by%202019nCoV%20Trial%20Version%204%20Available%20online%20httpwwwnhcgovcnjkjs3577202002573340613ab243b3a7f61df260551dd4filesc791e5a7ea5149f680fdcb34dac0f54epdf%20accessed%20on%206%20February%202020",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Fehr%20AR%20Channappanavar%20R%20Perlman%20S%20Middle%20East%20respiratory%20syndrome%20Emergence%20of%20a%20pathogenic%20human%20coronavirus%20Annu%20Rev%20Med%202017%2068%20387399%20CrossRef%20PubMed%2031%20National%20Health%20Commission%20of%20the%20Peoples%20Republic%20of%20China%20Diagnosis%20and%20Treatment%20of%20Pneumonia%20Caused%20by%202019nCoV%20Trial%20Version%204%20Available%20online%20httpwwwnhcgovcnjkjs3577202002573340613ab243b3a7f61df260551dd4filesc791e5a7ea5149f680fdcb34dac0f54epdf%20accessed%20on%206%20February%202020"
        },
        {
            "id": "32",
            "alt_id": "Lessler_et+al_2009_a",
            "entry": "32. Yang, F. Pulmonary rehabilitation guidelines in the principle of 4S for patients infected with 2019 novel coronavirus (2019-nCoV). Zhonghua Jie He He Hu Xi Za Zhi 2020, 43, E004.",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Lessler%2C%20J.%20Reich%2C%20N.G.%20Brookmeyer%2C%20R.%20Perl%2C%20T.M.%20Incubation%20periods%20of%20acute%20respiratory%20viral%20infections%3A%20A%20systematic%20review%202009",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Lessler%2C%20J.%20Reich%2C%20N.G.%20Brookmeyer%2C%20R.%20Perl%2C%20T.M.%20Incubation%20periods%20of%20acute%20respiratory%20viral%20infections%3A%20A%20systematic%20review%202009",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Lessler%2C%20J.%20Reich%2C%20N.G.%20Brookmeyer%2C%20R.%20Perl%2C%20T.M.%20Incubation%20periods%20of%20acute%20respiratory%20viral%20infections%3A%20A%20systematic%20review%202009"
        },
        {
            "id": "33",
            "alt_id": "Zhu_et+al_2019_a",
            "entry": "33. Lessler, J.; Reich, N.G.; Brookmeyer, R.; Perl, T.M.; Nelson, K.E.; Cummings, D.A. Incubation periods of acute respiratory viral infections: A systematic review. Lancet. Infect. Dis. 2009, 9, 291\u2013300. [CrossRef] 34. Meltzer, M.I. Multiple contact dates and SARS incubation periods. Emerg. Infect. Dis. 2004, 10, 207. [CrossRef] 35.",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Lessler%20J%20Reich%20NG%20Brookmeyer%20R%20Perl%20TM%20Nelson%20KE%20Cummings%20DA%20Incubation%20periods%20of%20acute%20respiratory%20viral%20infections%20A%20systematic%20review%20Lancet%20Infect%20Dis%202009%209%20291300%20CrossRef%2034%20Meltzer%20MI%20Multiple%20contact%20dates%20and%20SARS%20incubation%20periods%20Emerg%20Infect%20Dis%202004%2010%20207%20CrossRef%2035",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Lessler%20J%20Reich%20NG%20Brookmeyer%20R%20Perl%20TM%20Nelson%20KE%20Cummings%20DA%20Incubation%20periods%20of%20acute%20respiratory%20viral%20infections%20A%20systematic%20review%20Lancet%20Infect%20Dis%202009%209%20291300%20CrossRef%2034%20Meltzer%20MI%20Multiple%20contact%20dates%20and%20SARS%20incubation%20periods%20Emerg%20Infect%20Dis%202004%2010%20207%20CrossRef%2035",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Lessler%20J%20Reich%20NG%20Brookmeyer%20R%20Perl%20TM%20Nelson%20KE%20Cummings%20DA%20Incubation%20periods%20of%20acute%20respiratory%20viral%20infections%20A%20systematic%20review%20Lancet%20Infect%20Dis%202009%209%20291300%20CrossRef%2034%20Meltzer%20MI%20Multiple%20contact%20dates%20and%20SARS%20incubation%20periods%20Emerg%20Infect%20Dis%202004%2010%20207%20CrossRef%2035"
        },
        {
            "id": "Yang_et+al_[CrossRef] 37._a",
            "alt_id": "30",
            "entry": "Zhu, N.; Zhang, D.; Wang, W.; Li, X.; Yang, B.; Song, J.; Zhao, X.; Huang, B.; Shi, W.; Lu, R.; et al. A novel coronavirus from patients with pneumonia in China, 2019. N. Engl. J. Med. 2020, 382, 727\u2013733. [CrossRef] 36.",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Zhu%20N%20Zhang%20D%20Wang%20W%20Li%20X%20Yang%20B%20Song%20J%20Zhao%20X%20Huang%20B%20Shi%20W%20Lu%20R%20et%20al%20A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China%202019%20N%20Engl%20J%20Med%202020%20382%20727733%20CrossRef%2036"
        },
        {
            "id": "Chan-Yeung_2003_a",
            "alt_id": "31",
            "entry": "Yang, Y.; Lu, Q.; Liu, M.; Wang, Y.; Zhang, A.; Jalali, N.; Dean, N.; Longini, I.; Halloran, M.E.; Xu, B.; et al. Epidemiological and clinical features of the 2019 novel coronavirus outbreak in China. medRxiv 2020. [CrossRef] 37.",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Chan-Yeung%2C%20M.%20Xu%2C%20R.H.%20SARS%3A%20Epidemiology%202003",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Chan-Yeung%2C%20M.%20Xu%2C%20R.H.%20SARS%3A%20Epidemiology%202003",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Chan-Yeung%2C%20M.%20Xu%2C%20R.H.%20SARS%3A%20Epidemiology%202003"
        },
        {
            "id": "Wang_et+al_0000_a",
            "alt_id": "32",
            "entry": "Chan-Yeung, M.; Xu, R.H. SARS: Epidemiology. Respirology 2003, 8, S9\u2013S14. [CrossRef] 38.",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Wang%2C%20C.%20Horby%2C%20P.W.%20Hayden%2C%20F.G.%20Gao%2C%20G.F.%20A%20novel%20coronavirus%20outbreak%20of%20global%20health%20concern",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Wang%2C%20C.%20Horby%2C%20P.W.%20Hayden%2C%20F.G.%20Gao%2C%20G.F.%20A%20novel%20coronavirus%20outbreak%20of%20global%20health%20concern",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Wang%2C%20C.%20Horby%2C%20P.W.%20Hayden%2C%20F.G.%20Gao%2C%20G.F.%20A%20novel%20coronavirus%20outbreak%20of%20global%20health%20concern"
        },
        {
            "id": "Peiris_et+al_2003_a",
            "alt_id": "33",
            "entry": "Wang, C.; Horby, P.W.; Hayden, F.G.; Gao, G.F. A novel coronavirus outbreak of global health concern. Lancet 2020, 395, 470\u2013473. [CrossRef] 39.",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Peiris%2C%20J.S.%20Yuen%2C%20K.Y.%20Osterhaus%2C%20A.D.%20St%C3%B6hr%2C%20K.%20The%20severe%20acute%20respiratory%20syndrome%202003"
        },
        {
            "id": "Leung_et+al_2004_a",
            "alt_id": "34",
            "entry": "Peiris, J.S.; Yuen, K.Y.; Osterhaus, A.D.; St\u00f6hr, K. The severe acute respiratory syndrome. N. Engl. J. Med. 2003, 349, 2431\u20132441. [CrossRef] [PubMed] 40.",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Peiris%20JS%20Yuen%20KY%20Osterhaus%20AD%20St%C3%B6hr%20K%20The%20severe%20acute%20respiratory%20syndrome%20N%20Engl%20J%20Med%202003%20349%2024312441%20CrossRef%20PubMed%2040"
        },
        {
            "id": "Li_et+al_2020_a",
            "alt_id": "35",
            "entry": "Leung, G.M.; Hedley, A.J.; Ho, L.-M.; Chau, P.; Wong, I.O.; Thach, T.Q.; Ghani, A.C.; Donnelly, C.; Fraser, C.; Riley, S.; et al. The epidemiology of severe acute respiratory syndrome in the 2003 Hong Kong epidemic: An analysis of all 1755 patients. Ann. Intern. Med. 2004, 141, 662\u2013673. [CrossRef] [PubMed] 41. Infectious Disease Expert Li Lanjuan Responded to Six Questions of 2019-nCoV. Available online: http://m.news.cctv.com/2020/01/23/ARTIEw78LIxqpgx6Ilm7NkBo200123.shtml (accessed on 23 January 2020).",
            "url": "http://m.news.cctv.com/2020/01/23/ARTIEw78LIxqpgx6Ilm7NkBo200123.shtml",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Leung%20GM%20Hedley%20AJ%20Ho%20LM%20Chau%20P%20Wong%20IO%20Thach%20TQ%20Ghani%20AC%20Donnelly%20C%20Fraser%20C%20Riley%20S%20et%20al%20The%20epidemiology%20of%20severe%20acute%20respiratory%20syndrome%20in%20the%202003%20Hong%20Kong%20epidemic%20An%20analysis%20of%20all%201755%20patients%20Ann%20Intern%20Med%202004%20141%20662673%20CrossRef%20PubMed%2041%20Infectious%20Disease%20Expert%20Li%20Lanjuan%20Responded%20to%20Six%20Questions%20of%202019nCoV%20Available%20online%20httpmnewscctvcom20200123ARTIEw78LIxqpgx6Ilm7NkBo200123shtml%20accessed%20on%2023%20January%202020",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Leung%20GM%20Hedley%20AJ%20Ho%20LM%20Chau%20P%20Wong%20IO%20Thach%20TQ%20Ghani%20AC%20Donnelly%20C%20Fraser%20C%20Riley%20S%20et%20al%20The%20epidemiology%20of%20severe%20acute%20respiratory%20syndrome%20in%20the%202003%20Hong%20Kong%20epidemic%20An%20analysis%20of%20all%201755%20patients%20Ann%20Intern%20Med%202004%20141%20662673%20CrossRef%20PubMed%2041%20Infectious%20Disease%20Expert%20Li%20Lanjuan%20Responded%20to%20Six%20Questions%20of%202019nCoV%20Available%20online%20httpmnewscctvcom20200123ARTIEw78LIxqpgx6Ilm7NkBo200123shtml%20accessed%20on%2023%20January%202020"
        },
        {
            "id": "42",
            "alt_id": "Chen_et+al_2019_a",
            "entry": "42. Li, Q.; Guan, X.; Wu, P.; Wang, X.; Zhou, L.; Tong, Y.; Ren, R.; Leung, K.S.; Lau, E.H.; Wong, J.Y.; et al. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia. N. Engl. J. Med. 2020. [CrossRef] [PubMed] 43. Huang, C.; Wang, Y.; Li, X.; Ren, L.; Zhao, J.; Hu, Y.; Zhang, L.; Fan, G.; Xu, J.; Gu, X.; et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020, 395, 497\u2013506. [CrossRef]",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Li%20Q%20Guan%20X%20Wu%20P%20Wang%20X%20Zhou%20L%20Tong%20Y%20Ren%20R%20Leung%20KS%20Lau%20EH%20Wong%20JY%20et%20al%20Early%20Transmission%20Dynamics%20in%20Wuhan%20China%20of%20Novel%20CoronavirusInfected%20Pneumonia%20N%20Engl%20J%20Med%202020%20CrossRef%20PubMed%2043%20Huang%20C%20Wang%20Y%20Li%20X%20Ren%20L%20Zhao%20J%20Hu%20Y%20Zhang%20L%20Fan%20G%20Xu%20J%20Gu%20X%20et%20al%20Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan%20China%20Lancet%202020%20395%20497506%20CrossRef",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Li%20Q%20Guan%20X%20Wu%20P%20Wang%20X%20Zhou%20L%20Tong%20Y%20Ren%20R%20Leung%20KS%20Lau%20EH%20Wong%20JY%20et%20al%20Early%20Transmission%20Dynamics%20in%20Wuhan%20China%20of%20Novel%20CoronavirusInfected%20Pneumonia%20N%20Engl%20J%20Med%202020%20CrossRef%20PubMed%2043%20Huang%20C%20Wang%20Y%20Li%20X%20Ren%20L%20Zhao%20J%20Hu%20Y%20Zhang%20L%20Fan%20G%20Xu%20J%20Gu%20X%20et%20al%20Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan%20China%20Lancet%202020%20395%20497506%20CrossRef",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Li%20Q%20Guan%20X%20Wu%20P%20Wang%20X%20Zhou%20L%20Tong%20Y%20Ren%20R%20Leung%20KS%20Lau%20EH%20Wong%20JY%20et%20al%20Early%20Transmission%20Dynamics%20in%20Wuhan%20China%20of%20Novel%20CoronavirusInfected%20Pneumonia%20N%20Engl%20J%20Med%202020%20CrossRef%20PubMed%2043%20Huang%20C%20Wang%20Y%20Li%20X%20Ren%20L%20Zhao%20J%20Hu%20Y%20Zhang%20L%20Fan%20G%20Xu%20J%20Gu%20X%20et%20al%20Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan%20China%20Lancet%202020%20395%20497506%20CrossRef"
        },
        {
            "id": "44",
            "alt_id": "44._0000_e",
            "entry": "44. Chen, N.; Zhou, M.; Dong, X.; Qu, J.; Gong, F.; Han, Y.; Qiu, Y.; Wang, J.; Liu, Y.; Wei, Y.; et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study. Lancet 2020, 395, 507\u2013513. [CrossRef]",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Chen%20N%20Zhou%20M%20Dong%20X%20Qu%20J%20Gong%20F%20Han%20Y%20Qiu%20Y%20Wang%20J%20Liu%20Y%20Wei%20Y%20et%20al%20Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan%20China%20A%20descriptive%20study%20Lancet%202020%20395%20507513%20CrossRef"
        },
        {
            "id": "45",
            "alt_id": "Yuan_et+al_2010_a",
            "entry": "45. Press Conference of the National Health Commission of the People\u2019s Republic of China on 3 February 2020. Available online: http://www.nhc.gov.cn/wjw/xwfbh/xwzb.shtml (accessed on 4 February 2020).",
            "url": "http://www.nhc.gov.cn/wjw/xwfbh/xwzb.shtml",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Yuan%2C%20J.%20Hon%2C%20C.-C.%20Li%2C%20Y.%20Wang%2C%20D.%20Intraspecies%20diversity%20of%20SARS-like%20coronaviruses%20in%20Rhinolophus%20sinicus%20and%20its%20implications%20for%20the%20origin%20of%20SARS%20coronaviruses%20in%20humans%202010",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Yuan%2C%20J.%20Hon%2C%20C.-C.%20Li%2C%20Y.%20Wang%2C%20D.%20Intraspecies%20diversity%20of%20SARS-like%20coronaviruses%20in%20Rhinolophus%20sinicus%20and%20its%20implications%20for%20the%20origin%20of%20SARS%20coronaviruses%20in%20humans%202010"
        },
        {
            "id": "46",
            "alt_id": "Phan_0000_a",
            "entry": "46. Yuan, J.; Hon, C.-C.; Li, Y.; Wang, D.; Xu, G.; Zhang, H.; Zhou, P.; Poon, L.; Lam, T.Y.; Leung, F.C.-C.; et al. Intraspecies diversity of SARS-like coronaviruses in Rhinolophus sinicus and its implications for the origin of SARS coronaviruses in humans. J. Gen. Virol. 2010, 91, 1058\u20131062. [CrossRef] [PubMed]",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Phan%2C%20T.%20Novel%20coronavirus%3A%20From%20discovery%20to%20clinical%20diagnostics",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Phan%2C%20T.%20Novel%20coronavirus%3A%20From%20discovery%20to%20clinical%20diagnostics",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Phan%2C%20T.%20Novel%20coronavirus%3A%20From%20discovery%20to%20clinical%20diagnostics"
        },
        {
            "id": "47",
            "alt_id": "Wang_et+al_2005_a",
            "entry": "47. Phan, T. Novel coronavirus: From discovery to clinical diagnostics. Infect. Genet. Evol. 2020, 79, 104211. [CrossRef]",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Wang%2C%20M.%20Yan%2C%20M.%20Xu%2C%20H.%20Liang%2C%20W.%20SARS-CoV%20infection%20in%20a%20restaurant%20from%20palm%20civet%202005",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Wang%2C%20M.%20Yan%2C%20M.%20Xu%2C%20H.%20Liang%2C%20W.%20SARS-CoV%20infection%20in%20a%20restaurant%20from%20palm%20civet%202005",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Wang%2C%20M.%20Yan%2C%20M.%20Xu%2C%20H.%20Liang%2C%20W.%20SARS-CoV%20infection%20in%20a%20restaurant%20from%20palm%20civet%202005"
        },
        {
            "id": "48",
            "alt_id": "Zhou_et+al_2020_a",
            "entry": "48. Wang, M.; Yan, M.; Xu, H.; Liang, W.; Kan, B.; Zheng, B.; Chen, H.; Zheng, H.; Xu, Y.; Zhang, E.; et al. SARS-CoV infection in a restaurant from palm civet. Emerg. Infect. Dis. 2005, 11, 1860. [CrossRef]",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Wang%20M%20Yan%20M%20Xu%20H%20Liang%20W%20Kan%20B%20Zheng%20B%20Chen%20H%20Zheng%20H%20Xu%20Y%20Zhang%20E%20et%20al%20SARSCoV%20infection%20in%20a%20restaurant%20from%20palm%20civet%20Emerg%20Infect%20Dis%202005%2011%201860%20CrossRef"
        },
        {
            "id": "49",
            "alt_id": "Guo_et+al_2019_a",
            "entry": "49. Zhou, P.; Yang, X.-L.; Wang, X.-G.; Hu, B.; Zhang, L.; Zhang, W.; Si, H.-R.; Zhu, Y.; Li, B.; Huang, C.-L.; et al. Discovery of a novel coronavirus associated with the recent pneumonia outbreak in humans and its potential bat origin. bioRxiv 2020. [CrossRef]",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Zhou%20P%20Yang%20XL%20Wang%20XG%20Hu%20B%20Zhang%20L%20Zhang%20W%20Si%20HR%20Zhu%20Y%20Li%20B%20Huang%20CL%20et%20al%20Discovery%20of%20a%20novel%20coronavirus%20associated%20with%20the%20recent%20pneumonia%20outbreak%20in%20humans%20and%20its%20potential%20bat%20origin%20bioRxiv%202020%20CrossRef"
        },
        {
            "id": "50",
            "alt_id": "Ji_et+al_0000_a",
            "entry": "50. Guo, Q.; Li, M.; Wang, C.; Wang, P.; Fang, Z.; Tan, J.; Wu, S.; Xiao, Y.; Zhu, H. Host and infectivity prediction of Wuhan 2019 novel coronavirus using deep learning algorithm. bioRxiv 2020. [CrossRef]",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Ji%2C%20W.%20Wang%2C%20W.%20Zhao%2C%20X.%20Zai%2C%20J.%20Homologous%20recombination%20within%20the%20spike%20glycoprotein%20of%20the%20newly%20identified%20coronavirus%20may%20boost%20cross-species%20transmission%20from%20snake%20to%20human",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Ji%2C%20W.%20Wang%2C%20W.%20Zhao%2C%20X.%20Zai%2C%20J.%20Homologous%20recombination%20within%20the%20spike%20glycoprotein%20of%20the%20newly%20identified%20coronavirus%20may%20boost%20cross-species%20transmission%20from%20snake%20to%20human",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Ji%2C%20W.%20Wang%2C%20W.%20Zhao%2C%20X.%20Zai%2C%20J.%20Homologous%20recombination%20within%20the%20spike%20glycoprotein%20of%20the%20newly%20identified%20coronavirus%20may%20boost%20cross-species%20transmission%20from%20snake%20to%20human"
        },
        {
            "id": "51",
            "alt_id": "51._0000_f",
            "entry": "51. Ji, W.; Wang, W.; Zhao, X.; Zai, J.; Li, X. Homologous recombination within the spike glycoprotein of the newly identified coronavirus may boost cross-species transmission from snake to human. J. Med. Virol. 2020, 92, 433\u2013440. [CrossRef]",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Ji%20W%20Wang%20W%20Zhao%20X%20Zai%20J%20Li%20X%20Homologous%20recombination%20within%20the%20spike%20glycoprotein%20of%20the%20newly%20identified%20coronavirus%20may%20boost%20crossspecies%20transmission%20from%20snake%20to%20human%20J%20Med%20Virol%202020%2092%20433440%20CrossRef"
        },
        {
            "id": "52",
            "alt_id": "Chowell_et+al_2004_a",
            "entry": "52. South China Agricultural University: Pangolin May Be a Potential Intermediate Host of New Coronavirus. Available online: http://www.chinanews.com/sh/2020/02-07/9082279.shtml (accessed on 7 February 2020).",
            "url": "http://www.chinanews.com/sh/2020/02-07/9082279.shtml",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Chowell%2C%20G.%20Castillo-Chavez%2C%20C.%20Fenimore%2C%20P.W.%20Kribs-Zaleta%2C%20C.M.%20Model%20parameters%20and%20outbreak%20control%20for%20SARS%202004",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Chowell%2C%20G.%20Castillo-Chavez%2C%20C.%20Fenimore%2C%20P.W.%20Kribs-Zaleta%2C%20C.M.%20Model%20parameters%20and%20outbreak%20control%20for%20SARS%202004"
        },
        {
            "id": "53",
            "alt_id": "Lau_et+al_2010_a",
            "entry": "53. Chowell, G.; Castillo-Chavez, C.; Fenimore, P.W.; Kribs-Zaleta, C.M.; Arriola, L.; Hyman, J.M. Model parameters and outbreak control for SARS. Emerg. Infect. Dis. 2004, 10, 1258. [CrossRef] [PubMed]",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Lau%2C%20E.H.Y.%20Hsiung%2C%20C.A.%20Cowling%2C%20B.J.%20Chen%2C%20C.-H.%20A%20comparative%20epidemiologic%20analysis%20of%20SARS%20in%20Hong%20Kong%2C%20Beijing%20and%20Taiwan%202010",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Lau%2C%20E.H.Y.%20Hsiung%2C%20C.A.%20Cowling%2C%20B.J.%20Chen%2C%20C.-H.%20A%20comparative%20epidemiologic%20analysis%20of%20SARS%20in%20Hong%20Kong%2C%20Beijing%20and%20Taiwan%202010",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Lau%2C%20E.H.Y.%20Hsiung%2C%20C.A.%20Cowling%2C%20B.J.%20Chen%2C%20C.-H.%20A%20comparative%20epidemiologic%20analysis%20of%20SARS%20in%20Hong%20Kong%2C%20Beijing%20and%20Taiwan%202010"
        },
        {
            "id": "54",
            "alt_id": "54._2019_g",
            "entry": "54. Lau, E.H.Y.; Hsiung, C.A.; Cowling, B.J.; Chen, C.-H.; Ho, L.-M.; Tsang, T.; Chang, C.-W.; Donnelly, C.; Leung, G.M. A comparative epidemiologic analysis of SARS in Hong Kong, Beijing and Taiwan. BMC Infect. Dis. 2010, 10, 50. [CrossRef] [PubMed]",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Lau%20EHY%20Hsiung%20CA%20Cowling%20BJ%20Chen%20CH%20Ho%20LM%20Tsang%20T%20Chang%20CW%20Donnelly%20C%20Leung%20GM%20A%20comparative%20epidemiologic%20analysis%20of%20SARS%20in%20Hong%20Kong%20Beijing%20and%20Taiwan%20BMC%20Infect%20Dis%202010%2010%2050%20CrossRef%20PubMed"
        },
        {
            "id": "55",
            "alt_id": "55._0000_h",
            "entry": "55. Chinese Center for Disease Control and Prevention. Distribution of Pneumonia Infected by 2019-nCoV. Available online: http://2019ncov.chinacdc.cn/2019-nCoV/ (accessed on 15 February 2020).",
            "url": "http://2019ncov.chinacdc.cn/2019-nCoV/"
        },
        {
            "id": "56",
            "alt_id": "Nishiura_et+al_2020_a",
            "entry": "56. Real-time Updates of COVID-19 Epidemic in China. Available online: https://ncov.dxy.cn/ncovh5/view/pneumonia (accessed on 15 February 2020).",
            "url": "https://ncov.dxy.cn/ncovh5/view/pneumonia",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Realtime%20Updates%20of%20COVID19%20Epidemic%20in%20China%20Available%20online%20httpsncovdxycnncovh5viewpneumonia%20accessed%20on%2015%20February%202020",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Realtime%20Updates%20of%20COVID19%20Epidemic%20in%20China%20Available%20online%20httpsncovdxycnncovh5viewpneumonia%20accessed%20on%2015%20February%202020"
        },
        {
            "id": "57",
            "alt_id": "Li_et+al_2019_a",
            "entry": "57. Nishiura, H.; Jung, S.-M.; Linton, N.; Kinoshita, R.; Yang, Y.; Hayashi, K.; Kobayashi, T.; Yuan, B.; Akhmetzhanov, A.R. The extent of transmission of novel coronavirus in Wuhan, China, 2020. J. Clin. Med. 2020, 9, 330. [CrossRef]",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Nishiura%20H%20Jung%20SM%20Linton%20N%20Kinoshita%20R%20Yang%20Y%20Hayashi%20K%20Kobayashi%20T%20Yuan%20B%20Akhmetzhanov%20AR%20The%20extent%20of%20transmission%20of%20novel%20coronavirus%20in%20Wuhan%20China%202020%20J%20Clin%20Med%202020%209%20330%20CrossRef",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Nishiura%20H%20Jung%20SM%20Linton%20N%20Kinoshita%20R%20Yang%20Y%20Hayashi%20K%20Kobayashi%20T%20Yuan%20B%20Akhmetzhanov%20AR%20The%20extent%20of%20transmission%20of%20novel%20coronavirus%20in%20Wuhan%20China%202020%20J%20Clin%20Med%202020%209%20330%20CrossRef",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Nishiura%20H%20Jung%20SM%20Linton%20N%20Kinoshita%20R%20Yang%20Y%20Hayashi%20K%20Kobayashi%20T%20Yuan%20B%20Akhmetzhanov%20AR%20The%20extent%20of%20transmission%20of%20novel%20coronavirus%20in%20Wuhan%20China%202020%20J%20Clin%20Med%202020%209%20330%20CrossRef"
        },
        {
            "id": "58",
            "alt_id": "Carlos_et+al_2019_a",
            "entry": "58. Li, X.; Zai, J.; Wang, X.; Li, Y. Potential of large \u2018first generation\u2019 human-to-human transmission of 2019-nCoV. J. Med. Virol. 2020, 92, 448\u2013454. [CrossRef]",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Carlos%2C%20W.G.%20Dela%20Cruz%2C%20C.S.%20Cao%2C%20B.%20Pasnick%2C%20S.%20Coronavirus%202019",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Carlos%2C%20W.G.%20Dela%20Cruz%2C%20C.S.%20Cao%2C%20B.%20Pasnick%2C%20S.%20Coronavirus%202019",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Carlos%2C%20W.G.%20Dela%20Cruz%2C%20C.S.%20Cao%2C%20B.%20Pasnick%2C%20S.%20Coronavirus%202019"
        },
        {
            "id": "59",
            "alt_id": "59._0000_i",
            "entry": "59. Carlos, W.G.; Dela Cruz, C.S.; Cao, B.; Pasnick, S.; Jamil, S. Novel Wuhan (2019-nCoV) Coronavirus. Am. J. Respir. Crit. Care Med. 2020, 201, 7\u20138. [CrossRef]",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Carlos%20WG%20Dela%20Cruz%20CS%20Cao%20B%20Pasnick%20S%20Jamil%20S%20Novel%20Wuhan%202019nCoV%20Coronavirus%20Am%20J%20Respir%20Crit%20Care%20Med%202020%20201%2078%20CrossRef"
        },
        {
            "id": "60",
            "alt_id": "60._0000_j",
            "entry": "60. National Health Commission of the People\u2019s Republic of China. The Role of Fecal-Oral Transmission in All transmission Still Need Further Observation and Research. Available online: http://news.cctv.com/2020/02/13/ARTISJWExxLSLWoL8mtJos97200213.shtml (accessed on 13 February 2020).",
            "url": "http://news.cctv.com/2020/02/13/ARTISJWExxLSLWoL8mtJos97200213.shtml"
        },
        {
            "id": "61",
            "alt_id": "Lau_et+al_2004_a",
            "entry": "61. Chinese Center for Disease Control and Prevention. There Is No Evidence That the New Coronavirus Can Be Transmitted through Aerosol. Available online: http://news.cctv.com/2020/02/09/ ARTIiVFnLC1ww5sTSMqbcXlz200209.shtml (accessed on 9 February 2020).",
            "url": "http://news.cctv.com/2020/02/09/ARTIiVFnLC1ww5sTSMqbcXlz200209.shtml",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Lau%2C%20J.T.%20Tsui%2C%20H.%20Lau%2C%20M.%20Yang%2C%20X.%20SARS%20transmission%2C%20risk%20factors%2C%20and%20prevention%20in%20Hong%20Kong%202004",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Lau%2C%20J.T.%20Tsui%2C%20H.%20Lau%2C%20M.%20Yang%2C%20X.%20SARS%20transmission%2C%20risk%20factors%2C%20and%20prevention%20in%20Hong%20Kong%202004"
        },
        {
            "id": "62",
            "alt_id": "Lu_et+al_0000_a",
            "entry": "62. Lau, J.T.; Tsui, H.; Lau, M.; Yang, X. SARS transmission, risk factors, and prevention in Hong Kong. Emerg. Infect. Dis. 2004, 10, 587. [CrossRef]",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Lu%2C%20H.%20Stratton%2C%20C.W.%20Tang%2C%20Y.W.%20Outbreak%20of%20Pneumonia%20of%20Unknown%20Etiology%20in%20Wuhan%20China%3A%20The%20Mystery%20and%20the%20Miracle",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Lu%2C%20H.%20Stratton%2C%20C.W.%20Tang%2C%20Y.W.%20Outbreak%20of%20Pneumonia%20of%20Unknown%20Etiology%20in%20Wuhan%20China%3A%20The%20Mystery%20and%20the%20Miracle",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Lu%2C%20H.%20Stratton%2C%20C.W.%20Tang%2C%20Y.W.%20Outbreak%20of%20Pneumonia%20of%20Unknown%20Etiology%20in%20Wuhan%20China%3A%20The%20Mystery%20and%20the%20Miracle"
        },
        {
            "id": "63",
            "alt_id": "Rouquet_et+al_2005_a",
            "entry": "63. Lu, H.; Stratton, C.W.; Tang, Y.W. Outbreak of Pneumonia of Unknown Etiology in Wuhan China: The Mystery and the Miracle. J. Med. Virol. 2020, 92, 401\u2013402. [CrossRef]",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Lu%20H%20Stratton%20CW%20Tang%20YW%20Outbreak%20of%20Pneumonia%20of%20Unknown%20Etiology%20in%20Wuhan%20China%20The%20Mystery%20and%20the%20Miracle%20J%20Med%20Virol%202020%2092%20401402%20CrossRef",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Lu%20H%20Stratton%20CW%20Tang%20YW%20Outbreak%20of%20Pneumonia%20of%20Unknown%20Etiology%20in%20Wuhan%20China%20The%20Mystery%20and%20the%20Miracle%20J%20Med%20Virol%202020%2092%20401402%20CrossRef",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Lu%20H%20Stratton%20CW%20Tang%20YW%20Outbreak%20of%20Pneumonia%20of%20Unknown%20Etiology%20in%20Wuhan%20China%20The%20Mystery%20and%20the%20Miracle%20J%20Med%20Virol%202020%2092%20401402%20CrossRef"
        },
        {
            "id": "64",
            "alt_id": "Yoo_2019_a",
            "entry": "64. Rouquet, P.; Froment, J.-M.; Bermejo, M.; Kilbourn, A.; Karesh, W.; Reed, P.; Kumulungui, B.; Yaba, P.; Delicat, A.; Rollin, P.E.; et al. Wild animal mortality monitoring and human Ebola outbreaks, Gabon and Republic of Congo, 2001\u20132003. Emerg. Infect. Dis. 2005, 11, 283. [CrossRef]",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Rouquet%20P%20Froment%20JM%20Bermejo%20M%20Kilbourn%20A%20Karesh%20W%20Reed%20P%20Kumulungui%20B%20Yaba%20P%20Delicat%20A%20Rollin%20PE%20et%20al%20Wild%20animal%20mortality%20monitoring%20and%20human%20Ebola%20outbreaks%20Gabon%20and%20Republic%20of%20Congo%2020012003%20Emerg%20Infect%20Dis%202005%2011%20283%20CrossRef",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Rouquet%20P%20Froment%20JM%20Bermejo%20M%20Kilbourn%20A%20Karesh%20W%20Reed%20P%20Kumulungui%20B%20Yaba%20P%20Delicat%20A%20Rollin%20PE%20et%20al%20Wild%20animal%20mortality%20monitoring%20and%20human%20Ebola%20outbreaks%20Gabon%20and%20Republic%20of%20Congo%2020012003%20Emerg%20Infect%20Dis%202005%2011%20283%20CrossRef",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Rouquet%20P%20Froment%20JM%20Bermejo%20M%20Kilbourn%20A%20Karesh%20W%20Reed%20P%20Kumulungui%20B%20Yaba%20P%20Delicat%20A%20Rollin%20PE%20et%20al%20Wild%20animal%20mortality%20monitoring%20and%20human%20Ebola%20outbreaks%20Gabon%20and%20Republic%20of%20Congo%2020012003%20Emerg%20Infect%20Dis%202005%2011%20283%20CrossRef"
        },
        {
            "id": "65",
            "alt_id": "de_Wit_et+al_2016_a",
            "entry": "65. Yoo, J.H. The Fight against the 2019-nCoV Outbreak: An Arduous March Has Just Begun. J. Korean Med. Sci. 2020, 35, e56. [CrossRef]",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=De%20Wit%2C%20E.%20van%20Doremalen%2C%20N.%20Falzarano%2C%20D.%20Munster%2C%20V.J.%20SARS%20and%20MERS%3A%20Recent%20insights%20into%20emerging%20coronaviruses%202016",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=De%20Wit%2C%20E.%20van%20Doremalen%2C%20N.%20Falzarano%2C%20D.%20Munster%2C%20V.J.%20SARS%20and%20MERS%3A%20Recent%20insights%20into%20emerging%20coronaviruses%202016",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=De%20Wit%2C%20E.%20van%20Doremalen%2C%20N.%20Falzarano%2C%20D.%20Munster%2C%20V.J.%20SARS%20and%20MERS%3A%20Recent%20insights%20into%20emerging%20coronaviruses%202016"
        },
        {
            "id": "66",
            "alt_id": "66._0000_k",
            "entry": "66. De Wit, E.; van Doremalen, N.; Falzarano, D.; Munster, V.J. SARS and MERS: Recent insights into emerging coronaviruses. Nat. Rev. Microbiol. 2016, 14, 523. [CrossRef] [PubMed]",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=De%20Wit%20E%20van%20Doremalen%20N%20Falzarano%20D%20Munster%20VJ%20SARS%20and%20MERS%20Recent%20insights%20into%20emerging%20coronaviruses%20Nat%20Rev%20Microbiol%202016%2014%20523%20CrossRef%20PubMed"
        },
        {
            "id": "67",
            "alt_id": "Zeng_et+al_2007_a",
            "entry": "67. Chinese Center for Disease Control and Prevention. The First New Coronavirus Species Information Was Published by the National Pathogen Microorganism Resource Bank. Available online: http://www.chinacdc.cn/yw_9324/202001/t20200124_211413.html (accessed on 1 February 2020).",
            "url": "http://www.chinacdc.cn/yw_9324/202001/t20200124_211413.html",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Zeng%2C%20Q.%20Khan%2C%20K.%20Wu%2C%20J.%20Zhu%2C%20H.%20The%20utility%20of%20preemptive%20mass%20influenza%20vaccination%20in%20controlling%20a%20SARS%20outbreak%20during%20flu%20season%202007",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Zeng%2C%20Q.%20Khan%2C%20K.%20Wu%2C%20J.%20Zhu%2C%20H.%20The%20utility%20of%20preemptive%20mass%20influenza%20vaccination%20in%20controlling%20a%20SARS%20outbreak%20during%20flu%20season%202007"
        },
        {
            "id": "68",
            "alt_id": "Wang_et+al_2019_a",
            "entry": "68. Zeng, Q.; Khan, K.; Wu, J.; Zhu, H. The utility of preemptive mass influenza vaccination in controlling a SARS outbreak during flu season. Math. Biosci. Eng. 2007, 4, 739. [PubMed]",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Wang%2C%20N.%20Luo%2C%20C.%20Liu%2C%20H.%20Yang%2C%20X.-L.%20Characterization%20of%20a%20New%20Member%20of%20Alphacoronavirus%20with%20Unique%20Genomic%20Features%20in%20Rhinolophus%20Bats%202019",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Wang%2C%20N.%20Luo%2C%20C.%20Liu%2C%20H.%20Yang%2C%20X.-L.%20Characterization%20of%20a%20New%20Member%20of%20Alphacoronavirus%20with%20Unique%20Genomic%20Features%20in%20Rhinolophus%20Bats%202019",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Wang%2C%20N.%20Luo%2C%20C.%20Liu%2C%20H.%20Yang%2C%20X.-L.%20Characterization%20of%20a%20New%20Member%20of%20Alphacoronavirus%20with%20Unique%20Genomic%20Features%20in%20Rhinolophus%20Bats%202019"
        },
        {
            "id": "69",
            "alt_id": "Bhadra_et+al_2015_a",
            "entry": "69. Wang, N.; Luo, C.; Liu, H.; Yang, X.-L.; Hu, B.; Zhang, W.; Li, B.; Zhu, Y.; Zhu, G.; Shen, X.; et al. Characterization of a New Member of Alphacoronavirus with Unique Genomic Features in Rhinolophus Bats. Viruses 2019, 11, 379. [CrossRef] [PubMed]",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Bhadra%2C%20S.%20Jiang%2C%20Y.S.%20Kumar%2C%20M.R.%20Johnson%2C%20R.F.%20Real-time%20sequence-validated%20loop-mediated%20isothermal%20amplification%20assays%20for%20detection%20of%20Middle%20East%20respiratory%20syndrome%20coronavirus%20%28MERS-CoV%29%202015",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Bhadra%2C%20S.%20Jiang%2C%20Y.S.%20Kumar%2C%20M.R.%20Johnson%2C%20R.F.%20Real-time%20sequence-validated%20loop-mediated%20isothermal%20amplification%20assays%20for%20detection%20of%20Middle%20East%20respiratory%20syndrome%20coronavirus%20%28MERS-CoV%29%202015",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Bhadra%2C%20S.%20Jiang%2C%20Y.S.%20Kumar%2C%20M.R.%20Johnson%2C%20R.F.%20Real-time%20sequence-validated%20loop-mediated%20isothermal%20amplification%20assays%20for%20detection%20of%20Middle%20East%20respiratory%20syndrome%20coronavirus%20%28MERS-CoV%29%202015"
        },
        {
            "id": "70",
            "alt_id": "Chan_et+al_2015_a",
            "entry": "70. Bhadra, S.; Jiang, Y.S.; Kumar, M.R.; Johnson, R.F.; Hensley, L.E.; Ellington, A.D. Real-time sequence-validated loop-mediated isothermal amplification assays for detection of Middle East respiratory syndrome coronavirus (MERS-CoV). PLoS ONE 2015, 10, e0123126. [CrossRef] [PubMed]",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Chan%2C%20J.F.-W.%20Choi%2C%20G.K.-Y.%20Tsang%2C%20A.K.-L.%20Tee%2C%20K.-M.%20Development%20and%20evaluation%20of%20novel%20real-time%20reverse%20transcription-PCR%20assays%20with%20locked%20nucleic%20acid%20probes%20targeting%20leader%20sequences%20of%20human-pathogenic%20coronaviruses%202015",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Chan%2C%20J.F.-W.%20Choi%2C%20G.K.-Y.%20Tsang%2C%20A.K.-L.%20Tee%2C%20K.-M.%20Development%20and%20evaluation%20of%20novel%20real-time%20reverse%20transcription-PCR%20assays%20with%20locked%20nucleic%20acid%20probes%20targeting%20leader%20sequences%20of%20human-pathogenic%20coronaviruses%202015",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Chan%2C%20J.F.-W.%20Choi%2C%20G.K.-Y.%20Tsang%2C%20A.K.-L.%20Tee%2C%20K.-M.%20Development%20and%20evaluation%20of%20novel%20real-time%20reverse%20transcription-PCR%20assays%20with%20locked%20nucleic%20acid%20probes%20targeting%20leader%20sequences%20of%20human-pathogenic%20coronaviruses%202015"
        },
        {
            "id": "71",
            "alt_id": "Wu_et+al_2000_a",
            "entry": "71. Chan, J.F.-W.; Choi, G.K.-Y.; Tsang, A.K.-L.; Tee, K.-M.; Lam, H.-Y.; Yip, C.C.-Y.; To, K.K.-W.; Cheng, V.C.-C.; Yeung, M.L.; Lau, S.K.; et al. Development and evaluation of novel real-time reverse transcription-PCR assays with locked nucleic acid probes targeting leader sequences of human-pathogenic coronaviruses. J. Clin. Microbiol. 2015, 53, 2722\u20132726. [CrossRef]",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Chan%20JFW%20Choi%20GKY%20Tsang%20AKL%20Tee%20KM%20Lam%20HY%20Yip%20CCY%20To%20KKW%20Cheng%20VCC%20Yeung%20ML%20Lau%20SK%20et%20al%20Development%20and%20evaluation%20of%20novel%20realtime%20reverse%20transcriptionPCR%20assays%20with%20locked%20nucleic%20acid%20probes%20targeting%20leader%20sequences%20of%20humanpathogenic%20coronaviruses%20J%20Clin%20Microbiol%202015%2053%2027222726%20CrossRef",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Chan%20JFW%20Choi%20GKY%20Tsang%20AKL%20Tee%20KM%20Lam%20HY%20Yip%20CCY%20To%20KKW%20Cheng%20VCC%20Yeung%20ML%20Lau%20SK%20et%20al%20Development%20and%20evaluation%20of%20novel%20realtime%20reverse%20transcriptionPCR%20assays%20with%20locked%20nucleic%20acid%20probes%20targeting%20leader%20sequences%20of%20humanpathogenic%20coronaviruses%20J%20Clin%20Microbiol%202015%2053%2027222726%20CrossRef",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Chan%20JFW%20Choi%20GKY%20Tsang%20AKL%20Tee%20KM%20Lam%20HY%20Yip%20CCY%20To%20KKW%20Cheng%20VCC%20Yeung%20ML%20Lau%20SK%20et%20al%20Development%20and%20evaluation%20of%20novel%20realtime%20reverse%20transcriptionPCR%20assays%20with%20locked%20nucleic%20acid%20probes%20targeting%20leader%20sequences%20of%20humanpathogenic%20coronaviruses%20J%20Clin%20Microbiol%202015%2053%2027222726%20CrossRef"
        },
        {
            "id": "72",
            "alt_id": "Administration_0000_a",
            "entry": "72. Wu, P.; Hao, X.; Lau, E.H.Y.; Wong, J.Y.; Leung, K.S.M.; Wu, J.T.; Cowling, B.J.; Leung, G.M. Real-time tentative assessment of the epidemiological characteristics of novel coronavirus infections in Wuhan, China, as at 22 January 2020. Euro. Surveill. 2020, 25, 2000044. [CrossRef]",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Administration%2C%20National%20Medical%20Products%20National%20Medical%20Products%20Administration%20Examined%20and%20Approved%20the%20New%20Nucleic%20Acid%20Test%20Reagent%20of%20Coronavirus%20Again"
        },
        {
            "id": "73",
            "alt_id": "Chen_et+al_0000_b",
            "entry": "73. National Medical Products Administration. National Medical Products Administration Examined and Approved the New Nucleic Acid Test Reagent of Coronavirus Again. Available online: http://www.nmpa.gov.cn/WS04/CL2056/374398.html (accessed on 28 January 2020).",
            "url": "http://www.nmpa.gov.cn/WS04/CL2056/374398.html",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Chen%2C%20Y.%20Liu%2C%20Q.%20Guo%2C%20D.%20Emerging%20coronaviruses%3A%20Genome%20structure%2C%20replication%2C%20and%20pathogenesis",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Chen%2C%20Y.%20Liu%2C%20Q.%20Guo%2C%20D.%20Emerging%20coronaviruses%3A%20Genome%20structure%2C%20replication%2C%20and%20pathogenesis"
        },
        {
            "id": "74",
            "alt_id": "Cinatl_et+al_2003_a",
            "entry": "74. Chen, Y.; Liu, Q.; Guo, D. Emerging coronaviruses: Genome structure, replication, and pathogenesis. J. Med. Virol. 2020, 92, 418\u2013423. [CrossRef]",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Cinatl%2C%20J.%20Morgenstern%2C%20B.%20Bauer%2C%20G.%20Chandra%2C%20P.%20Treatment%20of%20SARS%20with%20human%20interferons%202003",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Cinatl%2C%20J.%20Morgenstern%2C%20B.%20Bauer%2C%20G.%20Chandra%2C%20P.%20Treatment%20of%20SARS%20with%20human%20interferons%202003",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Cinatl%2C%20J.%20Morgenstern%2C%20B.%20Bauer%2C%20G.%20Chandra%2C%20P.%20Treatment%20of%20SARS%20with%20human%20interferons%202003"
        },
        {
            "id": "75",
            "alt_id": "Chu_et+al_2004_a",
            "entry": "75. Cinatl, J.; Morgenstern, B.; Bauer, G.; Chandra, P.; Rabenau, H.; Doerr, H.W. Treatment of SARS with human interferons. Lancet 2003, 362, 293\u2013294. [CrossRef]",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Chu%2C%20C.M.%20Cheng%2C%20V.C.C.%20Hung%2C%20I.F.N.%20Wong%2C%20M.M.L.%20Role%20of%20lopinavir/ritonavir%20in%20the%20treatment%20of%20SARS%3A%20Initial%20virological%20and%20clinical%20findings%202004",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Chu%2C%20C.M.%20Cheng%2C%20V.C.C.%20Hung%2C%20I.F.N.%20Wong%2C%20M.M.L.%20Role%20of%20lopinavir/ritonavir%20in%20the%20treatment%20of%20SARS%3A%20Initial%20virological%20and%20clinical%20findings%202004",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Chu%2C%20C.M.%20Cheng%2C%20V.C.C.%20Hung%2C%20I.F.N.%20Wong%2C%20M.M.L.%20Role%20of%20lopinavir/ritonavir%20in%20the%20treatment%20of%20SARS%3A%20Initial%20virological%20and%20clinical%20findings%202004"
        },
        {
            "id": "76",
            "alt_id": "Lu_2019_a",
            "entry": "76. Chu, C.M.; Cheng, V.C.C.; Hung, I.F.N.; Wong, M.M.L.; Chan, K.; Kao, R.Y.; Poon, L.; Wong, C.L.P.; Guan, Y.; Peiris, J.S.M.; et al. Role of lopinavir/ritonavir in the treatment of SARS: Initial virological and clinical findings. Thorax 2004, 59, 252\u2013256. [CrossRef]",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Chu%20CM%20Cheng%20VCC%20Hung%20IFN%20Wong%20MML%20Chan%20K%20Kao%20RY%20Poon%20L%20Wong%20CLP%20Guan%20Y%20Peiris%20JSM%20et%20al%20Role%20of%20lopinavirritonavir%20in%20the%20treatment%20of%20SARS%20Initial%20virological%20and%20clinical%20findings%20Thorax%202004%2059%20252256%20CrossRef",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Chu%20CM%20Cheng%20VCC%20Hung%20IFN%20Wong%20MML%20Chan%20K%20Kao%20RY%20Poon%20L%20Wong%20CLP%20Guan%20Y%20Peiris%20JSM%20et%20al%20Role%20of%20lopinavirritonavir%20in%20the%20treatment%20of%20SARS%20Initial%20virological%20and%20clinical%20findings%20Thorax%202004%2059%20252256%20CrossRef",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Chu%20CM%20Cheng%20VCC%20Hung%20IFN%20Wong%20MML%20Chan%20K%20Kao%20RY%20Poon%20L%20Wong%20CLP%20Guan%20Y%20Peiris%20JSM%20et%20al%20Role%20of%20lopinavirritonavir%20in%20the%20treatment%20of%20SARS%20Initial%20virological%20and%20clinical%20findings%20Thorax%202004%2059%20252256%20CrossRef"
        },
        {
            "id": "77",
            "alt_id": "77._0000_l",
            "entry": "77. Lu, H. Drug treatment options for the 2019-new coronavirus (2019-nCoV). Biosci. Trends 2020. [CrossRef] 78. Beijing Municipal Health Commission. Explanation on the Situation that Drugs for AIDS Can Be Tried to Treat Pneumonia Caused by 2019-nCoV Infection. Available online: http://wjw.beijing.gov.cn/wjwh/ztzl/xxgzbd/202001/t20200126_1621354.html (accessed on 26 January 2020).",
            "url": "http://wjw.beijing.gov.cn/wjwh/ztzl/xxgzbd/202001/t20200126_1621354.html"
        },
        {
            "id": "79",
            "alt_id": "79._2019_m",
            "entry": "79. The Joint Research Team of Shanghai Institute of Materia Medica, Chinese Academy of Sciences, and ShanghaiTech University Discovered a Batch of Old Drugs and Traditional Chinese Medicines with Therapeutic Potential for COVID-19. Available online: http://www.shanghaitech.edu.cn/2020/0125/c1001a50141/page.htm (accessed on 25 January 2020).",
            "url": "http://www.shanghaitech.edu.cn/2020/0125/c1001a50141/page.htm"
        },
        {
            "id": "80",
            "alt_id": "Xu_et+al_2019_a",
            "entry": "80. High-Resolution Crystal Structure of 2019-nCoV Coronavirus 3CL Hydrolase (Mpro) was Announced by the Joint Research Team of Shanghai Institute of Materia Medica, Chinese Academy of Sciences, and ShanghaiTech University. Available online: http://www.shanghaitech.edu.cn/2020/0126/c1001a50145/page.htm (accessed on 26 January 2020).",
            "url": "http://www.shanghaitech.edu.cn/2020/0126/c1001a50145/page.htm",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=HighResolution%20Crystal%20Structure%20of%202019nCoV%20Coronavirus%203CL%20Hydrolase%20Mpro%20was%20Announced%20by%20the%20Joint%20Research%20Team%20of%20Shanghai%20Institute%20of%20Materia%20Medica%20Chinese%20Academy%20of%20Sciences%20and%20ShanghaiTech%20University%20Available%20online%20httpwwwshanghaitecheducn20200126c1001a50145pagehtm%20accessed%20on%2026%20January%202020",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=HighResolution%20Crystal%20Structure%20of%202019nCoV%20Coronavirus%203CL%20Hydrolase%20Mpro%20was%20Announced%20by%20the%20Joint%20Research%20Team%20of%20Shanghai%20Institute%20of%20Materia%20Medica%20Chinese%20Academy%20of%20Sciences%20and%20ShanghaiTech%20University%20Available%20online%20httpwwwshanghaitecheducn20200126c1001a50145pagehtm%20accessed%20on%2026%20January%202020"
        },
        {
            "id": "81",
            "alt_id": "Mulangu_et+al_2019_a",
            "entry": "81. Xu, Z.; Peng, C.; Shi, Y.; Zhu, Z.; Mu, K.; Wang, X.; Zhu, W. Nelfinavir was predicted to be a potential inhibitor of 2019 nCov main protease by an integrative approach combining homology modelling, molecular docking and binding free energy calculation. bioRxiv 2020. [CrossRef] 82. Sheahan, T.P.; Sims, A.C.; Leist, S.R.; Sch\u00e4fer, A.; Won, J.; Brown, A.J.; Montgomery, S.A.; Hogg, A.; Babusis, D.; Clarke, M.O.; et al. Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV. Nat. Commun. 2020, 11, 222. [CrossRef] [PubMed] 83.",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Mulangu%2C%20S.%20Dodd%2C%20L.E.%20Davey%2C%20R.T.%20Mbaya%2C%20O.T.%20A%20randomized%2C%20controlled%20trial%20of%20Ebola%20virus%20disease%20therapeutics%202019",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Mulangu%2C%20S.%20Dodd%2C%20L.E.%20Davey%2C%20R.T.%20Mbaya%2C%20O.T.%20A%20randomized%2C%20controlled%20trial%20of%20Ebola%20virus%20disease%20therapeutics%202019",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Mulangu%2C%20S.%20Dodd%2C%20L.E.%20Davey%2C%20R.T.%20Mbaya%2C%20O.T.%20A%20randomized%2C%20controlled%20trial%20of%20Ebola%20virus%20disease%20therapeutics%202019"
        },
        {
            "id": "Holshue_et+al_2019_a",
            "alt_id": "74",
            "entry": "Mulangu, S.; Dodd, L.E.; Davey, R.T.; Mbaya, O.T.; Proschan, M.; Mukadi, D.; Manzo, M.L.; Nzolo, D.; Oloma, A.T.; Ibanda, A.; et al. A randomized, controlled trial of Ebola virus disease therapeutics. N. Engl. J. Med. 2019, 381, 2293\u20132303. [CrossRef] [PubMed]",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Holshue%2C%20M.L.%20DeBolt%2C%20C.%20Lindquist%2C%20S.%20Lofy%2C%20K.H.%20Novel%20Coronavirus%20in%20the%20United%20States%202019",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Holshue%2C%20M.L.%20DeBolt%2C%20C.%20Lindquist%2C%20S.%20Lofy%2C%20K.H.%20Novel%20Coronavirus%20in%20the%20United%20States%202019",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Holshue%2C%20M.L.%20DeBolt%2C%20C.%20Lindquist%2C%20S.%20Lofy%2C%20K.H.%20Novel%20Coronavirus%20in%20the%20United%20States%202019"
        },
        {
            "id": "84",
            "alt_id": "Song_et+al_2019_a",
            "entry": "84. Holshue, M.L.; DeBolt, C.; Lindquist, S.; Lofy, K.H.; Wiesman, J.; Bruce, H.; Spitters, C.; Ericson, K.; Wilkerson, S.; Tural, A.; et al. First Case of 2019 Novel Coronavirus in the United States. N. Engl. J. Med. 2020. [CrossRef]",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Song%2C%20G.%20Cheng%2C%20M.Q.%20Wei%2C%20X.W.%20Research%20progress%20on%20novel%20coronavirus%202019"
        },
        {
            "id": "85",
            "alt_id": "85._0000_n",
            "entry": "85. Song, G.; Cheng, M.Q.; Wei, X.W. Research progress on novel coronavirus (2019-nCoV) related drugs in vitro/vivo. Bing Du Xue Bao 2020. [CrossRef]",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Song%20G%20Cheng%20MQ%20Wei%20XW%20Research%20progress%20on%20novel%20coronavirus%202019nCoV%20related%20drugs%20in%20vitrovivo%20Bing%20Du%20Xue%20Bao%202020%20CrossRef"
        },
        {
            "id": "86",
            "alt_id": "Lai_1996_a",
            "entry": "86. China-Japan Friendship Hospital: Clinical Experimental Research Work Is Being Carried Out on Remdesivir. Available online: http://www.chinanews.com/sh/shipin/cns-d/2020/02-12/news847712.shtml (accessed on 12 February 2020).",
            "url": "http://www.chinanews.com/sh/shipin/cns-d/2020/02-12/news847712.shtml",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Lai%2C%20M.M.%20Recombination%20in%20large%20RNA%20viruses%3A%20Coronaviruses.%20Semin%201996",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Lai%2C%20M.M.%20Recombination%20in%20large%20RNA%20viruses%3A%20Coronaviruses.%20Semin%201996"
        },
        {
            "id": "87",
            "alt_id": "Lu_et+al_2019_b",
            "entry": "87. Lai, M.M. Recombination in large RNA viruses: Coronaviruses. Semin. Virol. 1996, 7, 381\u2013388. [CrossRef] 88. Woo, P.C.Y.; Lau, S.K.; Lam, C.S.F.; Lau, C.C.Y.; Tsang, A.K.L.; Lau, J.H.N.; Bai, R.; Teng, J.L.L.; Tsang, C.C.C.; Wang, M.; et al. Discovery of seven novel Mammalian and avian coronaviruses in the genus deltacoronavirus supports bat coronaviruses as the gene source of alphacoronavirus and betacoronavirus and avian coronaviruses as the gene source of gammacoronavirus and deltacoronavirus. J. Virol. 2012, 86, 3995\u20134008.",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Lai%20MM%20Recombination%20in%20large%20RNA%20viruses%20Coronaviruses%20Semin%20Virol%201996%207%20381388%20CrossRef%2088%20Woo%20PCY%20Lau%20SK%20Lam%20CSF%20Lau%20CCY%20Tsang%20AKL%20Lau%20JHN%20Bai%20R%20Teng%20JLL%20Tsang%20CCC%20Wang%20M%20et%20al%20Discovery%20of%20seven%20novel%20Mammalian%20and%20avian%20coronaviruses%20in%20the%20genus%20deltacoronavirus%20supports%20bat%20coronaviruses%20as%20the%20gene%20source%20of%20alphacoronavirus%20and%20betacoronavirus%20and%20avian%20coronaviruses%20as%20the%20gene%20source%20of%20gammacoronavirus%20and%20deltacoronavirus%20J%20Virol%202012%2086%2039954008",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Lai%20MM%20Recombination%20in%20large%20RNA%20viruses%20Coronaviruses%20Semin%20Virol%201996%207%20381388%20CrossRef%2088%20Woo%20PCY%20Lau%20SK%20Lam%20CSF%20Lau%20CCY%20Tsang%20AKL%20Lau%20JHN%20Bai%20R%20Teng%20JLL%20Tsang%20CCC%20Wang%20M%20et%20al%20Discovery%20of%20seven%20novel%20Mammalian%20and%20avian%20coronaviruses%20in%20the%20genus%20deltacoronavirus%20supports%20bat%20coronaviruses%20as%20the%20gene%20source%20of%20alphacoronavirus%20and%20betacoronavirus%20and%20avian%20coronaviruses%20as%20the%20gene%20source%20of%20gammacoronavirus%20and%20deltacoronavirus%20J%20Virol%202012%2086%2039954008",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Lai%20MM%20Recombination%20in%20large%20RNA%20viruses%20Coronaviruses%20Semin%20Virol%201996%207%20381388%20CrossRef%2088%20Woo%20PCY%20Lau%20SK%20Lam%20CSF%20Lau%20CCY%20Tsang%20AKL%20Lau%20JHN%20Bai%20R%20Teng%20JLL%20Tsang%20CCC%20Wang%20M%20et%20al%20Discovery%20of%20seven%20novel%20Mammalian%20and%20avian%20coronaviruses%20in%20the%20genus%20deltacoronavirus%20supports%20bat%20coronaviruses%20as%20the%20gene%20source%20of%20alphacoronavirus%20and%20betacoronavirus%20and%20avian%20coronaviruses%20as%20the%20gene%20source%20of%20gammacoronavirus%20and%20deltacoronavirus%20J%20Virol%202012%2086%2039954008"
        },
        {
            "id": "89",
            "alt_id": "Menachery_et+al_2017_a",
            "entry": "89. Lu, R.; Zhao, X.; Li, J.; Niu, P.; Yang, B.; Wu, H.; Wang, W.; Song, H.; Huang, B.; Zhu, N.; et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: Implications for virus origins and receptor binding. Lancet 2020, 395, 565\u2013574. [CrossRef] 90. Shi, C.S.; Nabar, N.R.; Huang, N.N.; Kehrl, J.H. SARS-Coronavirus Open Reading Frame-8b triggers intracellular stress pathways and activates NLRP3 inflammasomes. Cell Death Discov. 2019, 5, 101. [CrossRef] 91.",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Menachery%2C%20V.D.%20Graham%2C%20R.L.%20Baric%2C%20R.S.%20Jumping%20species%E2%80%94A%20mechanism%20for%20coronavirus%20persistence%20and%20survival%202017",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Menachery%2C%20V.D.%20Graham%2C%20R.L.%20Baric%2C%20R.S.%20Jumping%20species%E2%80%94A%20mechanism%20for%20coronavirus%20persistence%20and%20survival%202017",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Menachery%2C%20V.D.%20Graham%2C%20R.L.%20Baric%2C%20R.S.%20Jumping%20species%E2%80%94A%20mechanism%20for%20coronavirus%20persistence%20and%20survival%202017"
        },
        {
            "id": "Wang_et+al_2018_a",
            "alt_id": "80",
            "entry": "Menachery, V.D.; Graham, R.L.; Baric, R.S. Jumping species\u2014A mechanism for coronavirus persistence and survival. Curr. Opin. Virol. 2017, 23, 1\u20137. [CrossRef] 92.",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Wang%2C%20N.%20Li%2C%20S.-Y.%20Yang%2C%20X.-L.%20Huang%2C%20H.-M.%20Serological%20evidence%20of%20bat%20SARS-related%20coronavirus%20infection%20in%20humans%2C%20China%202018",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Wang%2C%20N.%20Li%2C%20S.-Y.%20Yang%2C%20X.-L.%20Huang%2C%20H.-M.%20Serological%20evidence%20of%20bat%20SARS-related%20coronavirus%20infection%20in%20humans%2C%20China%202018",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Wang%2C%20N.%20Li%2C%20S.-Y.%20Yang%2C%20X.-L.%20Huang%2C%20H.-M.%20Serological%20evidence%20of%20bat%20SARS-related%20coronavirus%20infection%20in%20humans%2C%20China%202018"
        },
        {
            "id": "Xia_et+al_2019_a",
            "alt_id": "81",
            "entry": "Wang, N.; Li, S.-Y.; Yang, X.-L.; Huang, H.-M.; Zhang, Y.-J.; Guo, H.; Luo, C.-M.; Miller, M.; Zhu, G.; Chmura, A.; et al. Serological evidence of bat SARS-related coronavirus infection in humans, China. Virol. Sin. 2018, 33, 104\u2013107. [CrossRef] [PubMed] 93.",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Xia%2C%20S.%20Yan%2C%20L.%20Xu%2C%20W.%20Agrawal%2C%20A.S.%20A%20pan-coronavirus%20fusion%20inhibitor%20targeting%20the%20HR1%20domain%20of%20human%20coronavirus%20spike%202019",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Xia%2C%20S.%20Yan%2C%20L.%20Xu%2C%20W.%20Agrawal%2C%20A.S.%20A%20pan-coronavirus%20fusion%20inhibitor%20targeting%20the%20HR1%20domain%20of%20human%20coronavirus%20spike%202019",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Xia%2C%20S.%20Yan%2C%20L.%20Xu%2C%20W.%20Agrawal%2C%20A.S.%20A%20pan-coronavirus%20fusion%20inhibitor%20targeting%20the%20HR1%20domain%20of%20human%20coronavirus%20spike%202019"
        },
        {
            "id": "Nicholls_et+al_2003_a",
            "alt_id": "82",
            "entry": "Xia, S.; Yan, L.; Xu, W.; Agrawal, A.S.; Algaissi, A.; Tseng, C.-T.K.; Wang, Q.; Du, L.; Tan, W.; Wilson, I.A.; et al. A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike. Sci. Adv. 2019, 5, eaav4580. [CrossRef] [PubMed] 94.",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Nicholls%2C%20J.%20DONG%2C%20X.P.%20Jiang%2C%20G.%20Peiris%2C%20M.%20SARS%3A%20Clinical%20virology%20and%20pathogenesis%202003",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Nicholls%2C%20J.%20DONG%2C%20X.P.%20Jiang%2C%20G.%20Peiris%2C%20M.%20SARS%3A%20Clinical%20virology%20and%20pathogenesis%202003",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Nicholls%2C%20J.%20DONG%2C%20X.P.%20Jiang%2C%20G.%20Peiris%2C%20M.%20SARS%3A%20Clinical%20virology%20and%20pathogenesis%202003"
        },
        {
            "id": "He_et+al_2006_a",
            "alt_id": "83",
            "entry": "Nicholls, J.; DONG, X.P.; Jiang, G.; Peiris, M. SARS: Clinical virology and pathogenesis. Respirology 2003, 8, S6\u2013S8. [CrossRef] [PubMed] 95.",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=He%2C%20L.%20Ding%2C%20Y.%20Zhang%2C%20Q.%20Che%2C%20X.%20Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2%2B%20cells%20in%20SARS%20patients%3A%20Relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS%202006",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=He%2C%20L.%20Ding%2C%20Y.%20Zhang%2C%20Q.%20Che%2C%20X.%20Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2%2B%20cells%20in%20SARS%20patients%3A%20Relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS%202006",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=He%2C%20L.%20Ding%2C%20Y.%20Zhang%2C%20Q.%20Che%2C%20X.%20Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2%2B%20cells%20in%20SARS%20patients%3A%20Relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS%202006"
        },
        {
            "id": "Hamming_et+al_2004_a",
            "alt_id": "84",
            "entry": "He, L.; Ding, Y.; Zhang, Q.; Che, X.; He, Y.; Shen, H.; Wang, H.; Li, Z.; Zhao, L.; Geng, J.; et al. Expression of elevated levels of pro-inflammatory cytokines in SARS-CoV-infected ACE2+ cells in SARS patients: Relation to the acute lung injury and pathogenesis of SARS. J. Pathol. 2006, 210, 288\u2013297. [CrossRef] [PubMed] 96.",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Hamming%2C%20I.%20Timens%2C%20W.%20Bulthuis%2C%20M.L.C.%20Lely%2C%20A.T.%20Tissue%20distribution%20of%20ACE2%20protein%2C%20the%20functional%20receptor%20for%20SARS%20coronavirus.%20A%20first%20step%20in%20understanding%20SARS%20pathogenesis%202004",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Hamming%2C%20I.%20Timens%2C%20W.%20Bulthuis%2C%20M.L.C.%20Lely%2C%20A.T.%20Tissue%20distribution%20of%20ACE2%20protein%2C%20the%20functional%20receptor%20for%20SARS%20coronavirus.%20A%20first%20step%20in%20understanding%20SARS%20pathogenesis%202004",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Hamming%2C%20I.%20Timens%2C%20W.%20Bulthuis%2C%20M.L.C.%20Lely%2C%20A.T.%20Tissue%20distribution%20of%20ACE2%20protein%2C%20the%20functional%20receptor%20for%20SARS%20coronavirus.%20A%20first%20step%20in%20understanding%20SARS%20pathogenesis%202004"
        },
        {
            "id": "Perlman_2009_a",
            "alt_id": "85",
            "entry": "Hamming, I.; Timens, W.; Bulthuis, M.L.C.; Lely, A.T.; Navis, G.J.; van Goor, H. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J. Pathol. 2004, 203, 631\u2013637. [CrossRef] [PubMed] 97.",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Perlman%2C%20S.%20Netland%2C%20J.%20Coronaviruses%20post-SARS%3A%20Update%20on%20replication%20and%20pathogenesis%202009",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Perlman%2C%20S.%20Netland%2C%20J.%20Coronaviruses%20post-SARS%3A%20Update%20on%20replication%20and%20pathogenesis%202009",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Perlman%2C%20S.%20Netland%2C%20J.%20Coronaviruses%20post-SARS%3A%20Update%20on%20replication%20and%20pathogenesis%202009"
        },
        {
            "id": "Ding_et+al_2003_a",
            "alt_id": "86",
            "entry": "Perlman, S.; Netland, J. Coronaviruses post-SARS: Update on replication and pathogenesis. Nat. Rev. Microbiol. 2009, 7, 439\u2013450. [CrossRef] 98.",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Ding%2C%20Y.%20Wang%2C%20H.%20Shen%2C%20H.%20Li%2C%20Z.%20The%20clinical%20pathology%20of%20severe%20acute%20respiratory%20syndrome%20%28SARS%29%3A%20A%20report%20from%20China%202003",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Ding%2C%20Y.%20Wang%2C%20H.%20Shen%2C%20H.%20Li%2C%20Z.%20The%20clinical%20pathology%20of%20severe%20acute%20respiratory%20syndrome%20%28SARS%29%3A%20A%20report%20from%20China%202003",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Ding%2C%20Y.%20Wang%2C%20H.%20Shen%2C%20H.%20Li%2C%20Z.%20The%20clinical%20pathology%20of%20severe%20acute%20respiratory%20syndrome%20%28SARS%29%3A%20A%20report%20from%20China%202003"
        },
        {
            "id": "Ding_et+al_2004_a",
            "alt_id": "87",
            "entry": "Ding, Y.; Wang, H.; Shen, H.; Li, Z.; Geng, J.; Han, H.; Cai, J.; Li, X.; Kang, W.; Weng, D.; et al. The clinical pathology of severe acute respiratory syndrome (SARS): A report from China. J. Pathol. 2003, 200, 282\u2013289. [CrossRef] 99.",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Ding%2C%20Y.%20He%2C%20L.%20Zhang%2C%20Q.%20Huang%2C%20Z.%20Organ%20distribution%20of%20severe%20acute%20respiratory%20syndrome%20%28SARS%29%20associated%20coronavirus%20%28SARS-CoV%29%20in%20SARS%20patients%3A%20Implications%20for%20pathogenesis%20and%20virus%20transmission%20pathways%202004",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Ding%2C%20Y.%20He%2C%20L.%20Zhang%2C%20Q.%20Huang%2C%20Z.%20Organ%20distribution%20of%20severe%20acute%20respiratory%20syndrome%20%28SARS%29%20associated%20coronavirus%20%28SARS-CoV%29%20in%20SARS%20patients%3A%20Implications%20for%20pathogenesis%20and%20virus%20transmission%20pathways%202004",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Ding%2C%20Y.%20He%2C%20L.%20Zhang%2C%20Q.%20Huang%2C%20Z.%20Organ%20distribution%20of%20severe%20acute%20respiratory%20syndrome%20%28SARS%29%20associated%20coronavirus%20%28SARS-CoV%29%20in%20SARS%20patients%3A%20Implications%20for%20pathogenesis%20and%20virus%20transmission%20pathways%202004"
        },
        {
            "id": "Millet_2015_a",
            "alt_id": "88",
            "entry": "Ding, Y.; He, L.; Zhang, Q.; Huang, Z.; Che, X.-Y.; Hou, J.-L.; Wang, H.; Shen, H.; Qiu, L.; Li, Z.; et al. Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: Implications for pathogenesis and virus transmission pathways. J. Pathol. 2004, 203, 622\u2013630. [CrossRef] 100. HUI, D.S.C.; WONG, P.C.; Wang, C. SARS: Clinical features and diagnosis. Respirology 2003, 8, S20\u2013S24. [CrossRef] 101.",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Millet%2C%20J.K.%20Whittaker%2C%20G.R.%20Host%20cell%20proteases%3A%20Critical%20determinants%20of%20coronavirus%20tropism%20and%20pathogenesis%202015",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Millet%2C%20J.K.%20Whittaker%2C%20G.R.%20Host%20cell%20proteases%3A%20Critical%20determinants%20of%20coronavirus%20tropism%20and%20pathogenesis%202015",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Millet%2C%20J.K.%20Whittaker%2C%20G.R.%20Host%20cell%20proteases%3A%20Critical%20determinants%20of%20coronavirus%20tropism%20and%20pathogenesis%202015"
        },
        {
            "id": "Zhou_et+al_2020_a",
            "alt_id": "89",
            "entry": "Millet, J.K.; Whittaker, G.R. Host cell proteases: Critical determinants of coronavirus tropism and pathogenesis. Virus. Res. 2015, 202, 120\u2013134. [CrossRef] 102.",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Zhou%2C%20P.%20Yang%2C%20X.-L.%20Wang%2C%20X.-G.%20Hu%2C%20B.%20A%20pneumonia%20outbreak%20associated%20with%20a%20new%20coronavirus%20of%20probable%20bat%20origin%202020",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Zhou%2C%20P.%20Yang%2C%20X.-L.%20Wang%2C%20X.-G.%20Hu%2C%20B.%20A%20pneumonia%20outbreak%20associated%20with%20a%20new%20coronavirus%20of%20probable%20bat%20origin%202020",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Zhou%2C%20P.%20Yang%2C%20X.-L.%20Wang%2C%20X.-G.%20Hu%2C%20B.%20A%20pneumonia%20outbreak%20associated%20with%20a%20new%20coronavirus%20of%20probable%20bat%20origin%202020"
        },
        {
            "id": "Kuba_et+al_2005_a",
            "alt_id": "90",
            "entry": "Zhou, P.; Yang, X.-L.; Wang, X.-G.; Hu, B.; Zhang, L.; Zhang, W.; Si, H.-R.; Zhu, Y.; Li, B.; Huang, C.-L.; et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 2020. [CrossRef] [PubMed] 103.",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Kuba%2C%20K.%20Imai%2C%20Y.%20Rao%2C%20S.%20Gao%2C%20H.%20A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20%28ACE2%29%20in%20SARS%20coronavirus%E2%80%93induced%20lung%20injury%202005",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Kuba%2C%20K.%20Imai%2C%20Y.%20Rao%2C%20S.%20Gao%2C%20H.%20A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20%28ACE2%29%20in%20SARS%20coronavirus%E2%80%93induced%20lung%20injury%202005",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Kuba%2C%20K.%20Imai%2C%20Y.%20Rao%2C%20S.%20Gao%2C%20H.%20A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20%28ACE2%29%20in%20SARS%20coronavirus%E2%80%93induced%20lung%20injury%202005"
        },
        {
            "id": "Imai_et+al_2005_a",
            "alt_id": "91",
            "entry": "Kuba, K.; Imai, Y.; Rao, S.; Gao, H.; Guo, F.; Guan, B.; Huan, Y.; Yang, P.; Zhang, Y.; Deng, W.; et al. A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus\u2013induced lung injury. Nat. Med. 2005, 11, 875\u2013879. [CrossRef] [PubMed]",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Imai%2C%20Y.%20Kuba%2C%20K.%20Rao%2C%20S.%20Huan%2C%20Y.%20Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure%202005",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Imai%2C%20Y.%20Kuba%2C%20K.%20Rao%2C%20S.%20Huan%2C%20Y.%20Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure%202005",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Imai%2C%20Y.%20Kuba%2C%20K.%20Rao%2C%20S.%20Huan%2C%20Y.%20Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure%202005"
        },
        {
            "id": "104",
            "alt_id": "Li_et+al_2003_a",
            "entry": "104. Imai, Y.; Kuba, K.; Rao, S.; Huan, Y.; Guo, F.; Guan, B.; Yang, P.; Sarao, R.; Wada, T.; Leong-Poi, H.; et al. Angiotensin-converting enzyme 2 protects from severe acute lung failure. Nature 2005, 436, 112\u2013116. [CrossRef] [PubMed]",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Li%2C%20W.%20Moore%2C%20M.J.%20Vasilieva%2C%20N.%20Sui%2C%20J.%20Angiotensin-converting%20enzyme%202%20is%20a%20functional%20receptor%20for%20the%20SARS%20coronavirus%202003",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Li%2C%20W.%20Moore%2C%20M.J.%20Vasilieva%2C%20N.%20Sui%2C%20J.%20Angiotensin-converting%20enzyme%202%20is%20a%20functional%20receptor%20for%20the%20SARS%20coronavirus%202003",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Li%2C%20W.%20Moore%2C%20M.J.%20Vasilieva%2C%20N.%20Sui%2C%20J.%20Angiotensin-converting%20enzyme%202%20is%20a%20functional%20receptor%20for%20the%20SARS%20coronavirus%202003"
        },
        {
            "id": "105",
            "alt_id": "Wan_et+al_2020_a",
            "entry": "105. Li, W.; Moore, M.J.; Vasilieva, N.; Sui, J.; Wong, S.K.; Berne, M.A.; Somasundaran, M.; Sullivan, J.L.; Luzuriaga, K.; Greenough, T.C.; et al. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 2003, 426, 450\u2013454. [CrossRef]",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Wan%2C%20Y.%20Shang%2C%20J.%20Graham%2C%20R.%20Baric%2C%20R.S.%20Receptor%20recognition%20by%20novel%20coronavirus%20from%20Wuhan%3A%20An%20analysis%20based%20on%20decade-long%20structural%20studies%20of%20SARS%202020",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Wan%2C%20Y.%20Shang%2C%20J.%20Graham%2C%20R.%20Baric%2C%20R.S.%20Receptor%20recognition%20by%20novel%20coronavirus%20from%20Wuhan%3A%20An%20analysis%20based%20on%20decade-long%20structural%20studies%20of%20SARS%202020",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Wan%2C%20Y.%20Shang%2C%20J.%20Graham%2C%20R.%20Baric%2C%20R.S.%20Receptor%20recognition%20by%20novel%20coronavirus%20from%20Wuhan%3A%20An%20analysis%20based%20on%20decade-long%20structural%20studies%20of%20SARS%202020"
        },
        {
            "id": "106",
            "alt_id": "Bassetti_et+al_2019_a",
            "entry": "106. Wan, Y.; Shang, J.; Graham, R.; Baric, R.S.; Li, F. Receptor recognition by novel coronavirus from Wuhan: An analysis based on decade-long structural studies of SARS. J. Virol. 2020. [CrossRef]",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Bassetti%2C%20M.%20Vena%2C%20A.%20Roberto%20Giacobbe%2C%20D.%20The%20Novel%20Chinese%20Coronavirus%202019",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Bassetti%2C%20M.%20Vena%2C%20A.%20Roberto%20Giacobbe%2C%20D.%20The%20Novel%20Chinese%20Coronavirus%202019",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Bassetti%2C%20M.%20Vena%2C%20A.%20Roberto%20Giacobbe%2C%20D.%20The%20Novel%20Chinese%20Coronavirus%202019"
        },
        {
            "id": "107",
            "alt_id": "Su_et+al_2016_a",
            "entry": "107. Bassetti, M.; Vena, A.; Roberto Giacobbe, D. The Novel Chinese Coronavirus (2019-nCoV) Infections: Challenges for fighting the storm. Eur. J. Clin. Investig. 2020. [CrossRef]",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Su%2C%20S.%20Wong%2C%20G.%20Shi%2C%20W.%20Liu%2C%20J.%20Epidemiology%2C%20genetic%20recombination%2C%20and%20pathogenesis%20of%20coronaviruses%202016",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Su%2C%20S.%20Wong%2C%20G.%20Shi%2C%20W.%20Liu%2C%20J.%20Epidemiology%2C%20genetic%20recombination%2C%20and%20pathogenesis%20of%20coronaviruses%202016",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Su%2C%20S.%20Wong%2C%20G.%20Shi%2C%20W.%20Liu%2C%20J.%20Epidemiology%2C%20genetic%20recombination%2C%20and%20pathogenesis%20of%20coronaviruses%202016"
        },
        {
            "id": "108",
            "alt_id": "Chu_et+al_2014_a",
            "entry": "108. Su, S.; Wong, G.; Shi, W.; Liu, J.; Lai, A.C.; Zhou, J.; Liu, W.; Bi, Y.; Gao, G.F. Epidemiology, genetic recombination, and pathogenesis of coronaviruses. Trends. Microbiol. 2016, 24, 490\u2013502. [CrossRef]",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Chu%2C%20D.K.W.%20Poon%2C%20L.%20Gomaa%2C%20M.%20Shehata%2C%20M.%20MERS%20coronaviruses%20in%20dromedary%20camels%2C%20Egypt%202014"
        }
    ],
    "facts": [
        "human coronaviruses have been reported as pathogens",
        "emerged HCoV isolated from the respiratory epithelium of unexplained pneumonia patients",
        "clinical features between these two viruses and diseases that are caused by these viruses",
        "Coronaviruses are a group of viruses that co-infect humans",
        "both coronaviruses that transmitted from animals to humans",
        "The source of unexplained pneumonia was first discovered in Wuhan in Dec",
        "The disease caused by SARS-CoV-2 was called",
        "The complete genomic sequences of SARS-CoV-2 were obtained from 2019 Novel Coronavirus Resource",
        "The DNA sequences of two other representative CoVs were included for comparative analysis",
        "The genomic information of latest SARS-CoV-2 strains is shown in Table S1",
        "Proteins from SARS and SARS-CoV-2 were treated as homologous: identity value \u2265 65%",
        "SARS were summarized in Table 1",
        "the prognosis of patients solely depends on their age",
        "the majority of the patients are still not cured in hospital",
        "all encoded proteins of SARS-CoV-2 are homologous to SARS-CoV proteins",
        "some key questions to be clarified in future studies"
    ],
    "claims": [
        "This paper summarized the similarities and differences between SARS-CoV-2 and SARS-CoV, both of which cause major disease outbreaks in China and worldwide, which will provide comprehensive reference for epidemic prevention",
        "Our results also showed that almost all encoded proteins of SARS-CoV-2 are homologous to SARS-CoV proteins (Table 2)",
        "Although more and more studies for SARS-CoV-2 have sprung up since the outbreak of this epidemic COVID-19, based on our comparison, we propose some key questions to be clarified in future studies (Table 3)"
    ],
    "findings": [
        "The genome of SARS-CoV-2 is more than 85% similar to the genome of the SARS-like virus ZC45 (bat-SL-CoVZC45, MG772933.1), and together these types of viruses form a unique Orthocoronavirinae subfamily with another SARS-like virus ZXC21 in the sarbecovirus subgenus [<a class=\"ref-link\" id=\"c35\" href=\"#r35\">35</a>]"
    ],
    "processes": [],
    "key_statements": [
        "Severe acute respiratory syndrome (SARS) in 2002 and the Middle East respiratory syndrome (MERS) in 2012 were both coronaviruses that transmitted from animals to humans [<a class=\"ref-link\" id=\"c4\" href=\"#r4\">4</a>,<a class=\"ref-link\" id=\"c5\" href=\"#r5\">5</a>]",
        "The source of unexplained pneumonia was first discovered in Wuhan in Dec, 2019, and severe acute respiratory syndrome-CoV-2, a new coronavirus, was isolated from the respiratory epithelium of patients",
        "The complete genomic sequences of severe acute respiratory syndrome-CoV-2 were obtained from 2019 Novel Coronavirus Resource (2019nCoVR) [<a class=\"ref-link\" id=\"c12\" href=\"#r12\">12</a>] and two databases, including the National Center for Biotechnology Information (NCBI) [<a class=\"ref-link\" id=\"c13\" href=\"#r13\">13</a>] and Global Initiative on Sharing All Influenza Data (GISAID) [<a class=\"ref-link\" id=\"c14\" href=\"#r14\">14</a>]",
        "The differences and similarities of clinical characteristics between COVID-19 and severe acute respiratory syndrome were summarized in Table 1",
        "Our results showed that almost all encoded proteins of severe acute respiratory syndrome-CoV-2 are homologous to severe acute respiratory syndrome-CoV proteins (Table 2)",
        "More and more studies for severe acute respiratory syndrome-CoV-2 have sprung up since the outbreak of this epidemic COVID-19, based on our comparison, we propose some key questions to be clarified in future studies (Table 3)"
    ],
    "top_statements": [
        "Coronaviruses (CoVs) are a group of viruses that co-infect humans and other vertebrate animals",
        "Severe acute respiratory syndrome (SARS) in 2002 and the Middle East respiratory syndrome (MERS) in 2012 were both coronaviruses that transmitted from animals to humans [<a class=\"ref-link\" id=\"c4\" href=\"#r4\">4</a>,<a class=\"ref-link\" id=\"c5\" href=\"#r5\">5</a>]",
        "The source of unexplained pneumonia was first discovered in Wuhan in Dec, 2019, and severe acute respiratory syndrome-CoV-2, a new coronavirus, was isolated from the respiratory epithelium of patients",
        "The complete genomic sequences of severe acute respiratory syndrome-CoV-2 were obtained from 2019 Novel Coronavirus Resource (2019nCoVR) [<a class=\"ref-link\" id=\"c12\" href=\"#r12\">12</a>] and two databases, including the National Center for Biotechnology Information (NCBI) [<a class=\"ref-link\" id=\"c13\" href=\"#r13\">13</a>] and Global Initiative on Sharing All Influenza Data (GISAID) [<a class=\"ref-link\" id=\"c14\" href=\"#r14\">14</a>]",
        "The differences and similarities of clinical characteristics between COVID-19 and severe acute respiratory syndrome were summarized in Table 1",
        "More and more studies for severe acute respiratory syndrome-CoV-2 have sprung up since the outbreak of this epidemic COVID-19, based on our comparison, we propose some key questions to be clarified in future studies (Table 3)"
    ],
    "headline": "The complete genomic sequences of severe acute respiratory syndrome-CoV-2 were obtained from 2019 Novel Coronavirus Resource  and two databases, including the National Center for Biotechnology Information  and Global Initiative on Sharing All Influenza Data",
    "contexts": [],
    "abbreviations": {
        "SARS": "severe acute respiratory syndrome",
        "HCoVs": "human coronaviruses",
        "MERS": "Middle East respiratory syndrome",
        "NCBI": "National Center for Biotechnology Information",
        "GISAID": "Global Initiative on Sharing All Influenza Data",
        "LDH": "lactic dehydrogenase",
        "CRP": "C-reactive protein",
        "AST": "aspartate transaminase",
        "cCoTm": "chest compfouutnedd toonmtohgeracphhesyt",
        "rRT-PCR": "reverse transcription PCR",
        "ARDS": "acute respiratory distress syndrome",
        "RD": "regions of difference",
        "NLRP3": "NOD-like receptor family pyrin domain-containing-3",
        "ACE2": "angiotensin-converting enzyme 2",
        "RBM": "receptor-binding motif"
    }
}
